Ligand source activities (1 row/activity)





Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Potency)
# tested GPCRs
(Potency)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
11272103 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL363840 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
11272103 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL363840 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
11272103 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nMAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nM
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL363840 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nMAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil at 30 nM
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
11272103 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL363840 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11272103 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None -37 8 Human 11.0 pIC50 = 11 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44455820 94985 0 None - 1 Human 11.0 pIC50 = 11.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257074 94985 0 None - 1 Human 11.0 pIC50 = 11.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
10458976 94556 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254930 94556 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44455711 168157 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL437031 168157 0 None - 1 Human 10.9 pIC50 = 10.9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11340670 126699 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
CHEMBL365820 126699 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
11328714 78573 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113074 78573 0 None - 1 Human 10.8 pIC50 = 10.8 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44455686 95035 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257293 95035 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455869 97083 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270582 97083 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455509 165862 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL427728 165862 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455485 154948 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404122 154948 0 None - 1 Human 10.7 pIC50 = 10.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11329244 70757 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL195433 70757 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11329244 70757 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70757 10 None 20 7 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11227406 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
11227406 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
CHEMBL250689 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of chemotaxis by cell based assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
11227406 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL250689 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11227406 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93896 1 None 107 4 Human 10.5 pIC50 = 10.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10050884 154103 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
CHEMBL399495 154103 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
11227406 93896 1 None 107 4 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophilsInhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93896 1 None 107 4 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophilsInhibition of eotaxin-induced chemotaxis of Cynomolgus monkey eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10050884 154103 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154103 10 None -1 3 Human 10.4 pIC50 = 10.4 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
11169258 140353 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
CHEMBL382108 140353 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
11488078 78576 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113077 78576 0 None - 1 Human 10.4 pIC50 = 10.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44455683 154537 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL401879 154537 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455745 154750 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL402983 154750 0 None - 1 Human 10.3 pIC50 = 10.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455793 94770 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL256068 94770 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
11397114 132935 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706810 132935 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44455766 95228 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258156 95228 0 None - 1 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11953409 93768 0 None 7 4 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93768 0 None 7 4 Human 10.2 pIC50 = 10.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445847 93975 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251079 93975 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11214474 70994 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195790 70994 0 None - 1 Human 10.1 pIC50 = 10.1 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44445845 93794 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250056 93794 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455845 96997 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270146 96997 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
44455846 96998 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270147 96998 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455458 166886 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429846 166886 0 None - 1 Human 10.0 pIC50 = 10 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
11454941 70783 0 None - 1 Human 10.0 pIC50 = 10 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL195555 70783 0 None - 1 Human 10.0 pIC50 = 10 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10050884 154103 10 None 1 3 Crab-eating macaque 9.8 pIC50 = 9.8 Functional
Antagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154103 10 None 1 3 Crab-eating macaque 9.8 pIC50 = 9.8 Functional
Antagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in cynomolgus monkey eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44455459 94635 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL255398 94635 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
10140602 166054 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428071 166054 0 None - 1 Human 9.7 pIC50 = 9.7 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11398022 98165 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL277131 98165 0 None - 1 Human 9.6 pIC50 = 9.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
44455484 166841 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429604 166841 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455483 97367 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL272068 97367 0 None - 1 Human 9.5 pIC50 = 9.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
11385766 132262 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL370082 132262 0 None - 1 Human 9.4 pIC50 = 9.4 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11236950 94313 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253210 94313 0 None - 1 Human 9.2 pIC50 = 9.2 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
71460523 81068 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISAAntagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISA
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160099 81068 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISAAntagonist activity at CCR3 receptor in human eosinophils assessed as inhibition of CCL11-induced degranulation after 4 hrs by ELISA
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44455817 154627 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL402331 154627 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
10050884 154103 10 None -1 3 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium fluxAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium flux
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154103 10 None -1 3 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium fluxAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-stimulated intracellular calcium flux
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44445854 93636 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249057 93636 0 None - 1 Human 9.1 pIC50 = 9.1 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in human eosinophils
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
45267588 194350 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 5 2 4 4.5 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
CHEMBL560275 194350 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 5 2 4 4.5 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
44512617 193658 0 None 79 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysisAntagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysis
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551735 193658 0 None 79 2 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysisAntagonist activity at human CCR3 expressed in mouse B300-19 cells by functional inhibition curve analysis
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44455658 166709 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429323 166709 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
44289715 169657 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL444568 169657 0 None - 1 Human 9.0 pIC50 = 9 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11272103 123843 0 None -37 8 Human 9.0 pIC50 = 9 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None -37 8 Human 9.0 pIC50 = 9 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11363006 70077 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL194601 70077 0 None - 1 Human 9.0 pIC50 = 9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
44455539 166418 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428775 166418 0 None - 1 Human 9.0 pIC50 = 9.0 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
45271892 193660 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 515 5 1 5 4.3 O=C(C=C1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551739 193660 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 515 5 1 5 4.3 O=C(C=C1CCN(C(=O)c2ccc3c(c2)OCO3)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
71460523 81068 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160099 81068 0 None - 1 Human 8.8 pIC50 = 8.8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccccc1OCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
45271891 193659 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1 10.1016/j.bmc.2009.06.066
CHEMBL551738 193659 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1 10.1016/j.bmc.2009.06.066
11363005 60167 0 None - 1 Human 8.0 pIC50 = 8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL175634 60167 0 None - 1 Human 8.0 pIC50 = 8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11329244 70757 10 None -20 7 Mouse 8.0 pIC50 = 8 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70757 10 None -20 7 Mouse 8.0 pIC50 = 8 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
45269392 194342 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 374 5 1 2 4.4 O=C(/C=C/c1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL560198 194342 0 None - 1 Human 7.0 pIC50 = 7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 374 5 1 2 4.4 O=C(/C=C/c1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
71449694 81072 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 3.9 O=C(Nc1ccccc1COCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160102 81072 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 3.9 O=C(Nc1ccccc1COCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70694703 75779 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1cccc(Br)c1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057764 75779 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1cccc(Br)c1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
44451981 160712 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(Oc2ccccc2)c1 10.1016/j.bmc.2007.10.003
CHEMBL412061 160712 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(Oc2ccccc2)c1 10.1016/j.bmc.2007.10.003
44282031 119297 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 488 8 2 5 3.2 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N1CCCC1 10.1016/s0960-894x(01)00249-9
CHEMBL34839 119297 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 488 8 2 5 3.2 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N1CCCC1 10.1016/s0960-894x(01)00249-9
11363005 60167 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL175634 60167 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44281673 109854 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 572 10 3 5 5.6 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@H](C(=O)Nc1ccccc1)c1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32410 109854 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 572 10 3 5 5.6 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)N[C@H](C(=O)Nc1ccccc1)c1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
76331527 102875 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 486 6 1 3 6.6 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1OC1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084575 102875 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 486 6 1 3 6.6 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1OC1CCCCC1 10.1016/j.bmc.2008.08.006
71458677 81044 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccc(OCCO)cc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159868 81044 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1ccc(OCCO)cc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
76316939 102879 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 513 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084579 102879 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 513 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCCC1 10.1016/j.bmc.2008.08.006
45270978 194829 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2cccc(F)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL563536 194829 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2cccc(F)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44282048 111133 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccccc1NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(C#N)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32852 111133 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccccc1NC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc(C#N)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44282385 99608 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 562 7 1 6 6.1 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nc(C(=O)N2CCc3ccccc3C2)cs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL287320 99608 0 None - 1 Human 4.9 pIC50 = 4.9 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 562 7 1 6 6.1 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nc(C(=O)N2CCc3ccccc3C2)cs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
76327878 102871 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccncc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084571 102871 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccncc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
70686358 75778 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccccc1Br)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057763 75778 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccccc1Br)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
70682102 75781 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 518 5 2 3 5.4 O=C(Nc1ccccc1F)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057766 75781 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 518 5 2 3 5.4 O=C(Nc1ccccc1F)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
2729098 80069 2 None -11 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.4 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL214726 80069 2 None -11 2 Human 5.9 pIC50 = 5.9 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.4 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
76309741 102880 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ncccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084580 102880 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ncccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
44399469 165562 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assayInhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assay
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL426089 165562 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Inhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assayInhibitory concentration against BaF3 cell line expressed recombinant human CCR3 using the LDH assay
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
71449677 81039 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 448 5 2 4 2.3 CS(=O)(=O)N1CCC(NC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmcl.2012.09.035
CHEMBL2159863 81039 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 448 5 2 4 2.3 CS(=O)(=O)N1CCC(NC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmcl.2012.09.035
45271843 194686 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(O)c(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
CHEMBL562574 194686 0 None - 1 Human 7.9 pIC50 = 7.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(O)c(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
45267629 194666 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL562475 194666 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
23509697 193271 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54273 193271 0 None - 1 Human 6.9 pIC50 = 6.9 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44282006 123117 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 525 10 3 5 4.3 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccccc2OC)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL36195 123117 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 525 10 3 5 4.3 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccccc2OC)cc1 10.1016/s0960-894x(01)00249-9
44440402 93471 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of calcium fluxAntagonist activity at human CCR3 receptor assessed as inhibition of calcium flux
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248179 93471 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of calcium fluxAntagonist activity at human CCR3 receptor assessed as inhibition of calcium flux
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440402 93471 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape changeAntagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape change
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248179 93471 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape changeAntagonist activity at human CCR3 receptor assessed as inhibition of eotaxin-induced eosinophil shape change
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
45270977 193471 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 4 1 3 3.2 CC(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL550255 193471 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 4 1 3 3.2 CC(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
70682100 75772 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 4 1 3 5.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057757 75772 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 4 1 3 5.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
11430170 123302 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL362466 123302 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
45271911 193377 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 362 5 1 2 3.9 O=C(Cc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL549514 193377 0 None - 1 Human 6.8 pIC50 = 6.8 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 362 5 1 2 3.9 O=C(Cc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44452250 95774 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.8 O=C(Nc1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL260900 95774 0 None - 1 Human 5.8 pIC50 = 5.8 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 362 4 1 2 4.8 O=C(Nc1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44281793 99639 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 414 7 1 5 4.7 CCn1ccnc1[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL287538 99639 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 414 7 1 5 4.7 CCn1ccnc1[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
70688459 75771 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 5 1 3 6.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(Cc2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057756 75771 0 None - 1 Human 7.8 pIC50 = 7.8 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 568 5 1 3 6.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(Cc2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
44281891 125174 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 474 8 2 6 4.7 CCNC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL36473 125174 0 None - 1 Human 4.8 pIC50 = 4.8 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 474 8 2 6 4.7 CCNC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
44281612 109124 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 510 9 3 5 4.2 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL32224 109124 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 510 9 3 5 4.2 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
10194663 81074 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1cccc(OCCO)c1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160104 81074 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 423 7 3 4 3.7 O=C(Nc1cccc(OCCO)c1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70692659 75717 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 499 7 1 3 5.5 O=C(NCCCN1CCC(C(c2ccccc2)c2ccccc2)CC1)N1CCc2cc(F)ccc2C1=O 10.1016/j.bmcl.2012.06.042
CHEMBL2057490 75717 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 499 7 1 3 5.5 O=C(NCCCN1CCC(C(c2ccccc2)c2ccccc2)CC1)N1CCc2cc(F)ccc2C1=O 10.1016/j.bmcl.2012.06.042
11409583 69424 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
CHEMBL193575 69424 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
11454941 70783 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL195555 70783 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11328714 78573 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113074 78573 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11488078 78576 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113077 78576 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11169258 140353 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
CHEMBL382108 140353 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
44401328 70737 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195348 70737 0 None - 1 Human 8.7 pIC50 = 8.7 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
71460525 81081 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 526 6 3 5 3.4 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160111 81081 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 526 6 3 5 3.4 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44290039 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL46905 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11953409 93768 0 None 7 4 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93768 0 None 7 4 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44447144 168196 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL437396 168196 0 None - 1 Human 8.6 pIC50 = 8.6 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10474776 113145 36 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 1 Human 7.7 pIC50 = 7.7 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
44281975 99155 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 491 8 2 6 3.9 C[C@@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OC(C)(C)C 10.1016/s0960-894x(01)00249-9
CHEMBL284166 99155 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 491 8 2 6 3.9 C[C@@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OC(C)(C)C 10.1016/s0960-894x(01)00249-9
44452168 95394 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL258996 95394 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
24882359 192435 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
CHEMBL522295 192435 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
70696744 75718 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2012.06.042
CHEMBL2057491 75718 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmcl.2012.06.042
24882359 192435 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL522295 192435 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
3492 684 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9868459 684 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
CHEMBL50593 684 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
11272103 123843 0 None -1995 8 Mouse 7.7 pIC50 = 7.7 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None -1995 8 Mouse 7.7 pIC50 = 7.7 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
22393339 186144 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL48873 186144 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
23509693 190887 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51937 190887 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
71462227 81078 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 466 4 0 3 6.6 O=C1OC2(CCN(Cc3ccc4cc(F)ccc4c3)CC2)c2ccccc2N1Cc1ccccc1 10.1016/j.bmcl.2012.09.035
CHEMBL2160108 81078 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 466 4 0 3 6.6 O=C1OC2(CCN(Cc3ccc4cc(F)ccc4c3)CC2)c2ccccc2N1Cc1ccccc1 10.1016/j.bmcl.2012.09.035
45270135 193587 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 441 5 2 4 3.6 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL551205 193587 0 None - 1 Human 5.7 pIC50 = 5.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 441 5 2 4 3.6 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
45268444 194334 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 458 6 1 3 5.6 O=C(C=C1CCC(Oc2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL560135 194334 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 458 6 1 3 5.6 O=C(C=C1CCC(Oc2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44282030 111129 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 8 1 7 3.5 CCOC(=O)C1COC([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)=N1 10.1016/s0960-894x(01)00249-9
CHEMBL32850 111129 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 8 1 7 3.5 CCOC(=O)C1COC([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)=N1 10.1016/s0960-894x(01)00249-9
76320670 102874 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 454 5 1 4 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1ccnc1 10.1016/j.bmc.2008.08.006
CHEMBL3084574 102874 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 454 5 1 4 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1ccnc1 10.1016/j.bmc.2008.08.006
45270980 193496 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccc(F)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL550464 193496 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccc(F)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44447361 94499 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254503 94499 0 None - 1 Human 7.7 pIC50 = 7.7 Functional
Antagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophilAntagonist activity at human CCR3 receptor assessed as inhibition of chemotaxis in eosinophil
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
23509695 189137 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51584 189137 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
76331526 102866 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 453 5 1 3 5.7 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1cccc1 10.1016/j.bmc.2008.08.006
CHEMBL3084566 102866 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 453 5 1 3 5.7 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-n1cccc1 10.1016/j.bmc.2008.08.006
76327880 102878 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 485 5 1 3 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084578 102878 0 None - 1 Human 6.7 pIC50 = 6.7 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 485 5 1 3 5.1 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCC1 10.1016/j.bmc.2008.08.006
44281943 99756 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 387 6 1 5 4.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1cnco1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL288554 99756 0 None - 1 Human 4.7 pIC50 = 4.7 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 387 6 1 5 4.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1cnco1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
71453334 81066 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 2 3 4.5 COCc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160097 81066 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 2 3 4.5 COCc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
76316938 102867 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 499 5 1 3 5.5 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084567 102867 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 499 5 1 3 5.5 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
44512619 102881 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 516 5 1 4 4.2 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084581 102881 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 516 5 1 4 4.2 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
45270199 194734 0 None 47 2 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
CHEMBL562897 194734 0 None 47 2 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
44401561 123589 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL363373 123589 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
45271882 193579 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 366 4 1 2 4.1 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
CHEMBL551134 193579 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 366 4 1 2 4.1 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
71455029 81045 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 464 7 2 4 3.8 CN(C)C(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159869 81045 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 464 7 2 4 3.8 CN(C)C(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70696753 75777 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 500 5 2 3 5.3 O=C(Nc1ccccc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057762 75777 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 500 5 2 3 5.3 O=C(Nc1ccccc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
44452009 95488 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmc.2007.10.003
CHEMBL259409 95488 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmc.2007.10.003
10474776 113145 36 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 1 Human 7.6 pIC50 = 7.6 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
71453337 81080 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 540 5 2 5 3.8 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
CHEMBL2160110 81080 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 540 5 2 5 3.8 O=C(NC1CCN(S(=O)(=O)c2ccccc2O)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
44290039 178214 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46905 178214 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
44282005 123223 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccc(C#N)cc2)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL36223 123223 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(C[C@H](NC(=O)c2cccc3ccccc23)C(=O)N[C@@H](C)C(=O)Nc2ccc(C#N)cc2)cc1 10.1016/s0960-894x(01)00249-9
45269291 194756 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 427 5 2 4 3.2 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL563019 194756 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 427 5 2 4 3.2 O=C(N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)NS(=O)(=O)c1ccccc1 10.1016/j.bmc.2009.06.066
45269385 194796 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL563319 194796 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 424 5 1 2 5.7 O=C(N[C@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
44281668 109920 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 500 8 3 4 4.4 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1cccnc1 10.1016/s0960-894x(01)00249-9
CHEMBL32451 109920 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 500 8 3 4 4.4 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1cccnc1 10.1016/s0960-894x(01)00249-9
44452168 95394 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL258996 95394 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 464 5 1 2 6.6 O=C(NC1C[C@@H]2CC[C@@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
76320671 102876 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084576 102876 0 None - 1 Human 6.6 pIC50 = 6.6 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 3 5.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1N1CCCCC1 10.1016/j.bmc.2008.08.006
71456839 81070 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 467 10 3 5 3.8 O=C(Nc1ccccc1OCCOCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160100 81070 0 None - 1 Human 7.6 pIC50 = 7.6 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 467 10 3 5 3.8 O=C(Nc1ccccc1OCCOCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44452220 160717 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 452 5 1 2 6.4 CC1(NC(=O)c2ccccc2-c2ccccc2)CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL412072 160717 0 None - 1 Human 5.6 pIC50 = 5.6 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 452 5 1 2 6.4 CC1(NC(=O)c2ccccc2-c2ccccc2)CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
76313428 102864 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cccnc1 10.1016/j.bmc.2008.08.006
CHEMBL3084564 102864 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cccnc1 10.1016/j.bmc.2008.08.006
70688469 75819 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 534 5 2 3 5.9 O=C(Nc1ccccc1Cl)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058070 75819 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 534 5 2 3 5.9 O=C(Nc1ccccc1Cl)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
44452119 95894 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1F 10.1016/j.bmc.2007.10.003
CHEMBL261574 95894 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1F 10.1016/j.bmc.2007.10.003
44281859 109324 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32334 109324 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44289926 176975 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46404 176975 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44289927 167753 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL43423 167753 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
45268462 194531 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
CHEMBL561535 194531 0 None - 1 Human 8.5 pIC50 = 8.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c(O)c1 10.1016/j.bmc.2009.06.066
45269302 194432 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 531 7 1 5 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1OC 10.1016/j.bmc.2009.06.066
CHEMBL560995 194432 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 531 7 1 5 4.5 COc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)cc1OC 10.1016/j.bmc.2009.06.066
70688470 75822 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 6 2 3 6.4 CC(C)c1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058073 75822 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 6 2 3 6.4 CC(C)c1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
9892753 16308 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
CHEMBL123611 16308 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
44281667 115148 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 10 3 5 3.9 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)NCc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL33537 115148 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 10 3 5 3.9 CC(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)NCc1ccccc1 10.1016/s0960-894x(01)00249-9
45273705 194115 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 376 5 1 2 4.3 O=C(Cc1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL557936 194115 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 376 5 1 2 4.3 O=C(Cc1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
10050884 154103 10 None -204 3 Mouse 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154103 10 None -204 3 Mouse 7.5 pIC50 = 7.5 Functional
Antagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxisAntagonist activity at CCR3 receptor in mouse eosinophil assessed as as inhibition of chemotaxis
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
70684230 75821 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 6 2 4 5.3 COc1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058072 75821 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 6 2 4 5.3 COc1ccccc1NC(=O)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
70682099 75767 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 532 4 1 3 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057752 75767 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 532 4 1 3 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(F)cc2)CC1 10.1016/j.bmcl.2012.06.042
10474776 113145 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
45268519 194589 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 5 0 2 6.4 O=C(c1ccccc1-c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL561941 194589 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 409 5 0 2 6.4 O=C(c1ccccc1-c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44281966 99338 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 403 6 1 5 4.9 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nccs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL285444 99338 0 None - 1 Human 4.5 pIC50 = 4.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 403 6 1 5 4.9 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)c1nccs1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44452361 96048 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 338 5 1 2 3.7 O=C(NC1CCN(C/C=C/c2ccc(F)cc2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL262588 96048 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 338 5 1 2 3.7 O=C(NC1CCN(C/C=C/c2ccc(F)cc2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
10474776 113145 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 1 Human 7.5 pIC50 = 7.5 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin-2 radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11442439 123526 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
CHEMBL363166 123526 0 None - 1 Human 7.5 pIC50 = 7.5 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
44386406 62143 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 9 2 6 3.3 C=C(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OCC 10.1016/s0960-894x(01)00249-9
CHEMBL178019 62143 0 None - 1 Human 6.5 pIC50 = 6.5 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 461 9 2 6 3.3 C=C(NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)OCC 10.1016/s0960-894x(01)00249-9
6918497 112918 1 None -213 4 Mouse 6.5 pIC50 = 6.5 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112918 1 None -213 4 Mouse 6.5 pIC50 = 6.5 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112918 1 None -213 4 Mouse 6.5 pIC50 = 6.5 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in mouse CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
44452044 155534 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1cccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)c1 10.1016/j.bmc.2007.10.003
CHEMBL406296 155534 0 None - 1 Human 5.5 pIC50 = 5.5 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1cccc(C(=O)NC2CCN(Cc3ccc4cc(F)ccc4c3)CC2)c1 10.1016/j.bmc.2007.10.003
70690518 75763 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 555 4 1 4 5.0 CN1CN(c2ccccc2)C2(CCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)C1=O 10.1016/j.bmcl.2012.06.042
CHEMBL2057748 75763 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 555 4 1 4 5.0 CN1CN(c2ccccc2)C2(CCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)C1=O 10.1016/j.bmcl.2012.06.042
10474776 113145 36 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 1 Human 7.4 pIC50 = 7.4 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using [Ca2+] mobilization assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
44451928 158605 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL409830 158605 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2007.10.003
44451928 158605 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL409830 158605 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
45268458 195058 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1O 10.1016/j.bmc.2009.06.066
CHEMBL565165 195058 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1O 10.1016/j.bmc.2009.06.066
71460524 81079 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 474 5 1 3 4.9 O=C(NC1CCN(Cc2ccccc2)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
CHEMBL2160109 81079 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 474 5 1 3 4.9 O=C(NC1CCN(Cc2ccccc2)CC1)N1CCCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.09.035
70686357 75768 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 529 4 2 4 4.6 Nc1ccc(C(=O)N2CCCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmcl.2012.06.042
CHEMBL2057753 75768 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 529 4 2 4 4.6 Nc1ccc(C(=O)N2CCCN(C(=O)NC3C[C@H]4CC[C@H](C3)N4Cc3ccc4cc(F)ccc4c3)CC2)cc1 10.1016/j.bmcl.2012.06.042
44282280 119874 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL35341 119874 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 463 9 2 6 3.2 CCOC(=O)[C@H](C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
11329244 70757 10 None 20 7 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70757 10 None 20 7 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11340670 126699 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
CHEMBL365820 126699 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
11397114 132935 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706810 132935 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44401123 135744 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
CHEMBL373347 135744 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
9847583 194782 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 471 5 1 3 4.5 O=C(C=C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL563189 194782 0 None - 1 Human 8.4 pIC50 = 8.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 471 5 1 3 4.5 O=C(C=C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
45273624 193984 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccccc2F)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL556500 193984 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 489 5 1 3 4.7 O=C(C=C1CCN(C(=O)c2ccccc2F)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
70696765 75820 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 6 2 5 5.2 O=C(Nc1ccccc1[N+](=O)[O-])[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2058071 75820 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 6 2 5 5.2 O=C(Nc1ccccc1[N+](=O)[O-])[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
25024651 115523 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influxInhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influx
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115523 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Inhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influxInhibition of CCR3 in human eosinophil assessed as inhibition of eotaxin-induced Ca2+ influx
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
44281706 111057 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 496 9 3 5 3.8 O=C(CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL32806 111057 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 496 9 3 5 3.8 O=C(CNC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
11227406 93896 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93896 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
71460504 81040 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 369 4 2 2 4.2 O=C(NC1CCCCC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159864 81040 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 369 4 2 2 4.2 O=C(NC1CCCCC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
11227406 93896 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93896 1 None -107 4 Mouse 7.4 pIC50 = 7.4 Functional
Inhibition of eotaxin-induced chemotaxis of mouse eosinophilsInhibition of eotaxin-induced chemotaxis of mouse eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
71456816 81042 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 3 3 3.9 O=C(Nc1ccccc1CCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159866 81042 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 407 6 3 3 3.9 O=C(Nc1ccccc1CCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
71455044 81075 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 450 8 2 4 4.3 CN(C)CCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160105 81075 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 450 8 2 4 4.3 CN(C)CCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
71453336 81076 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 436 7 3 4 3.2 NC(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160106 81076 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 436 7 3 4 3.2 NC(=O)COc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
76327879 102877 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 527 6 1 3 6.3 CN(C(=O)c1ccccc1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)C1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084577 102877 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 527 6 1 3 6.3 CN(C(=O)c1ccccc1C(=O)N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)C1CCCCC1 10.1016/j.bmc.2008.08.006
70682098 75765 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 4 2 4 5.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057750 75765 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 545 4 2 4 5.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3c(F)cccc32)CC1 10.1016/j.bmcl.2012.06.042
70682101 75773 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(O)cc2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057758 75773 0 None - 1 Human 6.4 pIC50 = 6.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccc(O)cc2)CC1 10.1016/j.bmcl.2012.06.042
44281852 99208 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 511 8 3 3 5.1 Cc1ccc(C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H](C)C(=O)Nc2ccc(Cl)cc2)c(C)c1 10.1016/s0960-894x(01)00249-9
CHEMBL284531 99208 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 511 8 3 3 5.1 Cc1ccc(C(=O)N[C@@H](Cc2ccc(Cl)cc2)C(=O)N[C@@H](C)C(=O)Nc2ccc(Cl)cc2)c(C)c1 10.1016/s0960-894x(01)00249-9
44281944 121266 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 529 9 3 4 5.0 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL35896 121266 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 529 9 3 4 5.0 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(Cl)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
70692666 75775 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 554 5 1 3 5.5 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)C2(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057760 75775 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 554 5 1 3 5.5 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)C2(c3ccccc3)CC2)CC1 10.1016/j.bmcl.2012.06.042
45273639 194741 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(O)c1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL562922 194741 0 None - 1 Human 7.4 pIC50 = 7.4 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 517 6 2 5 4.2 COc1cccc(O)c1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
44452172 95395 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 378 4 1 3 5.2 O=C(Nc1ccccc1)OC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL258997 95395 0 None - 1 Human 5.3 pIC50 = 5.3 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 378 4 1 3 5.2 O=C(Nc1ccccc1)OC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
76324312 102868 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 514 5 1 4 4.3 CN1CCN(C(=O)c2ccccc2C(=O)N[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2008.08.006
CHEMBL3084568 102868 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 514 5 1 4 4.3 CN1CCN(C(=O)c2ccccc2C(=O)N[C@H]2C[C@@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2008.08.006
10474776 113145 36 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL33227 113145 36 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
9957612 162699 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 499 8 3 3 5.0 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL418588 162699 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 499 8 3 3 5.0 C[C@H](NC(=O)[C@H](Cc1ccc(Cl)cc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccccc1 10.1016/s0960-894x(01)00249-9
45273632 194020 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2cccc(O)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL556916 194020 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2cccc(O)c2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44455847 154895 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403839 154895 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
45272697 193938 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccccc1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL556227 193938 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1ccccc1C(=O)N1CCC(=CC(=O)N[C@@H]2CCN(Cc3ccc4cc(F)ccc4c3)C2)CC1 10.1016/j.bmc.2009.06.066
45273698 194742 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccc(O)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL562923 194742 0 None - 1 Human 8.3 pIC50 = 8.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccc(O)cc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
45273689 194043 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
CHEMBL557118 194043 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 501 6 1 4 4.5 COc1cccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)c1 10.1016/j.bmc.2009.06.066
71455028 81041 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 363 4 2 2 4.4 O=C(Nc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159865 81041 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 363 4 2 2 4.4 O=C(Nc1ccccc1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
71453335 81073 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 4.1 O=C(Nc1ccccc1OCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160103 81073 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 3 4 4.1 O=C(Nc1ccccc1OCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
11179592 69234 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL193442 69234 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11316656 69904 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL194141 69904 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44281755 99213 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 502 9 3 6 3.8 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2cscn2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL284576 99213 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 502 9 3 6 3.8 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2cscn2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
44281999 121330 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 459 8 1 7 4.6 CCOC(=O)c1coc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL35900 121330 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 459 8 1 7 4.6 CCOC(=O)c1coc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
71462226 81067 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 421 7 3 3 4.3 O=C(Nc1ccccc1CCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160098 81067 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 421 7 3 3 4.3 O=C(Nc1ccccc1CCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
70694702 75770 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 548 4 2 4 4.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(O)cccc2F)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057755 75770 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 548 4 2 4 4.9 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(O)cccc2F)CC1 10.1016/j.bmcl.2012.06.042
70690519 75764 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 527 4 2 4 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057749 75764 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 527 4 2 4 5.2 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC(n2c(=O)[nH]c3ccccc32)CC1 10.1016/j.bmcl.2012.06.042
10474776 113145 36 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 1 Human 7.3 pIC50 = 7.3 Functional
Agonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assayAgonistic activity against C-C chemokine receptor type 3 by displacing Eotaxin radioligand, using Eosinophil chemotaxis assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
45271905 193341 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
CHEMBL549302 193341 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 438 5 1 2 6.0 O=C(NC1CCCN(Cc2ccc3cc(F)ccc3c2)C1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2009.06.066
70690520 75776 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 550 5 1 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(S(=O)(=O)c2ccccc2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057761 75776 0 None - 1 Human 7.3 pIC50 = 7.3 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 550 5 1 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(S(=O)(=O)c2ccccc2)CC1 10.1016/j.bmcl.2012.06.042
9952288 110002 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 389 6 1 5 3.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C1=NCCO1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32493 110002 0 None - 1 Human 6.3 pIC50 = 6.3 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 389 6 1 5 3.5 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C1=NCCO1)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
76324313 102873 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccn1 10.1016/j.bmc.2008.08.006
CHEMBL3084573 102873 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccn1 10.1016/j.bmc.2008.08.006
70690517 75762 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 541 4 2 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2012.06.042
CHEMBL2057747 75762 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 541 4 2 4 4.6 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCC2(CC1)C(=O)NCN2c1ccccc1 10.1016/j.bmcl.2012.06.042
45268467 194558 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 505 5 2 4 4.4 O=C(C=C1CCN(C(=O)c2ccc(F)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL561740 194558 0 None - 1 Human 8.2 pIC50 = 8.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 505 5 2 4 4.4 O=C(C=C1CCN(C(=O)c2ccc(F)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
6918497 112918 1 None 1 4 Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112918 1 None 1 4 Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112918 1 None 1 4 Human 8.2 pIC50 = 8.2 Functional
Inhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptorInhibitory activity against I-Eotaxin induced [Ca2+] response in human CCR3 receptor
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
44455872 154965 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404202 154965 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxisAntagonist activity at human CCR3 receptor in human eosinophil assessed as inhibition of eotaxin-induced chemotaxis
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44281987 99174 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 542 9 3 4 5.4 C[C@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL284313 99174 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 542 9 3 4 5.4 C[C@H](NC(=O)[C@H](Cc1ccncc1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(-c2ccccc2)cc1 10.1016/s0960-894x(01)00249-9
44281794 167437 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.3 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N(C)c1ccccc1 10.1016/s0960-894x(01)00249-9
CHEMBL432088 167437 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.3 C[C@H](NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12)C(=O)N(C)c1ccccc1 10.1016/s0960-894x(01)00249-9
44452304 157291 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 348 5 1 2 4.7 Fc1ccc2cc(CN3CCC(NCc4ccccc4)CC3)ccc2c1 10.1016/j.bmc.2007.10.003
CHEMBL408368 157291 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 348 5 1 2 4.7 Fc1ccc2cc(CN3CCC(NCc4ccccc4)CC3)ccc2c1 10.1016/j.bmc.2007.10.003
71449695 81077 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 416 5 0 2 5.0 O=C1N(CCc2ccccc2)CCC12CCN(Cc1ccc3cc(F)ccc3c1)CC2 10.1016/j.bmcl.2012.09.035
CHEMBL2160107 81077 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 416 5 0 2 5.0 O=C1N(CCc2ccccc2)CCC12CCN(Cc1ccc3cc(F)ccc3c1)CC2 10.1016/j.bmcl.2012.09.035
9826988 75716 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 492 7 0 7 4.2 Cc1nnc2n(CCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)c(=O)c3ccccc3n12 10.1016/j.bmcl.2012.06.042
CHEMBL2057489 75716 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 492 7 0 7 4.2 Cc1nnc2n(CCCN3CCN(C(c4ccccc4)c4ccccc4)CC3)c(=O)c3ccccc3n12 10.1016/j.bmcl.2012.06.042
76320667 102863 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccncc1 10.1016/j.bmc.2008.08.006
CHEMBL3084563 102863 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 465 5 1 3 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccncc1 10.1016/j.bmc.2008.08.006
24882359 192435 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
CHEMBL522295 192435 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 464 5 1 2 6.6 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1ccccc1 10.1016/j.bmc.2008.08.006
70694701 75769 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 582 4 1 3 6.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057754 75769 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 582 4 1 3 6.3 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2c(Cl)cccc2Cl)CC1 10.1016/j.bmcl.2012.06.042
70696752 75774 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccccc2O)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057759 75774 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 530 4 2 4 4.7 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCCN(C(=O)c2ccccc2O)CC1 10.1016/j.bmcl.2012.06.042
44452086 157333 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2007.10.003
CHEMBL408407 157333 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2007.10.003
44452086 157333 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
CHEMBL408407 157333 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccc(F)cc1 10.1016/j.bmc.2009.06.066
44281775 115051 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.6 C[C@@H](C(=O)Nc1ccccc1)N(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL33534 115051 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 524 9 2 5 4.6 C[C@@H](C(=O)Nc1ccccc1)N(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44281951 119709 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 475 8 1 7 5.1 CCOC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL35217 119709 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 475 8 1 7 5.1 CCOC(=O)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
44281686 111521 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 462 9 3 5 2.7 CCNC(=O)C(C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
CHEMBL32895 111521 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 462 9 3 5 2.7 CCNC(=O)C(C)NC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00249-9
44452120 155676 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(F)c1 10.1016/j.bmc.2007.10.003
CHEMBL406468 155676 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 380 4 1 2 4.5 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1cccc(F)c1 10.1016/j.bmc.2007.10.003
76313429 102869 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 501 5 1 4 4.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084569 102869 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 501 5 1 4 4.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1C(=O)N1CCOCC1 10.1016/j.bmc.2008.08.006
11953409 93768 0 None -7 4 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93768 0 None -7 4 Mouse 8.2 pIC50 = 8.2 Functional
Antagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophilsAntagonist activity at CCR3 assessed as eotaxin-induced chemotaxis in BALB/c mouse eosinophils
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
45269320 194907 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 521 5 2 4 4.9 O=C(C=C1CCN(C(=O)c2ccc(Cl)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL564022 194907 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 521 5 2 4 4.9 O=C(C=C1CCN(C(=O)c2ccc(Cl)cc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44281774 116154 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 501 9 3 4 5.1 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](CC2CCCCC2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL33708 116154 0 None - 1 Human 6.2 pIC50 = 6.2 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 501 9 3 4 5.1 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](CC2CCCCC2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
71456840 81071 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 2 4 4.4 COCCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2160101 81071 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 437 8 2 4 4.4 COCCOc1ccccc1NC(=O)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44387842 130766 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
CHEMBL368683 130766 0 None - 1 Human 7.2 pIC50 = 7.2 Functional
Inhibition of eotaxin-induced chemotaxis of human eosinophilsInhibition of eotaxin-induced chemotaxis of human eosinophils
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
44452083 95717 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccccc1C(=O)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL260649 95717 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 392 5 1 3 4.4 COc1ccccc1C(=O)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44281872 108857 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 522 8 2 6 6.2 O=C(Nc1ccccc1)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
CHEMBL32191 108857 0 None - 1 Human 5.1 pIC50 = 5.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 522 8 2 6 6.2 O=C(Nc1ccccc1)c1csc([C@H](Cc2ccc([N+](=O)[O-])cc2)NC(=O)c2cccc3ccccc23)n1 10.1016/s0960-894x(01)00249-9
70684221 75761 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 461 3 1 2 5.4 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCc2cc(F)ccc2C1 10.1016/j.bmcl.2012.06.042
CHEMBL2057746 75761 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 461 3 1 2 5.4 O=C(NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)N1CCc2cc(F)ccc2C1 10.1016/j.bmcl.2012.06.042
11227406 93896 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93896 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assayAntagonist activity at CCR3 in human eosinophils assessed as eotaxin-induced calcium mobilization by FLIPR assay
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
70696751 75766 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 4 3 5 4.7 Nc1ccc2c(c1)[nH]c(=O)n2C1CCN(C(=O)NC2C[C@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.06.042
CHEMBL2057751 75766 0 None - 1 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 542 4 3 5 4.7 Nc1ccc2c(c1)[nH]c(=O)n2C1CCN(C(=O)NC2C[C@H]3CC[C@H](C2)N3Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmcl.2012.06.042
11227406 93896 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93896 1 None 107 4 Human 8.1 pIC50 = 8.1 Functional
Inhibition of calcium mobilization in human eosinophilsInhibition of calcium mobilization in human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44512617 193658 0 None 79 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551735 193658 0 None 79 2 Human 8.1 pIC50 = 8.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
22393430 168126 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43677 168126 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
In vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 activity of compound by using eotaxin induced human eosinophil chemotaxis assay
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44281754 112666 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 506 8 3 5 4.4 C[C@H](NC(=O)[C@H](Cc1cscn1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(Cl)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL33144 112666 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 506 8 3 5 4.4 C[C@H](NC(=O)[C@H](Cc1cscn1)NC(=O)c1cccc2ccccc12)C(=O)Nc1ccc(Cl)cc1 10.1016/s0960-894x(01)00249-9
44452248 95772 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 376 4 0 2 4.7 CN(C(=O)c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL260899 95772 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 376 4 0 2 4.7 CN(C(=O)c1ccccc1)C1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44295672 188160 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50535 188160 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
In vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assayIn vitro C-C chemokine receptor type 3 receptor activity of compound to inhibit eotaxin induced [Ca2+] mobilization in human eosinophil chemotaxis assay
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44452280 95353 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 398 5 1 3 3.9 O=S(=O)(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL258790 95353 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 398 5 1 3 3.9 O=S(=O)(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1 10.1016/j.bmc.2007.10.003
76313430 102872 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cnccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084572 102872 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cnccc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
76320668 102865 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 4 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1nccs1 10.1016/j.bmc.2008.08.006
CHEMBL3084565 102865 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 471 5 1 4 6.0 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1nccs1 10.1016/j.bmc.2008.08.006
71451489 81043 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 451 9 3 4 4.5 O=C(Nc1ccccc1OCCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
CHEMBL2159867 81043 0 None - 1 Human 8.0 pIC50 = 8 Functional
Antagonist activity at CCR3 receptorAntagonist activity at CCR3 receptor
ChEMBL 451 9 3 4 4.5 O=C(Nc1ccccc1OCCCCO)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmcl.2012.09.035
44282047 162605 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(C#N)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
CHEMBL418041 162605 0 None - 1 Human 7.1 pIC50 = 7.1 Functional
Antagonist activity against C-C chemokine receptor type 3Antagonist activity against C-C chemokine receptor type 3
ChEMBL 520 9 3 5 4.2 COc1ccc(NC(=O)[C@H](C)NC(=O)[C@H](Cc2ccc(C#N)cc2)NC(=O)c2cccc3ccccc23)cc1 10.1016/s0960-894x(01)00249-9
45273619 194794 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 485 6 1 3 4.8 O=C(/C=C/C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL563303 194794 0 None - 1 Human 6.1 pIC50 = 6.1 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 485 6 1 3 4.8 O=C(/C=C/C1CCN(C(=O)c2ccccc2)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
70688460 75780 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccc(Br)cc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
CHEMBL2057765 75780 0 None - 1 Human 6.0 pIC50 = 6.0 Functional
Antagonist activity at human CCR3Antagonist activity at human CCR3
ChEMBL 578 5 2 3 6.1 O=C(Nc1ccc(Br)cc1)[C@@H]1CCCN1C(=O)NC1C[C@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1 10.1016/j.bmcl.2012.06.042
76313415 105893 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 466 5 1 4 5.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cncnc1 10.1016/j.bmc.2008.08.006
CHEMBL3084359 105893 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 466 5 1 4 5.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cncnc1 10.1016/j.bmc.2008.08.006
CHEMBL3139342 105893 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 466 5 1 4 5.4 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1ccccc1-c1cncnc1 10.1016/j.bmc.2008.08.006
3536 3831 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assay
ChEMBL 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10.1021/jm300682j
44560289 3831 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assay
ChEMBL 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10.1021/jm300682j
CHEMBL1186993 3831 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assayAntagonist activity at CCR3 assessed as inhibition of CCL11-induced chemotaxis by cell based assay
ChEMBL 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10.1021/jm300682j
44451983 158803 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1Oc1ccccc1 10.1016/j.bmc.2007.10.003
CHEMBL410041 158803 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 454 6 1 3 6.2 O=C(NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1)c1ccccc1Oc1ccccc1 10.1016/j.bmc.2007.10.003
44452198 157417 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
CHEMBL408486 157417 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influxAntagonist activity at CCR3 expressed in B300-19 cells assessed as inhibition of eotaxin-induced calcium influx
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2007.10.003
44452198 157417 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
CHEMBL408486 157417 0 None - 1 Human 5.0 pIC50 = 5.0 Functional
Antagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium fluxAntagonist activity at human CCR3 expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium flux
ChEMBL 388 5 1 2 4.8 O=C(/C=C/c1ccccc1)NC1CCN(Cc2ccc3cc(F)ccc3c2)CC1 10.1016/j.bmc.2009.06.066
76320669 102870 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cccnc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
CHEMBL3084570 102870 0 None - 1 Human 7.0 pIC50 = 7.0 Functional
Antagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometryAntagonist activity at CCR3 receptor expressed in mouse B300-19 cells assessed as inhibition of eotaxin-induced calcium influx by spectrophotometry
ChEMBL 500 5 1 4 4.9 O=C(N[C@H]1C[C@@H]2CC[C@H](C1)N2Cc1ccc2cc(F)ccc2c1)c1cccnc1C(=O)N1CCCCC1 10.1016/j.bmc.2008.08.006
11753159 542 3 None 4 2 Human 7.0 pKd = 7 Functional
Antagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysisAntagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysis
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
7679 542 3 None 4 2 Human 7.0 pKd = 7 Functional
Antagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysisAntagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysis
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2158814 542 3 None 4 2 Human 7.0 pKd = 7 Functional
Antagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysisAntagonist activity at CCR3 receptor in human polymorphonuclear leukocytes assessed as inhibition of eotaxin-induced CD11b expression after 15 mins by flow cytometric analysis
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
16040671 80853 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysisAntagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysis
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158791 80853 0 None - 0 Human 7.9 pKd = 7.9 Functional
Antagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysisAntagonist activity at CCR3 in human eosinophils assessed as inhibition of CCL24-induced morphological changes by FACS flow cytometric analysis
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
16681693 82146 1 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assayAntagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assay
ChEMBL 487 5 1 5 3.6 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)nn1 10.1021/jm300682j
CHEMBL2178580 82146 1 None - 0 Human 8.7 pKi = 8.7 Functional
Antagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assayAntagonist activity at human CCR3 assessed as inhibition of CCL11-induced calcium influx by cell based assay
ChEMBL 487 5 1 5 3.6 Cc1ccc(C(=O)N2CCC(=CC(=O)N[C@@H]3CCN(Cc4ccc5cc(F)ccc5c4)C3)CC2)nn1 10.1021/jm300682j
44399573 67679 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 465 6 1 3 5.4 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)C1CCCCC1 10.1016/j.bmcl.2005.04.054
CHEMBL191418 67679 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 465 6 1 3 5.4 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)C1CCCCC1 10.1016/j.bmcl.2005.04.054
44399538 67181 0 None - 0 Human 6.8 pKi = 6.8 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 7 1 4 5.7 O=C(NCC1CCCN(C2CCN(CCc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL189680 67181 0 None - 0 Human 6.8 pKi = 6.8 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 7 1 4 5.7 O=C(NCC1CCCN(C2CCN(CCc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399469 165562 0 None - 1 Human 7.6 pKi = 7.6 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL426089 165562 0 None - 1 Human 7.6 pKi = 7.6 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399385 67270 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]ccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190436 67270 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]ccc2c1 10.1016/j.bmcl.2005.04.054
11540776 69103 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
CHEMBL193354 69103 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
44399272 67117 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1nccc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL189206 67117 0 None - 0 Human 7.5 pKi = 7.5 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1nccc2ccccc12 10.1016/j.bmcl.2005.04.054
11540776 69103 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
CHEMBL193354 69103 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2cccnc12 10.1016/j.bmcl.2005.04.054
44399482 165464 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2[nH]ccc12 10.1016/j.bmcl.2005.04.054
CHEMBL425548 165464 0 None - 0 Human 7.4 pKi = 7.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 498 6 2 3 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2[nH]ccc12 10.1016/j.bmcl.2005.04.054
44399443 68823 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)ccc3Cl)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL192584 68823 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)ccc3Cl)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399574 67434 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)cc(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190894 67434 0 None - 0 Human 6.4 pKi = 6.4 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3cc(Cl)cc(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399389 126971 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 499 6 2 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]cnc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL366143 126971 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 499 6 2 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2[nH]cnc2c1 10.1016/j.bmcl.2005.04.054
44399331 126982 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ccccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL366199 126982 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ccccc2c1 10.1016/j.bmcl.2005.04.054
44399395 67235 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.0 CC1(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.04.054
CHEMBL190149 67235 0 None - 0 Human 7.3 pKi = 7.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.0 CC1(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2005.04.054
44399552 67106 0 None - 0 Human 6.3 pKi = 6.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 397 5 1 3 3.8 CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL189158 67106 0 None - 0 Human 6.3 pKi = 6.3 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 397 5 1 3 3.8 CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399524 134980 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL372868 134980 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 509 6 1 3 6.3 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cccc2ccccc12 10.1016/j.bmcl.2005.04.054
44399368 66843 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 473 6 1 3 5.4 Cc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL187779 66843 0 None - 0 Human 7.2 pKi = 7.2 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 473 6 1 3 5.4 Cc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399303 67734 0 None - 0 Human 8.1 pKi = 8.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 5.9 CC1CN(Cc2ccc(Cl)c(Cl)c2)CCC1N1CCCC(CNC(=O)c2ccc3ncccc3c2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL191464 67734 0 None - 0 Human 8.1 pKi = 8.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 5.9 CC1CN(Cc2ccc(Cl)c(Cl)c2)CCC1N1CCCC(CNC(=O)c2ccc3ncccc3c2)C1 10.1016/j.bmcl.2005.04.054
44399332 68925 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.2 CC(c1ccc(Cl)c(Cl)c1)N1CCC(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CC1 10.1016/j.bmcl.2005.04.054
CHEMBL192757 68925 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 524 6 1 4 6.2 CC(c1ccc(Cl)c(Cl)c1)N1CCC(N2CCCC(CNC(=O)c3ccc4ncccc4c3)C2)CC1 10.1016/j.bmcl.2005.04.054
44399290 67255 0 None - 0 Human 6.1 pKi = 6.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 538 6 1 4 5.2 O=C(NCC1CCCN(C2CCN(C(=O)Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190312 67255 0 None - 0 Human 6.1 pKi = 6.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 538 6 1 4 5.2 O=C(NCC1CCCN(C2CCN(C(=O)Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399567 67419 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccnc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL190852 67419 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 510 6 1 4 5.6 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1ccnc2ccccc12 10.1016/j.bmcl.2005.04.054
44399407 67212 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 487 7 1 3 5.3 Cc1ccccc1CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL189917 67212 0 None - 0 Human 7.1 pKi = 7.1 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 487 7 1 3 5.3 Cc1ccccc1CC(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399442 67297 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 489 7 1 4 5.1 COc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
CHEMBL190646 67297 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 489 7 1 4 5.1 COc1ccccc1C(=O)NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2005.04.054
44399537 67262 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 476 6 1 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)cc3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
CHEMBL190362 67262 0 None - 0 Human 7.0 pKi = 7.0 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 476 6 1 4 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)cc3)CC2)C1)c1ccc2ncccc2c1 10.1016/j.bmcl.2005.04.054
44399479 67225 0 None - 0 Human 7.0 pKi = 7 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 511 6 1 5 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cnnc2ccccc12 10.1016/j.bmcl.2005.04.054
CHEMBL190048 67225 0 None - 0 Human 7.0 pKi = 7 Functional
In vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligandIn vitro binding activity against C-C chemokine receptor type 3 using [35S]GTP-gamma-S, as radioligand
ChEMBL 511 6 1 5 5.0 O=C(NCC1CCCN(C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C1)c1cnnc2ccccc12 10.1016/j.bmcl.2005.04.054
3536 3831 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.
Guide to Pharmacology 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10854442
44560289 3831 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.
Guide to Pharmacology 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10854442
CHEMBL1186993 3831 0 None -9 2 Human 7.0 pIC50 = 7.0 Functional
Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.Measuring antagonism of CCL11-induced chemotaxis <i>in vitro</i>.
Guide to Pharmacology 515 5 1 2 7.3 CC[N+]1(CCC(CC1)NC(=O)C1c2cc(Cl)ccc2Oc2c1cc(Cl)cc2)CC1CCCCCC1 10854442
4382 818 0 None 25 2 Human 7.5 pIC50 = 7.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 23951310
9680 1859 4 None - 1 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 22931505
9825034 1859 4 None - 1 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 22931505
CHEMBL2178574 1859 4 None - 1 Human 8.0 pIC50 = 8 Functional
UnclassifiedUnclassified
Guide to Pharmacology 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 22931505
776 838 0 None -1 2 Human 8.4 pIC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10488147
776 838 0 None -1 2 Human 8.4 pIC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15207250
776 838 0 None -1 2 Human 8.4 pIC50 = 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
754 815 0 None 5 2 Human 8.6 pIC50 = 8.6 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9346309
775 834 0 None 316 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 15207250
775 834 0 None 316 2 Human 8.7 pIC50 = 8.7 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
769 810 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10488147
769 810 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10854442
769 810 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 12761559
769 810 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
769 810 0 None 14 3 Human 8.9 pIC50 = 8.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276730
770 813 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 16339911
770 813 0 None 7 2 Human 9.5 pIC50 = 9.5 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9276730
773 1898 0 None -12 2 Human 7.2 pIC50 None 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 9789057
10098735 3279 0 None - 1 Human 7.2 pIC50 None 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 537 10 2 5 6.1 COc1cc(NC(=O)N[C@H](C(C)C)CN2CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060
789 3279 0 None - 1 Human 7.2 pIC50 None 7.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology 537 10 2 5 6.1 COc1cc(NC(=O)N[C@H](C(C)C)CN2CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060
11556309 4044 0 None - 1 Human 7.9 pIC50 None 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 502 5 2 5 3.9 O=C(C=C1CCN(CC1)C(=O)c1ncc(cc1O)C)N[C@@H]1CCN(C1)Cc1ccc2c(c1)ccc(c2)F 16339911
793 4044 0 None - 1 Human 7.9 pIC50 None 7.9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 502 5 2 5 3.9 O=C(C=C1CCN(CC1)C(=O)c1ncc(cc1O)C)N[C@@H]1CCN(C1)Cc1ccc2c(c1)ccc(c2)F 16339911
788 2448 0 None - 1 Human 8.2 pIC50 None 8.2 Functional
UnclassifiedUnclassified
Guide to Pharmacology None None None None 10640766
10304110 3285 0 None - 1 Human 8.3 pIC50 None 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 560 11 2 7 5.3 COc1cc(ccc1OC)c1cnc(nc1)SCC(=O)NCC[C@H]1NC[C@@H](C1)Cc1ccc(c(c1)Cl)Cl 12070060
792 3285 0 None - 1 Human 8.3 pIC50 None 8.3 Functional
UnclassifiedUnclassified
Guide to Pharmacology 560 11 2 7 5.3 COc1cc(ccc1OC)c1cnc(nc1)SCC(=O)NCC[C@H]1NC[C@@H](C1)Cc1ccc(c(c1)Cl)Cl 12070060
10255622 3283 0 None - 1 Human 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 505 10 3 6 4.2 COc1cc(NC(=O)N[C@H](C(O)C)CN2CCC(CC2)Cc2ccc(cc2)Cl)cc(c1OC)OC 12070060
791 3283 0 None - 1 Human 8.4 pIC50 None 8.4 Functional
UnclassifiedUnclassified
Guide to Pharmacology 505 10 3 6 4.2 COc1cc(NC(=O)N[C@H](C(O)C)CN2CCC(CC2)Cc2ccc(cc2)Cl)cc(c1OC)OC 12070060
790 3280 0 None - 1 Human 9.0 pIC50 None 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 10 2 4 6.3 COc1cc(NC(=O)N[C@H](C(C)C)C[N+]2(C)CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060
9915610 3280 0 None - 1 Human 9.0 pIC50 None 9 Functional
UnclassifiedUnclassified
Guide to Pharmacology 552 10 2 4 6.3 COc1cc(NC(=O)N[C@H](C(C)C)C[N+]2(C)CCC(CC2)Cc2ccc(c(c2)Cl)Cl)cc(c1OC)OC 12070060




Ligands Receptor Assay information Chemical information
Sel. page Common
name
GPCRdb ID #Vendors Reference
ligand
Fold selectivity
(Affinity)
# tested GPCRs
(Affinity)
Species p-value
(-log)
Type Activity
Relation
Activity
Value
Assay Type Assay Description Source Mol
weight
Rot
Bonds
H don H acc LogP Smiles DOI
38347547 145910 5 None - 0 Human 5.9 pEC50 = 5.9 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 430 11 0 7 4.5 C=CCc1cc(OC)c(O[C@@H](C)[C@H](OC(C)=O)c2ccc(OC)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
CHEMBL3922119 145910 5 None - 0 Human 5.9 pEC50 = 5.9 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 430 11 0 7 4.5 C=CCc1cc(OC)c(O[C@@H](C)[C@H](OC(C)=O)c2ccc(OC)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
25751147 149416 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 404 10 2 7 3.7 C=CCc1cc(OC)c(O[C@H](C)[C@@H](O)c2cc(OC)c(O)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
CHEMBL3949874 149416 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 404 10 2 7 3.7 C=CCc1cc(OC)c(O[C@H](C)[C@@H](O)c2cc(OC)c(O)c(OC)c2)c(OC)c1 10.1021/acs.jnatprod.6b00262
124396489 143919 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 356 5 1 5 4.7 C/C=C/c1cc(OC)c2c(c1)[C@@H](C)[C@H](c1cc(OC)c(O)c(OC)c1)O2 10.1021/acs.jnatprod.6b00262
CHEMBL3906647 143919 2 None - 0 Human 5.8 pEC50 = 5.8 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 356 5 1 5 4.7 C/C=C/c1cc(OC)c2c(c1)[C@@H](C)[C@H](c1cc(OC)c(O)c(OC)c1)O2 10.1021/acs.jnatprod.6b00262
10474776 113145 36 None - 0 Human 6.1 pEC50 = 6.1 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1021/acs.jnatprod.6b00262
CHEMBL33227 113145 36 None - 0 Human 6.1 pEC50 = 6.1 Binding
Antagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assayAntagonist activity at human EGFP-fused CCR3 expressed in mouse L1.2 cells assessed as inhibition of CCL11-induced chemotaxis measured after 1.5 hrs by PicoGreen dsDNA reagent-based assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1021/acs.jnatprod.6b00262
11272103 123843 0 None - 0 Rat 11.0 pIC50 = 11 Binding
Inhibition of eotaxin-induced chemotaxis of rat eosinophilsInhibition of eotaxin-induced chemotaxis of rat eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None - 0 Rat 11.0 pIC50 = 11 Binding
Inhibition of eotaxin-induced chemotaxis of rat eosinophilsInhibition of eotaxin-induced chemotaxis of rat eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44570583 190338 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL505914 190338 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL518571 190338 0 None - 0 Human 9.9 pIC50 = 9.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44570583 190338 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL505914 190338 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL518571 190338 0 None - 0 Human 9.8 pIC50 = 9.8 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 550 7 2 8 3.3 CN1CC(C)(NC(=O)Nc2cccc(-c3nnnn3C)c2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44593547 176282 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
CHEMBL461445 176282 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
44447136 94103 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 3 7 2.8 CCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL251837 94103 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 3 7 2.8 CCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447381 94437 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 12 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)CCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254095 94437 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 12 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)CCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447137 153607 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 12 3 7 3.2 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL398548 153607 0 None - 0 Human 9.7 pIC50 = 9.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 12 3 7 3.2 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44570537 177575 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 7 2 8 2.9 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL464902 177575 0 None - 0 Human 9.6 pIC50 = 9.6 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 7 2 8 2.9 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
10050884 154103 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2008.11.002
CHEMBL399495 154103 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2008.11.002
44447143 94138 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 4 7 2.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CNCCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL252035 94138 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 469 11 4 7 2.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CNCCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10050884 154103 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
CHEMBL399495 154103 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
44447144 168196 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL437396 168196 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.0 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10050884 154103 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL399495 154103 10 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44455658 166709 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429323 166709 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 3 5 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nccn2C)c1 10.1016/j.bmcl.2007.11.067
11488078 78576 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113077 78576 0 None - 0 Human 9.5 pIC50 = 9.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44593553 177782 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
CHEMBL465272 177782 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
44447139 94104 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 495 12 3 7 3.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC1CC1 10.1016/j.bmcl.2007.11.087
CHEMBL251838 94104 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 495 12 3 7 3.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC1CC1 10.1016/j.bmcl.2007.11.087
44447135 94225 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 455 10 3 7 2.5 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)CCCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL252631 94225 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 455 10 3 7 2.5 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)CCCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44447361 94499 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254503 94499 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447138 154267 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 11 3 7 3.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CC1 10.1016/j.bmcl.2007.11.087
CHEMBL400378 154267 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 11 3 7 3.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CC1 10.1016/j.bmcl.2007.11.087
44447382 166049 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 497 12 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL428062 166049 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 497 12 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)CCCc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
10050884 154103 10 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
CHEMBL399495 154103 10 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3/CCR2 chimeric receptor in CHO cells
ChEMBL 481 8 3 7 2.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.087
44455841 154894 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CC(C)[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403838 154894 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CC(C)[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11328714 78573 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113074 78573 0 None - 0 Human 9.4 pIC50 = 9.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44593547 176282 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
CHEMBL461445 176282 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 538 10 2 8 3.3 CCN(CCCc1ccc(F)cc1)CC1OC(=O)N(C)CC1(C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2008.11.002
44419331 82348 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 9 3 4 4.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL217987 82348 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 9 3 4 4.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
25032958 94099 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 10 4 8 2.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)[C@@H](C)[C@@H](O)c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL251822 94099 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 481 10 4 8 2.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(C)[C@@H](C)[C@@H](O)c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447145 94523 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 13 3 7 3.8 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cc(CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254676 94523 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 13 3 7 3.8 CCCN(CCCc1ccc(F)cc1)C[C@H](O)[C@@H](C)NC(=O)Nc1cc(CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44455744 94974 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 8 3 7 3.5 Cc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257029 94974 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 8 3 7 3.5 Cc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455817 154627 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL402331 154627 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 538 9 3 8 3.6 CNC(=O)O[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44455788 155066 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 536 10 2 7 4.3 CCc1cc(NC(=O)N[C@H](C)C[C@@H](N(C)C)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404585 155066 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 536 10 2 7 4.3 CCc1cc(NC(=O)N[C@H](C)C[C@@H](N(C)C)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11329244 70757 10 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70757 10 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11272103 123843 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None - 0 Human 9.3 pIC50 = 9.3 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
6918497 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(03)00748-0
CHEMBL277930 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(03)00748-0
CHEMBL331897 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(03)00748-0
6918497 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL277930 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL331897 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1016/s0960-894x(01)00176-7
6918497 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against I-Eotaxin binding to human CCR3 receptorsInhibitory activity against I-Eotaxin binding to human CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against I-Eotaxin binding to human CCR3 receptorsInhibitory activity against I-Eotaxin binding to human CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112918 1 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory activity against I-Eotaxin binding to human CCR3 receptorsInhibitory activity against I-Eotaxin binding to human CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
11236950 94313 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253210 94313 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 479 9 2 6 4.3 CN(CCCc1ccc(F)cc1)C[C@@H]1CCCC[C@H]1NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447146 94524 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 12 3 7 3.5 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254677 94524 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 12 3 7 3.5 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447147 94550 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 13 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254881 94550 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 13 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC2CC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445886 93771 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL249857 93771 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44455844 96953 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 10 3 7 4.0 CCC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL269933 96953 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 10 3 7 4.0 CCC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455791 155067 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 522 9 3 7 3.3 CC(=O)N[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
CHEMBL404586 155067 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 522 9 3 7 3.3 CC(=O)N[C@H](C[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)N1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1016/j.bmcl.2007.11.067
44289927 167753 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL43423 167753 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11698698 122711 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(Cl)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL361369 122711 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(Cl)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44289927 167753 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43423 167753 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44390955 123160 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 8 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CCC2(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL362179 123160 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 8 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CCC2(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44419344 141229 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 11 2 4 5.9 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL386073 141229 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 11 2 4 5.9 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11272103 123843 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL363840 123843 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44445865 154304 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL400589 154304 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 544 7 3 6 3.9 CNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44455461 155070 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 10 3 7 4.2 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404618 155070 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 10 3 7 4.2 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
44390838 127975 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL366710 127975 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11398022 98165 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL277131 98165 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
11272103 123843 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL363840 123843 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11397114 132935 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706810 132935 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2cn[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
10459751 99697 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 533 9 2 10 2.7 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL288009 99697 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 533 9 2 10 2.7 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44289701 100624 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 508 9 3 7 2.8 CNC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295081 100624 0 None - 0 Human 9.2 pIC50 = 9.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 508 9 3 7 2.8 CNC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44455793 94770 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL256068 94770 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44455625 97128 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 565 9 3 7 6.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nccs2)cc(-c2nccs2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270806 97128 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 565 9 3 7 6.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nccs2)cc(-c2nccs2)c1 10.1016/j.bmcl.2007.11.067
11227406 93896 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93896 1 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human eosinophilsInhibition of [125I]eotaxin binding to human eosinophils
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44419295 82788 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 497 11 3 5 4.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218568 82788 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 497 11 3 5 4.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44419298 137598 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 11 2 5 5.0 CC(=O)CN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL376737 137598 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 11 2 5 5.0 CC(=O)CN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11329244 70757 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL195433 70757 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445863 94006 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL251275 94006 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44445872 94064 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCF)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251622 94064 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCF)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445868 166411 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(Cc3ccco3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL428761 166411 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(Cc3ccco3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11329244 70757 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
CHEMBL195433 70757 10 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 486 7 2 5 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1021/jm049530m
11156406 124638 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364508 124638 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44290100 178035 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 481 9 3 7 3.0 Cn1nnnc1-c1cc(CO)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL46747 178035 0 None - 0 Human 9.1 pIC50 = 9.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 481 9 3 7 3.0 Cn1nnnc1-c1cc(CO)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44419345 82727 0 None - 0 Human 9.0 pIC50 = 9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 493 11 2 4 5.6 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218262 82727 0 None - 0 Human 9.0 pIC50 = 9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 493 11 2 4 5.6 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11272103 123843 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL363840 123843 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.087
44445842 155025 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2COCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL404416 155025 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2COCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455686 95035 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257293 95035 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 9 3 7 4.3 CC(C)c1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455871 97084 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 9 3 7 3.6 CC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270583 97084 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 495 9 3 7 3.6 CC[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11272103 123843 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL363840 123843 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
44455511 154476 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL401545 154476 0 None - 0 Human 9.0 pIC50 = 9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44295462 187815 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 519 12 3 7 4.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50194 187815 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 519 12 3 7 4.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/s0960-894x(02)00206-8
44295536 187841 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50233 187841 0 None - 0 Human 9.0 pIC50 = 9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
9892753 16308 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
CHEMBL123611 16308 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm049530m
11213416 132937 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2nc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706812 132937 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2nc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11169258 140353 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
CHEMBL382108 140353 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 587 8 2 10 3.8 Cn1nnnc1-c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1021/jm049530m
11966688 12251 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 518 7 2 4 6.0 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2C[N+]2(C)CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL1185532 12251 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 518 7 2 4 6.0 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2C[N+]2(C)CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL419599 12251 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 518 7 2 4 6.0 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2C[N+]2(C)CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
9892753 16308 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL123611 16308 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11730796 116315 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 499 7 3 4 5.2 CNC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL337962 116315 0 None - 0 Human 9.0 pIC50 = 9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 499 7 3 4 5.2 CNC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44570617 177791 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 7 2 7 4.1 CC(=O)c1sc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
CHEMBL465291 177791 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 7 2 7 4.1 CC(=O)c1sc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
44445885 168431 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL439253 168431 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44455483 97367 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL272068 97367 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 3.8 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)(C)C(=O)O)c1 10.1016/j.bmcl.2007.11.067
44455458 166886 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429846 166886 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ccon2)cc(-c2ccon2)c1 10.1016/j.bmcl.2007.11.067
44400941 68507 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 426 6 3 3 3.9 O=C(NC1C=CC=CN1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL192240 68507 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 426 6 3 3 3.9 O=C(NC1C=CC=CN1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11409583 69424 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
CHEMBL193575 69424 0 None - 0 Human 9.0 pIC50 = 9.0 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 8 2 4 5.9 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1021/jm049530m
44445901 159648 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
CHEMBL410959 159648 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2008.11.002
44447375 94319 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253244 94319 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445854 93636 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249057 93636 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 522 7 2 7 3.3 CC(=O)c1sc(NC(=O)N[C@@H]2CS(=O)(=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445891 93971 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCF)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251044 93971 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 533 9 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCF)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445915 154878 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCOCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL403742 154878 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCOCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445888 155106 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC#N)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL404857 155106 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC#N)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445901 159648 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL410959 159648 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455818 94984 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 10 3 7 4.2 CC(C)C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257073 94984 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 523 10 3 7 4.2 CC(C)C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455510 95133 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.2 Cc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257737 95133 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.2 Cc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455790 95265 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 480 8 3 7 3.2 C[C@H](C[C@@H](N)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258322 95265 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 480 8 3 7 3.2 C[C@H](C[C@@H](N)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44289926 176975 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46404 176975 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44390883 63728 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.8 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180746 63728 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.8 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11167549 78575 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 480 6 2 4 6.1 O=C(Nc1ccc2ncsc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113076 78575 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 480 6 2 4 6.1 O=C(Nc1ccc2ncsc2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44290018 166140 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 9 2 6 4.0 CCn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42826 166140 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 9 2 6 4.0 CCn1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44289741 170153 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 519 8 2 6 4.5 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(F)(F)F)c1 10.1016/j.bmcl.2004.01.059
CHEMBL44522 170153 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 519 8 2 6 4.5 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(F)(F)F)c1 10.1016/j.bmcl.2004.01.059
44289926 176975 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2004.01.059
CHEMBL46404 176975 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 453 9 2 4 4.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2004.01.059
44419296 140906 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 511 12 3 5 4.8 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL384199 140906 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 511 12 3 5 4.8 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCCO)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44445884 93769 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL249855 93769 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 559 9 2 7 3.7 COCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44445867 93843 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC#N)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250437 93843 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 526 8 2 7 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC#N)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
16747712 154303 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(C)=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL400588 154303 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(C)=O)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445870 166700 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL429303 166700 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44455539 166418 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428775 166418 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
10096657 64508 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 8 2 6 3.9 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL182086 64508 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 8 2 6 3.9 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11306550 78578 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 497 6 3 3 6.0 O=C(Nc1ccc2[nH]nc(Cl)c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113079 78578 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 497 6 3 3 6.0 O=C(Nc1ccc2[nH]nc(Cl)c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44419328 82881 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 411 8 3 3 4.5 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL219048 82881 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 411 8 3 3 4.5 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44445895 94000 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251220 94000 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455482 97366 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 9 3.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL272067 97366 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 9 3.2 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
11363005 60167 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL175634 60167 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11442162 70309 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 444 6 2 4 5.2 Cc1csc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
CHEMBL195044 70309 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 444 6 2 4 5.2 Cc1csc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
11454941 70783 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL195555 70783 0 None - 0 Human 8.9 pIC50 = 8.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 505 7 2 6 4.7 Cc1nnnn1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44445864 94033 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL251446 94033 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 558 8 3 6 4.3 CCNC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44445916 154879 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCOCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL403743 154879 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 599 8 2 7 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCOCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455820 94985 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL257074 94985 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 551 11 3 7 4.9 CCC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
44455869 97083 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270582 97083 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 7 4.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44289715 169657 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL444568 169657 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11340670 126699 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
CHEMBL365820 126699 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 7 2 3 5.8 CC(=O)c1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)ccc1F 10.1021/jm049530m
44289715 169657 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL444568 169657 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 465 8 2 6 3.8 Cc1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44445887 93772 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)CN(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249858 93772 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)CN(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445866 154412 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)CN(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL401159 154412 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)CN(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455847 154895 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403839 154895 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 501 9 2 6 4.7 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
10322255 62183 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178230 62183 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390945 62605 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 9 2 6 4.5 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178503 62605 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 507 9 2 6 4.5 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(C)C)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11154845 60378 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 6 2 2 5.8 Cc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL176077 60378 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 6 2 2 5.8 Cc1ccccc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11454015 132938 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2cc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL3706813 132938 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2cc[nH]c2c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
16126667 82639 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 425 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218174 82639 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 425 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C)c1 10.1016/j.bmcl.2006.08.012
44445839 154970 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCO[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL404213 154970 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.4 CC(=O)c1sc(NC(=O)N[C@@H]2CCCO[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455846 96998 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270147 96998 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 515 9 2 6 5.1 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455765 154809 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 543 8 2 6 4.6 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL403331 154809 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 543 8 2 6 4.6 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11751629 78579 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 464 6 3 3 5.4 O=C(Nc1ccc2c(c1)CCN2)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113080 78579 0 None - 0 Human 8.8 pIC50 = 8.8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 464 6 3 3 5.4 O=C(Nc1ccc2c(c1)CCN2)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
10458976 94556 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254930 94556 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 509 9 3 7 3.4 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445873 154413 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC(=O)N(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL401160 154413 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC(=O)N(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455766 95228 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258156 95228 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 8 2 6 4.3 C[C@H](C[C@@H](C)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455745 154750 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL402983 154750 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 559 8 3 7 4.0 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(Br)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455711 168157 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL437031 168157 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 509 9 3 7 3.8 CCc1cc(NC(=O)N[C@H](C)C[C@@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44390938 62611 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178506 62611 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11351206 69065 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccccc1F)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL193330 69065 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccccc1F)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11477384 132936 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 6 3 2 6.6 Cc1[nH]c2cc(NC(=O)N[C@@H]3CCCC[C@H]3CN3CCC[C@@H](Cc4ccc(F)cc4)C3)ccc2c1C 10.1021/jm049530m
CHEMBL3706811 132936 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 6 3 2 6.6 Cc1[nH]c2cc(NC(=O)N[C@@H]3CCCC[C@H]3CN3CCC[C@@H](Cc4ccc(F)cc4)C3)ccc2c1C 10.1021/jm049530m
44419301 83654 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 491 10 2 4 5.1 C#CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220765 83654 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 491 10 2 4 5.1 C#CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11953409 93768 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93768 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445845 93794 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250056 93794 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CCNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390837 63202 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180042 63202 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11419003 70549 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 4 4.9 O=C(Nc1nccs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195129 70549 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 4 4.9 O=C(Nc1nccs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44401328 70737 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195348 70737 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 462 6 3 2 5.9 O=C(Nc1ccc2[nH]ccc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
11373714 126640 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 427 6 2 4 4.2 Cn1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
CHEMBL365732 126640 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 427 6 2 4 4.2 Cn1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1021/jm049530m
9680 1859 4 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
9825034 1859 4 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
CHEMBL2178574 1859 4 None - 0 Human 8.0 pIC50 = 8 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 450 7 3 4 2.8 O=C(NCc1ccc(cc1)C(=O)N)NC[C@H]1OCCN(C1)Cc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
22393282 100723 0 None - 1 Human 8.0 pIC50 = 8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL295832 100723 0 None - 1 Human 8.0 pIC50 = 8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393282 100723 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL295832 100723 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11385178 124274 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1cccc(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364263 124274 0 None - 0 Human 8.0 pIC50 = 8 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1cccc(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
22393282 100723 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295832 100723 0 None - 1 Human 8.0 pIC50 = 8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44440398 92888 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 584 8 0 5 6.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(C2CCCCC2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL245310 92888 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 584 8 0 5 6.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(C2CCCCC2)n1C 10.1016/j.bmcl.2007.05.035
44440420 93086 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 608 9 0 6 5.8 COc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
CHEMBL246347 93086 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 608 9 0 6 5.8 COc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
44440424 148716 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 621 9 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N(C)C)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL394443 148716 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 621 9 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N(C)C)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440426 148719 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 613 8 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cnccc2Cl)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL394444 148719 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 613 8 0 6 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cnccc2Cl)n1C 10.1016/j.bmcl.2007.05.035
44440411 149546 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cccc(F)c2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395090 149546 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2cccc(F)c2)n1C 10.1016/j.bmcl.2007.05.035
44440414 150479 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 594 8 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(O)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395851 150479 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 594 8 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(O)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440417 150482 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 623 9 0 7 5.7 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc([N+](=O)[O-])cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395852 150482 0 None - 0 Human 7.0 pIC50 = 7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 623 9 0 7 5.7 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc([N+](=O)[O-])cc2)n1C 10.1016/j.bmcl.2007.05.035
44295264 186882 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 2 3 5.6 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ccco2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL49404 186882 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 2 3 5.6 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ccco2)c1 10.1016/s0960-894x(02)00206-8
44295664 188100 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50423 188100 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
44295405 188483 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 3 3 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ncc[nH]2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50988 188483 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 8 3 3 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2ncc[nH]2)c1 10.1016/s0960-894x(02)00206-8
22393436 188711 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 7 2 2 4.1 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC1CCCCC1 10.1016/s0960-894x(02)00206-8
CHEMBL51229 188711 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 7 2 2 4.1 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC1CCCCC1 10.1016/s0960-894x(02)00206-8
44295567 190049 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51815 190049 0 None - 0 Human 7.0 pIC50 = 7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
9979012 79377 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 411 7 1 5 4.4 O=C(CSc1nc2ccccc2s1)NCC1CCCN(Cc2ccccc2)C1 10.1016/s0960-894x(01)00176-7
CHEMBL21199 79377 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 411 7 1 5 4.4 O=C(CSc1nc2ccccc2s1)NCC1CCCN(Cc2ccccc2)C1 10.1016/s0960-894x(01)00176-7
44273640 98458 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 417 7 1 5 4.8 O=C(CSc1nc2ccccc2s1)NCC1CCCN(CC2CCCCC2)C1 10.1016/s0960-894x(01)00176-7
CHEMBL279450 98458 0 None - 0 Human 6.0 pIC50 = 6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 417 7 1 5 4.8 O=C(CSc1nc2ccccc2s1)NCC1CCCN(CC2CCCCC2)C1 10.1016/s0960-894x(01)00176-7
57401421 67508 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 486 6 1 3 5.1 O=C(NCCCN1CCC(c2ccc(F)cc2)CC1)C1=Cc2cc(Br)ccc2OCC1 10.1016/j.bmcl.2011.09.013
CHEMBL1910161 67508 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 486 6 1 3 5.1 O=C(NCCCN1CCC(c2ccc(F)cc2)CC1)C1=Cc2cc(Br)ccc2OCC1 10.1016/j.bmcl.2011.09.013
44440435 92993 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2ccccn2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL245956 92993 0 None - 0 Human 6.0 pIC50 = 6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2ccccn2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295529 186707 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 368 8 1 2 4.3 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL49296 186707 0 None - 0 Human 6.0 pIC50 = 6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 368 8 1 2 4.3 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44349617 117602 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CCC3C(C2)c2cccc4c2N3CC4)cc1 10.1021/jm0201767
CHEMBL340770 117602 0 None - 0 Human 6.0 pIC50 = 6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CCC3C(C2)c2cccc4c2N3CC4)cc1 10.1021/jm0201767
5481702 204099 1 None - 0 Human 5.0 pIC50 = 5 Binding
Compound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptorCompound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
CHEMBL83338 204099 1 None - 0 Human 5.0 pIC50 = 5 Binding
Compound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptorCompound concentration that causes 50 % inhibition of binding of specific radioligand to human CCR3 receptor
ChEMBL 556 8 0 4 5.3 CN(C[C@@H](CCN1CCC2(CC1)C[S+]([O-])c1ccccc12)c1cccc(Cl)c1)S(=O)(=O)c1ccccc1 10.1016/s0960-894x(00)00639-9
44442590 93326 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 606 11 6 5 3.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NC(C)C)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
CHEMBL247455 93326 0 None - 0 Human 5.0 pIC50 = 5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 606 11 6 5 3.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2NC(=O)NC(C)C)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
44295435 189051 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 6 1 4 2.7 O=S(=O)(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51512 189051 0 None - 0 Human 5.0 pIC50 = 5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 6 1 4 2.7 O=S(=O)(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44346194 15358 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL121905 15358 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
11006582 11336 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 2 4 5.5 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL1180359 11336 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 2 4 5.5 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL123616 11336 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 2 4 5.5 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11059789 16578 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124438 16578 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
10983981 16654 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124821 16654 1 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
10895831 117896 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 8 2 3 6.0 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL341074 117896 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 8 2 3 6.0 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44295486 101016 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1cccc(I)c1 10.1016/s0960-894x(02)00206-8
CHEMBL297945 101016 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1cccc(I)c1 10.1016/s0960-894x(02)00206-8
20576924 188640 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 364 5 0 3 4.0 O=C(CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51163 188640 0 None - 0 Human 6.0 pIC50 = 6.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 364 5 0 3 4.0 O=C(CCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
45270199 194734 0 None - 0 Mouse 6.0 pIC50 = 6.0 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
CHEMBL562897 194734 0 None - 0 Mouse 6.0 pIC50 = 6.0 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 516 5 1 4 4.2 O=C(NC1CC2CCC(C1)N2Cc1ccc2cc(F)ccc2c1)c1cc[n+]([O-])cc1C(=O)N1CCCCC1 10.1016/j.bmc.2009.06.066
44295408 188203 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 6 1 3 3.7 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C1CCCCC1 10.1016/s0960-894x(02)00206-8
CHEMBL50591 188203 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 6 1 3 3.7 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C1CCCCC1 10.1016/s0960-894x(02)00206-8
11101888 112794 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 421 5 2 2 6.0 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(c2ccccc2)CC1 10.1021/jm0201767
CHEMBL331530 112794 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 421 5 2 2 6.0 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(c2ccccc2)CC1 10.1021/jm0201767
10983308 17779 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.1 N#Cc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL126174 17779 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.1 N#Cc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
57392726 67514 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910167 67514 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 490 8 0 5 4.2 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
44346153 15313 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL121637 15313 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
44346154 168085 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL436363 168085 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
44440437 145918 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 600 9 0 8 4.9 Cc1ccnc(C)c1C(=O)N1CCC(N(CCc2ccc([N+](=O)[O-])cc2)Cc2c(C)n(C)n(-c3ccc(F)cc3)c2=O)CC1 10.1016/j.bmcl.2007.05.035
CHEMBL392218 145918 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 600 9 0 8 4.9 Cc1ccnc(C)c1C(=O)N1CCC(N(CCc2ccc([N+](=O)[O-])cc2)Cc2c(C)n(C)n(-c3ccc(F)cc3)c2=O)CC1 10.1016/j.bmcl.2007.05.035
23657036 145919 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 572 9 0 8 4.3 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3ccccn3)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL392219 145919 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 572 9 0 8 4.3 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3ccccn3)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44390848 121862 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360062 121862 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3cccc(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
9868532 60149 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL175502 60149 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11396995 69944 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 6 2 2 5.7 O=C(Nc1ccc(F)c(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL194384 69944 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 6 2 2 5.7 O=C(Nc1ccc(F)c(F)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44387837 123301 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL362465 123301 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
44419303 141303 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 517 11 2 4 5.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL386493 141303 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 517 11 2 4 5.7 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44390843 63833 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 477 9 2 7 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(OC)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180860 63833 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 477 9 2 7 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(OC)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44295374 101107 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 404 9 2 3 4.8 N#Cc1cccc(NC(=O)NCCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298681 101107 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 404 9 2 3 4.8 N#Cc1cccc(NC(=O)NCCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295352 188089 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 380 9 1 3 4.2 COc1cccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50400 188089 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 380 9 1 3 4.2 COc1cccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295372 188564 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 7 2 2 5.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51113 188564 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 7 2 2 5.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
10623381 16707 0 None - 1 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 2 3 5.3 NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL125111 16707 0 None - 1 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 2 3 5.3 NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
44349204 17011 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 350 5 0 2 3.8 CC1C2=C(CC=CC2)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125643 17011 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 350 5 0 2 3.8 CC1C2=C(CC=CC2)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
11037869 16529 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL124317 16529 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11037869 16529 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124317 16529 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 7 2 3 6.1 CC(=O)c1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44419314 82874 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218997 82874 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44593553 177782 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
CHEMBL465272 177782 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
44390891 63628 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180694 63628 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
44295544 188333 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 8 1 3 4.0 N#Cc1ccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL50801 188333 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 375 8 1 3 4.0 N#Cc1ccc(C(=O)NCCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
11826382 17075 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1ccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL125695 17075 1 None - 0 Human 5.9 pIC50 = 5.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1ccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
44419305 82205 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 535 10 2 4 6.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL217928 82205 0 None - 0 Human 5.9 pIC50 = 5.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 535 10 2 4 6.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(F)(F)F)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44390867 62235 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 7 2 6 3.4 CCc1cc(NC(=O)N[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178278 62235 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 7 2 6 3.4 CCc1cc(NC(=O)N[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11396851 60159 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL175559 60159 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
11247999 77601 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096763 77601 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10972522 16934 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 456 7 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL125549 16934 0 None - 0 Human 7.9 pIC50 = 7.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 456 7 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11004663 117086 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL340080 117086 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
10917990 16302 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 491 7 2 5 5.7 COc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL123580 16302 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 491 7 2 5 5.7 COc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
11729258 16651 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 409 8 0 3 5.1 N#CC(CCCN1CCN(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL124808 16651 0 None - 0 Human 4.9 pIC50 = 4.9 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 409 8 0 3 5.1 N#CC(CCCN1CCN(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
44419323 83706 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 390 8 3 3 4.5 N#Cc1cccc(NC(=O)NCCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220800 83706 0 None - 0 Human 6.9 pIC50 = 6.9 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 390 8 3 3 4.5 N#Cc1cccc(NC(=O)NCCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
11609863 16652 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 343 6 1 2 4.6 OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124813 16652 0 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 343 6 1 2 4.6 OC1(c2ccc(Cl)cc2)CCN(CCCCc2ccccc2)CC1 10.1021/jm0201767
44390851 123328 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL362613 123328 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
44442599 93203 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 585 9 5 5 3.3 Cc1cc(Br)ccc1CNC[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1N)C(=O)NC(C)(C)C 10.1016/j.bmcl.2007.07.028
CHEMBL246804 93203 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 585 9 5 5 3.3 Cc1cc(Br)ccc1CNC[C@H](NC(=O)CNC(=O)c1cccc(C(F)(F)F)c1N)C(=O)NC(C)(C)C 10.1016/j.bmcl.2007.07.028
44295145 190991 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(I)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51953 190991 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 502 5 2 3 4.0 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(I)cc1 10.1016/s0960-894x(02)00206-8
11059385 157839 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 1 2 5.6 O=C(Cc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL409001 157839 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 448 8 1 2 5.6 O=C(Cc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44440419 93085 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 603 8 0 6 5.6 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C#N)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246346 93085 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 603 8 0 6 5.6 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C#N)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440393 93470 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 586 10 0 5 6.8 Cc1c(CN(CCCCc2ccccc2)C2CCN(C(=O)c3cccc4ccccc34)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248178 93470 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 586 10 0 5 6.8 Cc1c(CN(CCCCc2ccccc2)C2CCN(C(=O)c3cccc4ccccc34)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
44445851 154032 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399133 154032 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44295354 188562 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 8 2 3 4.2 CN(C)c1ccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51110 188562 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 8 2 3 4.2 CN(C)c1ccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
23509664 193267 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54251 193267 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
9907041 167255 2 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 7 2 5 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccc(C)cc1 10.1016/s0960-894x(01)00248-7
CHEMBL430745 167255 2 None - 0 Human 4.8 pIC50 = 4.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 7 2 5 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NS(=O)(=O)c1ccc(C)cc1 10.1016/s0960-894x(01)00248-7
10974378 113785 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 664 12 3 4 7.4 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL333063 113785 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 664 12 3 4 7.4 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
71458114 79191 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL2114958 79191 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
10983419 116945 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 7 3 3 5.6 O=C(Nc1ccccc1)Nc1cccc(C(=O)O)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL339884 116945 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 461 7 3 3 5.6 O=C(Nc1ccccc1)Nc1cccc(C(=O)O)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295480 189009 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.2 COc1cccc(NC(=O)N2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51480 189009 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.2 COc1cccc(NC(=O)N2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
20613253 112830 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.4 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL331702 112830 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.4 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44281525 109202 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 314 6 2 5 1.7 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccn1 10.1016/s0960-894x(01)00248-7
CHEMBL32282 109202 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 314 6 2 5 1.7 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccn1 10.1016/s0960-894x(01)00248-7
10928228 16601 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 435 6 2 2 6.1 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124583 16601 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 435 6 2 2 6.1 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
10874167 170265 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 457 7 2 4 5.2 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL445379 170265 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 457 7 2 4 5.2 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
44281789 110849 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 454 8 1 5 4.8 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)OCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL32692 110849 0 None - 0 Human 7.8 pIC50 = 7.8 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 454 8 1 5 4.8 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)OCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11026634 112819 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL331634 112819 0 None - 0 Human 6.8 pIC50 = 6.8 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
22022826 16257 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.5 Cc1ccc(C(=O)NC(CN2C3CCC2CC(Cc2ccc(Cl)c(Cl)c2)C3)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL123308 16257 0 None - 0 Human 5.8 pIC50 = 5.8 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.5 Cc1ccc(C(=O)NC(CN2C3CCC2CC(Cc2ccc(Cl)c(Cl)c2)C3)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44419322 83940 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 362 6 3 3 3.7 N#Cc1cccc(NC(=O)NCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL221901 83940 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 362 6 3 3 3.7 N#Cc1cccc(NC(=O)NCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
15907328 162799 31 None - 0 Human 4.7 pIC50 = 4.7 Binding
Evaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cellsEvaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cells
ChEMBL 301 3 1 2 3.8 OC1(c2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL419244 162799 31 None - 0 Human 4.7 pIC50 = 4.7 Binding
Evaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cellsEvaluated for its inhibitory activity against human Chemokine receptor type 3 expressed in chinese hamster ovary cells
ChEMBL 301 3 1 2 3.8 OC1(c2ccc(Cl)cc2)CCN(Cc2ccccc2)CC1 10.1021/jm0201767
44447374 94278 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL253034 94278 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44289763 164488 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 412 7 2 3 4.3 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3F)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42264 164488 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 412 7 2 3 4.3 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3F)C2)c1 10.1016/j.bmcl.2004.01.059
22143196 183395 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 509 7 5 6 2.0 CSc1ccc(C(=O)NC2CCNCC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
CHEMBL481790 183395 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 509 7 5 6 2.0 CSc1ccc(C(=O)NC2CCNCC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
209394 116119 10 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 297 6 1 3 2.6 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33693 116119 10 None - 0 Human 6.7 pIC50 = 6.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 297 6 1 3 2.6 CCOC(=O)[C@H](Cc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
11814253 116442 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm0201767
CHEMBL338624 116442 0 None - 0 Human 4.7 pIC50 = 4.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cccc(C(F)(F)F)c1 10.1021/jm0201767
12000105 83812 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 10 2 3 5.7 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL221067 83812 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 453 10 2 3 5.7 CCCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11227406 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
CHEMBL250689 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm300682j
11272103 123843 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2008.11.002
CHEMBL363840 123843 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 505 7 2 6 4.7 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2008.11.002
44445876 93640 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249060 93640 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 501 7 2 6 4.2 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445856 93815 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250262 93815 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11227406 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44445892 93972 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC(=O)N(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251045 93972 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 572 9 2 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC(=O)N(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445840 94002 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCOC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251232 94002 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 488 7 2 6 4.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCOC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445894 154181 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C(C)=O)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399893 154181 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C3CCN(C(C)=O)CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
21362425 154452 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL401394 154452 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 584 8 2 7 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11227406 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL250689 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
44455509 165862 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL427728 165862 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.4 CCc1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455560 168702 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 517 9 2 8 3.8 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL441334 168702 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 517 9 2 8 3.8 C[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2ccnn2)cc(-n2ccnn2)c1 10.1016/j.bmcl.2007.11.067
11363006 70077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
CHEMBL194601 70077 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1 10.1021/jm049530m
11227406 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL250689 93896 1 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44401123 135744 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
CHEMBL373347 135744 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 516 7 2 5 4.9 N#CC1=CC(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)CC=C1n1cccn1 10.1021/jm049530m
11017618 11350 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 501 6 2 4 5.7 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL1180385 11350 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 501 6 2 4 5.7 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124689 11350 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 501 6 2 4 5.7 C[N+]1(Cc2cc3c(cc2NC(=O)Nc2cccc(C#N)c2)OCO3)CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11762511 16371 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 474 7 3 3 5.3 CNC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL123837 16371 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 474 7 3 3 5.3 CNC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11134936 16551 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 504 8 3 4 5.3 CNC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124334 16551 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 504 8 3 4 5.3 CNC(=O)c1cccc(NC(=O)Nc2cccc(OC)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11038430 16629 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124722 16629 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44570581 177831 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 10 2 8 3.1 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN(CCCc2ccc(F)cc2)C2CC2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL465942 177831 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 536 10 2 8 3.1 CN1C[C@@H](NC(=O)Nc2cccc(-c3nnnn3C)c2)[C@H](CN(CCCc2ccc(F)cc2)C2CC2)OC1=O 10.1016/j.bmcl.2008.11.002
44445847 93975 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251079 93975 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 487 7 3 6 3.8 CC(=O)c1sc(NC(=O)N[C@@H]2CNCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445878 154049 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399150 154049 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 557 8 2 6 4.7 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445880 154685 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL402707 154685 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
21362416 93637 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C(C)=O)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249058 93637 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 612 8 2 7 4.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C3CCN(C(C)=O)CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390927 62656 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 9 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178671 62656 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 493 9 2 6 4.3 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2CC)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390894 121832 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360039 121832 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.0 CCc1cc(NC(=O)NC[C@H]2CCCN(CCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
11179351 124081 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 7 2 5 5.0 O=C(Nc1ccc(-n2cncn2)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364068 124081 0 None - 0 Human 8.7 pIC50 = 8.7 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 7 2 5 5.0 O=C(Nc1ccc(-n2cncn2)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44419300 83575 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 499 11 2 4 5.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCF)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220713 83575 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 499 11 2 4 5.4 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCF)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
795 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
796 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
9913085 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
CHEMBL20921 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(03)00748-0
795 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
796 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
9913085 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
CHEMBL20921 568 3 None - 1 Human 8.6 pIC50 = 8.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 10.1016/s0960-894x(01)00176-7
44445875 93638 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCO)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249059 93638 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CCO)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445859 154236 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL400173 154236 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44401561 123589 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL363373 123589 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 463 6 3 3 5.3 O=C(Nc1ccc2[nH]ncc2c1)N[C@@H]1CCCC[C@H]1CN1CCCC(Cc2ccc(F)cc2)C1 10.1021/jm049530m
11750808 125662 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 431 6 2 5 4.3 O=C(Nc1nncs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364977 125662 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 431 6 2 5 4.3 O=C(Nc1nncs1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44346210 167381 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL431670 167381 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44455845 96997 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL270146 96997 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 537 10 3 7 4.5 CC[C@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2nnnn2C)cc(C(C)(C)O)c1 10.1016/j.bmcl.2007.11.067
44289713 165544 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 527 9 2 6 5.2 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2ccccc2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42599 165544 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 527 9 2 6 5.2 Cn1nnnc1-c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2ccccc2)c1 10.1016/j.bmcl.2004.01.059
44419335 83712 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 10 2 3 5.7 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC2CC2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220819 83712 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 10 2 3 5.7 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC2CC2)c1 10.1016/j.bmcl.2006.08.012
44447140 94105 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 4.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CCCCC1 10.1016/j.bmcl.2007.11.087
CHEMBL251839 94105 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 4.2 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)C1CCCCC1 10.1016/j.bmcl.2007.11.087
44447154 94241 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 559 13 3 7 4.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)Cc2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL252792 94241 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 559 13 3 7 4.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)Cc2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447380 94436 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)CCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL254093 94436 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 483 11 3 7 3.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)CCc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44445907 94379 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 409 7 2 3 4.6 CC(=O)c1cccc(NC(=O)N/C=C/CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL253676 94379 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 409 7 2 3 4.6 CC(=O)c1cccc(NC(=O)N/C=C/CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44445883 154686 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL402708 154686 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44290039 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL46905 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.11.067
11430170 123302 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL362466 123302 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 2 5.5 O=C(Nc1ccccc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11385766 132262 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL370082 132262 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44290039 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL46905 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
44290039 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL46905 178214 0 None - 1 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44445849 94003 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251243 94003 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 573 7 2 7 5.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445889 154315 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CN(Cc3ccco3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL400649 154315 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 567 9 2 7 5.4 CC(=O)c1sc(NC(=O)N[C@@H]2CN(Cc3ccco3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44289919 100671 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL295415 100671 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455683 154537 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL401879 154537 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 531 9 3 7 4.4 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-n2cccn2)cc(-n2cccn2)c1 10.1016/j.bmcl.2007.11.067
44455485 154948 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404122 154948 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 507 9 2 6 5.0 CC(C)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44455484 166841 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL429604 166841 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 493 9 2 6 4.6 CC(C)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
44387842 130766 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
CHEMBL368683 130766 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 369 5 2 3 4.2 CC(=O)c1cccc(NC(=O)NN2CCCCC2Cc2ccc(F)cc2)c1 10.1021/jm049530m
10457573 116534 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 473 8 2 3 6.2 CC(=O)c1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL339110 116534 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 473 8 2 3 6.2 CC(=O)c1cccc(NC(=O)Nc2ccccc2CCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44289919 100671 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295415 100671 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 493 9 2 7 3.7 CC(=O)c1cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.01.059
44445893 153866 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL398889 153866 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CC3CC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455459 94635 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL255398 94635 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44455460 94636 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ncco2)cc(-c2ncco2)c1 10.1016/j.bmcl.2007.11.067
CHEMBL255399 94636 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 533 9 3 7 5.3 C[C@H](C[C@@H](O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cc(-c2ncco2)cc(-c2ncco2)c1 10.1016/j.bmcl.2007.11.067
44455767 95264 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@@H](C)C[C@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258309 95264 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 483 9 3 5 4.4 CC(=O)c1cc(NC(=O)N[C@@H](C)C[C@H](O)N2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
11487192 69317 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 428 6 2 4 4.8 Cc1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)no1 10.1021/jm049530m
CHEMBL193526 69317 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 428 6 2 4 4.8 Cc1cc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)no1 10.1021/jm049530m
44445896 153987 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCO)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399088 153987 0 None - 0 Human 8.6 pIC50 = 8.6 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 531 9 3 7 3.6 CC(=O)c1sc(NC(=O)N[C@@H]2CN(CCO)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445855 154235 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL400172 154235 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CCCC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11113940 79157 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 509 8 1 6 5.9 CCOc1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
CHEMBL21143 79157 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 509 8 1 6 5.9 CCOc1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
44440402 93471 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL248179 93471 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295648 101517 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 9 3 4 4.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](C)O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL301601 101517 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 9 3 4 4.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](C)O)c1 10.1016/s0960-894x(02)00206-8
44295555 101571 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL301974 101571 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393430 168126 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43677 168126 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393339 186144 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL48873 186144 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 410 7 2 3 4.7 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(Cl)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295306 188286 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50726 188286 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393469 188775 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51286 188775 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
44295566 193037 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL53444 193037 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
22393430 168126 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43677 168126 0 None - 1 Human 7.7 pIC50 = 7.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44440429 93197 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 580 8 0 5 5.4 Cc1c(CN(CCc2ccc(F)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246768 93197 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 580 8 0 5 5.4 Cc1c(CN(CCc2ccc(F)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440445 146202 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 0 6 4.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3cccc[n+]3[O-])CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL392430 146202 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 0 6 4.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3cccc[n+]3[O-])CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295674 101149 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 483 10 2 3 6.0 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2Cc2ccccc2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298999 101149 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 483 10 2 3 6.0 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2Cc2ccccc2)c1 10.1016/s0960-894x(02)00206-8
22393362 101206 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00206-8
CHEMBL299385 101206 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1C(F)(F)F 10.1016/s0960-894x(02)00206-8
9842640 166809 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL42948 166809 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295267 187639 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL49938 187639 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
44295406 187770 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 3 6.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2cccs2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50129 187770 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 3 6.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(-c2cccs2)c1 10.1016/s0960-894x(02)00206-8
44295664 188100 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50423 188100 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 435 10 2 3 5.5 CCC[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
22393307 188175 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3F)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50557 188175 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3F)CC2)c1 10.1016/s0960-894x(02)00206-8
44295304 188529 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 9 3 4 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(C)O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51052 188529 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 9 3 4 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(C)O)c1 10.1016/s0960-894x(02)00206-8
22393366 191912 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL52094 191912 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 411 8 2 3 4.5 CC(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
9842640 166809 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42948 166809 0 None - 1 Human 6.7 pIC50 = 6.7 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44349614 117933 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 402 5 0 3 3.6 O=C1CC2(CCc3ccccc32)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
CHEMBL341144 117933 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 402 5 0 3 3.6 O=C1CC2(CCc3ccccc32)C(=O)N1CC1CCN(CCc2ccccc2)CC1 10.1021/jm0201767
44281791 115758 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 406 7 1 5 4.0 CC(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33589 115758 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 406 7 1 5 4.0 CC(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11103845 12005 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 455 6 3 3 5.5 C[N+]1(Cc2cc(O)ccc2NC(=O)Nc2cccc(C#N)c2)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL1184106 12005 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 455 6 3 3 5.5 C[N+]1(Cc2cc(O)ccc2NC(=O)Nc2cccc(C#N)c2)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL332591 12005 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 455 6 3 3 5.5 C[N+]1(Cc2cc(O)ccc2NC(=O)Nc2cccc(C#N)c2)CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11812807 16386 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.5 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL123917 16386 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.5 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44447161 94430 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 12 3 8 2.3 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)S(C)(=O)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254055 94430 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 12 3 8 2.3 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)S(C)(=O)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44447153 153386 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 617 13 3 7 5.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC23CC4CC(CC(C4)C2)C3)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL398344 153386 0 None - 0 Human 6.7 pIC50 = 6.7 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 617 13 3 7 5.6 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC23CC4CC(CC(C4)C2)C3)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44419314 82874 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218997 82874 0 None - 0 Human 7.7 pIC50 = 7.7 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
11828215 113948 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 613 12 3 3 7.1 O=C(NCCc1ccc(F)cc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL333422 113948 1 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 613 12 3 3 7.1 O=C(NCCc1ccc(F)cc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11104005 116844 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 602 12 3 4 6.2 O=C(NCCN1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL339752 116844 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 602 12 3 4 6.2 O=C(NCCN1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11813735 117629 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 562 12 3 4 5.3 CN(C)CCNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL340797 117629 0 None - 0 Human 5.7 pIC50 = 5.7 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 562 12 3 4 5.3 CN(C)CCNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11730610 16491 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 2 5 5.7 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL124272 16491 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 2 5 5.7 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
44390949 64059 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181311 64059 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
44512617 193658 0 None - 0 Mouse 6.6 pIC50 = 6.6 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
CHEMBL551735 193658 0 None - 0 Mouse 6.6 pIC50 = 6.6 Binding
Inhibition of mouse CCR3Inhibition of mouse CCR3
ChEMBL 487 5 2 4 4.2 O=C(C=C1CCN(C(=O)c2ccccc2O)CC1)N[C@@H]1CCN(Cc2ccc3cc(F)ccc3c2)C1 10.1016/j.bmc.2009.06.066
44295686 162439 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 407 5 1 3 4.6 COc1cccc(NC(=O)N2CCC(N3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL417547 162439 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 407 5 1 3 4.6 COc1cccc(NC(=O)N2CCC(N3CCC(Cc4ccccc4)CC3)CC2)c1 10.1016/s0960-894x(02)00206-8
10995218 16423 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 549 12 4 4 5.1 O=C(NCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL124127 16423 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 549 12 4 4 5.1 O=C(NCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
9982077 16395 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 468 6 2 5 5.4 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL123962 16395 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 468 6 2 5 5.4 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccccc4)CC2)OCO3)c1 10.1021/jm0201767
44447373 94224 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
CHEMBL252628 94224 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
10863252 170780 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.5 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL446164 170780 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.5 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295479 101073 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 6 1 3 4.6 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298414 101073 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 6 1 3 4.6 COc1cccc(NC(=O)N2CCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
11285792 864 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
801 864 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
CHEMBL2110727 864 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
DB11758 864 30 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from CCR3 expressed in CHO cells
ChEMBL 696 17 1 7 8.7 CCCCOCCOc1ccc(cc1)c1ccc2c(c1)C=C(CCCN2CC(C)C)C(=O)Nc1ccc(cc1)[S@@](=O)Cc1cncn1CCC 10.1021/jm0509703
10983106 16733 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL125282 16733 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 443 8 2 3 5.5 COc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
11124782 117952 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 587 11 3 3 7.3 O=C(NCC1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL341306 117952 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 587 11 3 3 7.3 O=C(NCC1CCCCC1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
22393396 167696 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3cccc(F)c3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43391 167696 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3cccc(F)c3)C2)c1 10.1016/j.bmcl.2004.01.059
11732727 16456 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 3 3 5.3 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124206 16456 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 3 3 5.3 O=C(Nc1ccccc1)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
44440396 152521 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 579 8 0 6 5.2 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccn2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL397599 152521 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 579 8 0 6 5.2 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccn2)n1C 10.1016/j.bmcl.2007.05.035
44440427 93196 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 609 9 0 7 5.2 COc1ccncc1-n1c(=O)c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(C)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246766 93196 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 609 9 0 7 5.2 COc1ccncc1-n1c(=O)c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(C)n1C 10.1016/j.bmcl.2007.05.035
44295499 188758 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 7 1 3 5.4 COc1cccc(NC(=O)N2CCCC(CCN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51267 188758 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 7 1 3 5.4 COc1cccc(NC(=O)N2CCCC(CCN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44440422 93087 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 622 9 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C(=O)O)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246348 93087 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 622 9 1 6 5.5 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(C(=O)O)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440440 93198 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 1 6 4.8 Cc1c(CN(CCc2ccc(N)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246769 93198 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 577 8 1 6 4.8 Cc1c(CN(CCc2ccc(N)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44440434 152817 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2cccnc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL397853 152817 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 563 8 0 6 4.6 Cc1c(CN(CCc2cccnc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44295409 101181 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 355 5 1 3 3.2 CC(C)(C)C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
CHEMBL299226 101181 0 None - 0 Human 4.6 pIC50 = 4.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 355 5 1 3 3.2 CC(C)(C)C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
44295433 186467 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL49117 186467 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
23497297 16680 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 3 5 5.4 O=C(Nc1ccc2c[nH]nc2c1)Nc1cc2c(cc1CN1CCC(Cc3ccccc3)CC1)OCO2 10.1021/jm0201767
CHEMBL124966 16680 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 483 6 3 5 5.4 O=C(Nc1ccc2c[nH]nc2c1)Nc1cc2c(cc1CN1CCC(Cc3ccccc3)CC1)OCO2 10.1021/jm0201767
11001953 113621 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 327 7 2 4 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Cc1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33290 113621 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 327 7 2 4 2.2 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)Cc1ccccc1 10.1016/s0960-894x(01)00248-7
11825113 16692 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 381 8 3 3 3.6 O=C(NCCCO)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125026 16692 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 381 8 3 3 3.6 O=C(NCCCO)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11762865 16369 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 9 2 2 7.1 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL123807 16369 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 9 2 2 7.1 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
44570714 189192 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 565 9 5 6 3.6 CSc1ccc(C(=O)NC2CCC(NC(C)C)CC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
CHEMBL516224 189192 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 565 9 5 6 3.6 CSc1ccc(C(=O)NC2CCC(NC(C)C)CC2NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)cc1 10.1016/j.bmcl.2008.12.062
11048458 117961 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 440 6 3 4 5.4 N#Cc1cccc(NC(=O)Nc2ccc(O)cc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL341343 117961 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 440 6 3 4 5.4 N#Cc1cccc(NC(=O)Nc2ccc(O)cc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
71449114 78522 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCCC(Cc3ccccc3)C2)c1 10.1021/jm049530m
CHEMBL2112987 78522 0 None - 0 Human 7.6 pIC50 = 7.6 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCCC(Cc3ccccc3)C2)c1 10.1021/jm049530m
10928173 76175 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL20612 76175 0 None - 0 Human 6.6 pIC50 = 6.6 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2cccc(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
10950225 116958 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.3 N#Cc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL339934 116958 0 None - 0 Human 5.6 pIC50 = 5.6 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 438 7 2 3 5.3 N#Cc1cccc(NC(=O)NCc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
76316987 103047 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 9 2 6 3.9 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL3085295 103047 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 9 2 6 3.9 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
11408397 77590 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096695 77590 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
22393329 100644 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295229 100644 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44390970 63718 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 533 8 2 6 4.4 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180728 63718 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 533 8 2 6 4.4 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2C(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390971 122592 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 541 9 2 6 5.0 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL361130 122592 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 541 9 2 6 5.0 CCc1cc(NC(=O)NC[C@H]2CN(CCc3ccc(F)cc3)CC[C@@H]2c2ccccc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44387856 130907 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 7 2 3 5.5 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL369073 130907 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 7 2 3 5.5 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
11465468 166473 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL428881 166473 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
44281521 99923 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 370 7 1 5 3.1 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccc(C)cc1C 10.1016/s0960-894x(01)00248-7
CHEMBL290104 99923 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 370 7 1 5 3.1 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccc(C)cc1C 10.1016/s0960-894x(01)00248-7
10255492 117645 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL340853 117645 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 502 8 3 4 5.2 CC(=O)c1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11733617 160695 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL411956 160695 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2cccc(C(N)=O)c2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44289910 100728 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 529 8 2 6 4.2 Cn1nnnc1-c1cc(Br)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295898 100728 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 529 8 2 6 4.2 Cn1nnnc1-c1cc(Br)cc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44290019 100739 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 479 9 2 6 4.5 CC(C)n1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL295970 100739 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 479 9 2 6 4.5 CC(C)n1nnnc1-c1cccc(NC(=O)NCCCN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44447149 94490 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 4.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CCCCC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254470 94490 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 4.7 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C2CCCCC2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445862 94005 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251274 94005 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 555 8 2 6 4.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)C3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390954 63522 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)c(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180351 63522 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 483 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)c(F)c3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44445861 93842 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL250436 93842 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 8 2 6 4.5 CCC(=O)N1CC[C@@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)[C@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)C1 10.1016/j.bmcl.2007.03.065
44447378 154289 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL400467 154289 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 527 12 4 8 2.8 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CC)[C@@H](C)[C@H](O)Cc2ccc(F)cc2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44390838 127975 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL366710 127975 0 None - 0 Human 8.5 pIC50 = 8.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44419299 141146 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 510 11 3 5 3.9 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(N)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL385607 141146 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 510 11 3 5 3.9 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CC(N)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
11953409 93768 0 None - 0 Mouse 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249854 93768 0 None - 0 Mouse 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 529 7 2 6 4.1 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(C)=O)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44445877 93766 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249851 93766 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 583 8 2 6 5.3 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)C3CCCC3)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390964 62254 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL178287 62254 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 481 8 2 6 4.2 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44289877 165477 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 5 4.3 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2nnco2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42562 165477 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 5 4.3 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2nnco2)c1 10.1016/j.bmcl.2004.01.059
11213457 94312 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 465 9 3 6 3.9 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CNCCCc2ccc(F)cc2)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253209 94312 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 465 9 3 6 3.9 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CNCCCc2ccc(F)cc2)c1 10.1016/j.bmcl.2007.11.087
44390919 121526 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 8 2 6 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL359609 121526 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 447 8 2 6 3.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44419306 140843 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 2 4 5.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL383879 140843 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 2 4 5.0 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44295434 101084 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL298505 101084 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCO[C@H](CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44295362 161660 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 369 7 2 2 4.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL416305 161660 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 369 7 2 2 4.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
22393419 164866 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL42388 164866 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
23509697 193271 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54273 193271 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 440 6 2 4 3.6 COc1cccc(NC(=O)N2CCNC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
22393419 164866 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42388 164866 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 399 8 2 3 4.3 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
9951883 168116 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43666 168116 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
22393378 188364 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 397 9 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCCc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL50829 188364 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 397 9 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCCc1ccccc1 10.1016/s0960-894x(02)00206-8
9951883 168116 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43666 168116 0 None - 1 Human 6.5 pIC50 = 6.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/j.bmcl.2004.01.059
11734303 168001 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 547 9 3 3 6.5 CC(C)(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL435812 168001 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 547 9 3 3 6.5 CC(C)(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11396966 78580 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 457 6 2 2 6.1 O=C(Nc1cccc(Cl)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL2113082 78580 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 457 6 2 2 6.1 O=C(Nc1cccc(Cl)c1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44289762 165371 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 380 7 2 3 3.8 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL42507 165371 0 None - 1 Human 7.5 pIC50 = 7.5 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 380 7 2 3 3.8 N#Cc1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
11059280 116392 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 442 6 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL338389 116392 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 442 6 2 3 5.8 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11037958 75603 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1021/jm300682j
CHEMBL20532 75603 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1021/jm300682j
11037958 75603 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL20532 75603 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 465 6 1 5 5.5 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/s0960-894x(01)00176-7
44440394 93277 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 578 8 0 5 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL247160 93277 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 578 8 0 5 5.8 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2)n1C 10.1016/j.bmcl.2007.05.035
9927733 116387 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 336 6 2 3 3.1 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33838 116387 1 None - 0 Human 6.5 pIC50 = 6.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 336 6 2 3 3.1 CCOC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
9888454 101396 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccccc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL300726 101396 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 421 6 1 3 4.9 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccccc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44281522 111011 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 391 6 1 4 3.2 CN(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL32784 111011 0 None - 0 Human 4.5 pIC50 = 4.5 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 391 6 1 4 3.2 CN(C)C(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11133428 16534 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 413 7 2 2 5.5 O=C(NCc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124321 16534 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 413 7 2 2 5.5 O=C(NCc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
10863284 18356 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 7 2 2 6.1 O=C(Nc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL127590 18356 0 None - 0 Human 7.5 pIC50 = 7.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 7 2 2 6.1 O=C(Nc1ccc(F)cc1)Nc1ccccc1CCN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44390931 122404 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360653 122404 0 None - 0 Human 6.5 pIC50 = 6.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(CCc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
76320703 103048 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL3085296 103048 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
10875472 113147 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 568 10 3 4 6.6 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccncc1 10.1021/jm0201767
CHEMBL332277 113147 0 None - 0 Human 5.5 pIC50 = 5.5 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 568 10 3 4 6.6 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccncc1 10.1021/jm0201767
9981262 64509 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL182087 64509 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
10874195 163793 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL421273 163793 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2cc(CO)ccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
11112528 16619 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 417 6 2 2 5.9 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124669 16619 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 417 6 2 2 5.9 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295487 168586 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 444 5 2 3 4.5 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL440477 168586 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 444 5 2 3 4.5 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
11145481 113056 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL332227 113056 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
22393395 168288 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3F)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43818 168288 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 394 7 2 3 4.2 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3F)C2)c1 10.1016/j.bmcl.2004.01.059
44390857 63284 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 9 2 7 3.6 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(N(C)C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180082 63284 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 490 9 2 7 3.6 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(N(C)C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
10939210 16714 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 445 8 2 2 5.6 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125167 16714 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 445 8 2 2 5.6 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11722772 98120 0 None - 2 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 307 7 0 1 5.0 c1ccc(CCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL276784 98120 0 None - 2 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 307 7 0 1 5.0 c1ccc(CCCCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
77033 113283 75 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 313 6 2 4 2.3 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL33242 113283 75 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 313 6 2 4 2.3 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
22966052 83795 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220866 83795 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44289959 99940 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2CC3(Cc4ccc(F)cc4)CCC2CC3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL290276 99940 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2CC3(Cc4ccc(F)cc4)CCC2CC3)c1 10.1016/j.bmcl.2004.01.059
44290040 171888 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL44817 171888 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 411 8 2 3 4.5 CC(=O)c1cccc(NC(=O)NCCCN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.01.059
44295259 161993 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 393 6 1 3 3.6 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL416835 161993 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 393 6 1 3 3.6 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
9935588 16705 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1ccccc1CN1CCC(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125108 16705 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 496 8 2 3 5.9 O=C(Nc1ccccc1CN1CCC(Cc2ccccc2)CC1)NC1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
10874991 163795 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 9 2 3 6.7 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL421274 163795 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 9 2 3 6.7 O=C(NCC(c1ccccc1)c1ccccc1)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
44445874 94065 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251623 94065 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 541 9 2 6 5.0 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(CC3CC3)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44455792 95266 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL258323 95266 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 465 8 2 6 3.9 C[C@@H](CCN1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
11214474 70994 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL195790 70994 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 514 6 2 4 6.7 O=C(Nc1nc2c(Cl)cccc2s1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
11442439 123526 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
CHEMBL363166 123526 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc1F 10.1021/jm049530m
9804542 129749 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
CHEMBL367992 129749 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm049530m
44419340 83941 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 451 10 2 3 5.4 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL221903 83941 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 451 10 2 3 5.4 C=CCN1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
10140602 166054 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
CHEMBL428071 166054 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 479 7 2 6 3.4 C[C@H](CC(=O)N1CCC[C@@H](Cc2ccc(F)cc2)C1)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.067
20636465 83661 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 4 4 4.3 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(=N)N)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220766 83661 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 495 9 4 4 4.3 CC(=O)c1cc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2C(=N)N)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44346153 15313 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL121637 15313 0 None - 0 Human 8.4 pIC50 = 8.4 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 519 8 3 5 4.1 C[C@H](O)[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
11259591 124990 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(F)cc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL364673 124990 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 455 6 2 2 5.9 Cc1ccc(F)cc1NC(=O)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44346194 15358 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL121905 15358 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Compound was tested for its ability to inhibit C-C chemokine receptor type 3 receptorCompound was tested for its ability to inhibit C-C chemokine receptor type 3 receptor
ChEMBL 501 9 2 5 5.4 COc1cc(NC(=O)N[C@H](C)CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44445879 93767 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL249852 93767 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 545 7 2 7 4.3 COC(=O)N1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
44440412 150477 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2F)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL395850 150477 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 596 8 0 5 5.9 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccccc2F)n1C 10.1016/j.bmcl.2007.05.035
44295554 187750 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL50094 187750 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 415 8 2 3 5.0 CSc1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
23509693 190887 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51937 190887 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 540 6 1 5 5.2 COc1cccc(NC(=O)N2CCN(C(=O)OC(C)(C)C)C(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
10029075 116319 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 7 2 5 5.9 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL337990 116319 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 503 7 2 5 5.9 CC(=O)c1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
44440423 146165 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 635 9 1 6 5.7 CC(=O)Nc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
CHEMBL392405 146165 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 635 9 1 6 5.7 CC(=O)Nc1ccc(-n2c(=O)c(CN(CCc3ccc(Cl)cc3)C3CCN(C(=O)c4c(F)cccc4F)CC3)c(C)n2C)cc1 10.1016/j.bmcl.2007.05.035
22393428 188059 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 383 8 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL50354 188059 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 383 8 2 2 4.0 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NCc1ccccc1 10.1016/s0960-894x(02)00206-8
22393333 188805 4 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 351 7 2 2 4.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL51307 188805 4 None - 0 Human 6.4 pIC50 = 6.4 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 351 7 2 2 4.2 O=C(NCCCN1CCC(Cc2ccccc2)CC1)Nc1ccccc1 10.1016/s0960-894x(02)00206-8
44281523 99214 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 453 8 2 4 4.4 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL284577 99214 0 None - 0 Human 5.4 pIC50 = 5.4 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 453 8 2 4 4.4 O=C(N[C@@H](Cc1ccc([N+](=O)[O-])cc1)C(=O)NCc1ccccc1)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11282712 78111 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
CHEMBL2112049 78111 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
22393315 168106 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43655 168106 0 None - 1 Human 7.4 pIC50 = 7.4 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 376 7 2 3 4.0 N#Cc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
11134412 164078 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 465 7 3 3 5.6 O=C(Nc1cc(F)ccc1F)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL421634 164078 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 465 7 3 3 5.6 O=C(Nc1cc(F)ccc1F)Nc1ccccc1C(O)CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
10864223 16690 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL125012 16690 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44447142 94219 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 589 12 3 7 5.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC12CC3CC(CC(C3)C1)C2 10.1016/j.bmcl.2007.11.087
CHEMBL252610 94219 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 589 12 3 7 5.0 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC12CC3CC(CC(C3)C1)C2 10.1016/j.bmcl.2007.11.087
9845853 127940 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL366654 127940 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
44593546 178170 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL468695 178170 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44445853 154033 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL399134 154033 0 None - 0 Human 7.4 pIC50 = 7.4 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
11144348 16392 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2cccc(CN3CCC(Cc4ccccc4)CC3)c2)c1 10.1021/jm0201767
CHEMBL123957 16392 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2cccc(CN3CCC(Cc4ccccc4)CC3)c2)c1 10.1021/jm0201767
11048445 16572 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2[nH]ncc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124390 16572 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2[nH]ncc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11091447 168813 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2c[nH]nc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL442210 168813 0 None - 0 Human 6.4 pIC50 = 6.4 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1ccc2c[nH]nc2c1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
6918497 112918 1 None - 0 Mouse 6.3 pIC50 = 6.3 Binding
Inhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptorsInhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL277930 112918 1 None - 0 Mouse 6.3 pIC50 = 6.3 Binding
Inhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptorsInhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
CHEMBL331897 112918 1 None - 0 Mouse 6.3 pIC50 = 6.3 Binding
Inhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptorsInhibitory activity against I-Eotaxin alpha binding to mouse CCR3 receptors
ChEMBL 527 5 1 2 7.6 CC[N+]1(C/C2=C/CCCCCC2)CCC(NC(=O)C2c3cc(Cl)ccc3Oc3ccc(Cl)cc32)CC1 10.1021/jm0004244
10916572 18316 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 408 8 0 2 6.2 N#CC(CCCN1CCC(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL127395 18316 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 408 8 0 2 6.2 N#CC(CCCN1CCC(Cc2ccccc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11102400 117578 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 6 2 3 5.7 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL340656 117578 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 449 6 2 3 5.7 O=C(Nc1cc(F)ccc1F)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
10906911 17791 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.4 COc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL126220 17791 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 477 8 3 4 5.4 COc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
68826395 103018 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL3085118 103018 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
10984360 96488 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 537 8 1 7 5.7 CCOC(=O)c1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
CHEMBL266181 96488 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 537 8 1 7 5.7 CCOC(=O)c1ccc2nc(SCC(=O)NC3CCN(Cc4ccc(Cl)c(Cl)c4)CC3)sc2c1 10.1016/s0960-894x(01)00176-7
44295375 167579 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 6 2 4 3.5 CN(C)c1ccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL433086 167579 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 419 6 2 4 3.5 CN(C)c1ccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
9840971 99265 41 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 342 7 1 5 2.5 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL284954 99265 41 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 342 7 1 5 2.5 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
11733139 16709 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.2 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL125132 16709 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 454 7 3 4 5.2 N#Cc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
44289699 167241 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43066 167241 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
10474776 113145 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(03)00748-0
CHEMBL33227 113145 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(03)00748-0
44390842 123306 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL362490 123306 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
44295485 101389 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 497 12 3 4 5.4 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccc(F)cc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL300699 101389 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 497 12 3 4 5.4 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccc(F)cc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
22393287 167390 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL43173 167390 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
11316656 69904 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL194141 69904 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 441 6 2 2 5.6 O=C(Nc1ccc(F)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
10474776 113145 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
22393287 167390 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL43173 167390 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 451 8 2 6 3.5 Cn1nnnc1-c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.01.059
44593553 177782 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
CHEMBL465272 177782 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 489 6 2 6 3.9 Cc1csc(NC(=O)NC2(C)CN(C)C(=O)OC2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)n1 10.1016/j.bmcl.2008.11.002
44593546 178170 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
CHEMBL468695 178170 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 531 6 2 6 4.9 CN1CC(C)(NC(=O)Nc2nc(C(C)(C)C)cs2)C(CN2CCC[C@@H](Cc3ccc(F)cc3)C2)OC1=O 10.1016/j.bmcl.2008.11.002
44390911 63461 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3Cl)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180229 63461 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(Cl)cc3Cl)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44390859 131255 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL369331 131255 0 None - 0 Human 8.3 pIC50 = 8.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 465 8 2 6 3.7 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccccc3F)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44447369 94161 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL252222 94161 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H]([C@H](O)c1ccccc1)N(C)C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44419308 140986 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 10 2 4 5.4 CCC(=O)N1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
CHEMBL384649 140986 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 509 10 2 4 5.4 CCC(=O)N1CC[C@@H](Cc2ccc(F)cc2)C[C@@H]1CCCNC(=O)Nc1cc(C(C)=O)cc(C(C)=O)c1 10.1016/j.bmcl.2006.08.012
44455872 154965 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
CHEMBL404202 154965 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 receptor expressed in CHO cells
ChEMBL 467 9 2 4 5.1 CC(=O)c1cc(NC(=O)N[C@@H](C)CCN2CCC[C@@H](Cc3ccc(F)cc3)C2)cc(C(C)=O)c1 10.1016/j.bmcl.2007.11.067
44295622 101008 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL297904 101008 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 10 3 4 4.7 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@@H](O)C(C)C)c1 10.1016/s0960-894x(02)00206-8
44295286 187705 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50034 187705 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 431 8 2 3 4.0 C[S+]([O-])c1cccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295672 188160 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50535 188160 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 439 6 1 3 5.0 COc1cccc(NC(=O)N2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44295641 188729 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 9 4 5 3.4 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(O)O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51244 188729 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 453 9 4 5 3.4 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2C(C)(O)O)c1 10.1016/s0960-894x(02)00206-8
23509695 189137 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL51584 189137 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 441 6 1 4 4.0 COc1cccc(NC(=O)N2CCOC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
44295364 193273 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54290 193273 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
22257689 16389 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.0 Cc1ccc(C(=O)NC(CN2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL123943 16389 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 446 7 1 2 6.0 Cc1ccc(C(=O)NC(CN2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44346211 163330 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 537 10 2 5 6.5 COc1cc(NC(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL420709 163330 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 537 10 2 5 6.5 COc1cc(NC(=O)NC(CC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)C(C)C)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44295130 100714 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 362 6 2 3 3.6 N#Cc1cccc(NC(=O)NCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL295726 100714 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 362 6 2 3 3.6 N#Cc1cccc(NC(=O)NCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
44295528 101424 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL300905 101424 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 336 4 0 2 4.0 Fc1ccc(CCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
22393370 189253 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 7 2 3 4.3 Cc1ccc(CC2CCN(CCCNC(=O)Nc3cccc(C#N)c3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51676 189253 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 7 2 3 4.3 Cc1ccc(CC2CCN(CCCNC(=O)Nc3cccc(C#N)c3)CC2)cc1 10.1016/s0960-894x(02)00206-8
22393398 193238 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 8 2 3 4.4 N#Cc1cccc(NC(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL54143 193238 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 390 8 2 3 4.4 N#Cc1cccc(NC(=O)NCCCCN2CCC(Cc3ccccc3)CC2)c1 10.1016/s0960-894x(02)00206-8
10979426 17765 1 None - 0 Human 4.3 pIC50 = 4.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 298 7 3 2 2.7 O=C(NCCCO)NC(Cc1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL126106 17765 1 None - 0 Human 4.3 pIC50 = 4.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 298 7 3 2 2.7 O=C(NCCCO)NC(Cc1ccccc1)c1ccccc1 10.1021/jm0201767
44295102 187358 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL49702 187358 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)cc1 10.1016/s0960-894x(02)00206-8
10985078 114227 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm0201767
CHEMBL333865 114227 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 635 10 3 3 8.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm0201767
11081509 18342 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 492 6 2 3 6.9 N#Cc1cccc(NC(=O)Nc2c(CN3CCC(Cc4ccc(F)cc4)CC3)ccc3ccccc23)c1 10.1021/jm0201767
CHEMBL127534 18342 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 492 6 2 3 6.9 N#Cc1cccc(NC(=O)Nc2c(CN3CCC(Cc4ccc(F)cc4)CC3)ccc3ccccc23)c1 10.1021/jm0201767
11004826 17790 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.4 O=C(Nc1ccccc1)Nc1cccc(CO)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL126218 17790 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 447 7 3 3 5.4 O=C(Nc1ccccc1)Nc1cccc(CO)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44295470 188231 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 5 1 3 4.8 COc1cccc(NC(=O)N2CCCC(N3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50645 188231 0 None - 0 Human 6.3 pIC50 = 6.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 425 5 1 3 4.8 COc1cccc(NC(=O)N2CCCC(N3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1016/s0960-894x(02)00206-8
22022834 112825 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.4 Cc1ccc(C(=O)NC(CN2CC3CCC2CC3Cc2ccc(Cl)c(Cl)c2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL331672 112825 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 472 7 1 2 6.4 Cc1ccc(C(=O)NC(CN2CC3CCC2CC3Cc2ccc(Cl)c(Cl)c2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
11072275 16603 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 632 10 3 5 5.9 COC(=O)N1CCC(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL124585 16603 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 632 10 3 5 5.9 COC(=O)N1CCC(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)CC1 10.1021/jm0201767
25024651 115523 0 None 39 3 Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assayInhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assay
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115523 0 None 39 3 Human 6.3 pIC50 = 6.3 Binding
Inhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assayInhibition of CCR3 in human eosinophil assessed as inhibition of shape change by autofluorescence assay
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
10257335 99966 4 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 565 6 2 4 3.5 CCOC(=O)[C@H](Cc1cc(I)c(O)c(I)c1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL290565 99966 4 None - 0 Human 6.3 pIC50 = 6.3 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 565 6 2 4 3.5 CCOC(=O)[C@H](Cc1cc(I)c(O)c(I)c1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
11227406 93896 1 None - 0 Mouse 7.3 pIC50 = 7.3 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
CHEMBL250689 93896 1 None - 0 Mouse 7.3 pIC50 = 7.3 Binding
Displacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from BALB/c mouse CCR3 expressed in CHO cells after 30 mins
ChEMBL 465 7 2 3 5.7 CC(=O)c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2007.03.065
44390858 63557 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL180534 63557 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 423 6 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCN(Cc3ccc(F)cc3)CC2)c1 10.1016/j.bmcl.2004.11.006
10928826 17603 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL125884 17603 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 472 7 3 4 5.3 N#Cc1cccc(NC(=O)Nc2ccc(CO)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
9951882 178580 0 None - 1 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL47220 178580 0 None - 1 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 381 8 2 3 4.2 COc1cccc(NC(=O)NCCCN2CCCC(Cc3ccccc3)C2)c1 10.1016/j.bmcl.2004.01.059
44295230 188518 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 379 5 1 3 3.2 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51038 188518 0 None - 0 Human 5.3 pIC50 = 5.3 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 379 5 1 3 3.2 O=C(NCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44290041 172149 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL45064 172149 0 None - 0 Human 7.3 pIC50 = 7.3 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 409 6 2 3 3.9 CC(=O)c1cccc(NC(=O)NCCCN2C[C@H]3Cc4ccc(F)cc4C[C@H]3C2)c1 10.1016/j.bmcl.2004.01.059
44281790 168636 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 420 6 1 5 4.4 CC(C)(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL440844 168636 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 420 6 1 5 4.4 CC(C)(C)OC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11082578 117554 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 603 10 3 3 7.5 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cc(F)ccc1F 10.1021/jm0201767
CHEMBL340491 117554 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 603 10 3 3 7.5 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1cc(F)ccc1F 10.1021/jm0201767
44447366 94160 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
CHEMBL252221 94160 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 453 9 4 8 1.8 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(C)[C@H](C)[C@H](O)c1ccccc1 10.1016/j.bmcl.2007.11.087
44447141 94137 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 3.4 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC(F)(F)F 10.1016/j.bmcl.2007.11.087
CHEMBL252034 94137 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 523 11 3 7 3.4 C[C@@H](NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](O)CN(CCCc1ccc(F)cc1)CC(F)(F)F 10.1016/j.bmcl.2007.11.087
9818195 109862 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 311 7 1 3 3.0 CCOC(=O)[C@H](CCc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL32413 109862 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 311 7 1 3 3.0 CCOC(=O)[C@H](CCc1ccccc1)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
10995329 17982 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 563 13 4 4 5.5 O=C(NCCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL126978 17982 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 563 13 4 4 5.5 O=C(NCCCCO)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
44419327 82790 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 393 8 3 3 4.4 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218581 82790 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 393 8 3 3 4.4 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44447155 154372 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 11 3 7 2.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C(C)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL401002 154372 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 511 11 3 7 2.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)C(C)=O)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44445843 93793 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL250054 93793 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CCN(C(=O)OC(C)(C)C)C[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390978 64226 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181575 64226 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 437 7 2 6 3.1 Cn1nnnc1-c1cccc(NC(=O)NCC2CCCN(CCc3ccc(F)cc3)C2)c1 10.1016/j.bmcl.2004.11.006
3492 684 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9868459 684 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
CHEMBL50593 684 0 None - 1 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
11179592 69234 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
CHEMBL193442 69234 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 501 6 2 2 6.2 O=C(Nc1ccc(Br)cc1)N[C@@H]1CCCC[C@H]1CN1CCC[C@@H](Cc2ccc(F)cc2)C1 10.1021/jm049530m
44440431 145917 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 607 9 0 7 5.2 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL392217 145917 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 607 9 0 7 5.2 Cc1c(CN(CCc2ccc([N+](=O)[O-])cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(F)cc2)n1C 10.1016/j.bmcl.2007.05.035
44445890 154398 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
CHEMBL401115 154398 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 543 9 2 7 4.1 CC(=O)CN1CC[C@@H](CN2CCC[C@@H](Cc3ccc(F)cc3)C2)[C@H](NC(=O)Nc2nc(C)c(C(C)=O)s2)C1 10.1016/j.bmcl.2007.03.065
11226588 94314 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 10 2 6 5.2 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN(CCCc2ccc(F)cc2)CC(F)(F)F)c1 10.1016/j.bmcl.2007.11.087
CHEMBL253211 94314 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 547 10 2 6 5.2 Cn1nnnc1-c1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN(CCCc2ccc(F)cc2)CC(F)(F)F)c1 10.1016/j.bmcl.2007.11.087
44295201 170766 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
CHEMBL446144 170766 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 11 3 4 5.1 CC(=O)c1cccc(NC(=O)NCCCN2CC[C@H](Cc3ccccc3)C[C@@H]2[C@H](O)CC(C)C)c1 10.1016/s0960-894x(02)00206-8
44295328 193069 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL53673 193069 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1016/s0960-894x(02)00206-8
11026367 16290 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL123511 16290 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
11060510 16310 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 533 10 3 3 6.1 CC(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL123622 16310 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 533 10 3 3 6.1 CC(C)NC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11004681 16638 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)Nc1ccc2[nH]ncc2c1 10.1021/jm0201767
CHEMBL124748 16638 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 439 6 3 3 5.7 O=C(Nc1cccc(CN2CCC(Cc3ccccc3)CC2)c1)Nc1ccc2[nH]ncc2c1 10.1021/jm0201767
7072714 109954 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 490 11 3 6 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL32468 109954 2 None - 0 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 490 11 3 6 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](Cc1ccccc1)NC(=O)OCc1ccccc1 10.1016/s0960-894x(01)00248-7
44440413 93142 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 612 8 0 5 6.4 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(Cl)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246549 93142 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 612 8 0 5 6.4 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(Cl)cc2)n1C 10.1016/j.bmcl.2007.05.035
10983980 17847 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1ccc(NC(=O)Nc2cccc(OC)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL126520 17847 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 8 2 5 5.7 COC(=O)c1ccc(NC(=O)Nc2cccc(OC)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44295463 161443 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 429 7 1 4 3.1 O=S(=O)(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL415950 161443 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 429 7 1 4 3.1 O=S(=O)(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
44419314 82874 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
CHEMBL218997 82874 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 376 7 3 3 4.1 N#Cc1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccccc3)CCN2)c1 10.1016/j.bmcl.2006.08.012
44346154 168085 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
CHEMBL436363 168085 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 489 7 2 4 4.7 C[C@H](CN1C2CCC1CC(Cc1ccc(Cl)cc1)C2)NC(=O)Nc1cccc(S(C)(=O)=O)c1 10.1016/s0960-894x(03)00748-0
11511522 67510 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 491 8 0 6 3.1 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCN(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910163 67510 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 491 8 0 6 3.1 COc1ccc(OC)c(S(=O)(=O)N2CCC(CN3CCN(Cc4ccc(F)cc4)CC3)CC2)c1 10.1016/j.bmcl.2011.09.013
44295407 189039 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 433 6 1 3 4.3 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
CHEMBL51507 189039 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 433 6 1 3 4.3 O=C(NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)C12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
9845853 127940 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL366654 127940 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 435 7 2 3 5.3 COc1cccc(NC(=O)NC2CCCCC2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
10929194 17776 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1ccc(NC(=O)Nc2cccc(C#N)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL126163 17776 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1ccc(NC(=O)Nc2cccc(C#N)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
44295065 183699 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccccc1C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
CHEMBL48401 183699 0 None - 0 Human 5.2 pIC50 = 5.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1ccccc1C(=O)NCCCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3 10.1016/s0960-894x(02)00206-8
10474776 113145 36 None - 0 Human 8.2 pIC50 = 8.2 Binding
Agonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assayAgonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL33227 113145 36 None - 0 Human 8.2 pIC50 = 8.2 Binding
Agonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assayAgonistic activity against C-C chemokine receptor type 3 by displacing [125I]-MCP-4 radioligand, using CCR3 binding assay
ChEMBL 378 6 1 5 3.3 COC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
22966050 83707 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 455 10 3 4 4.2 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)c1 10.1016/j.bmcl.2006.08.012
CHEMBL220801 83707 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Binding affinity to CCR3Binding affinity to CCR3
ChEMBL 455 10 3 4 4.2 CC(=O)c1cccc(NC(=O)NCCC[C@H]2C[C@H](Cc3ccc(F)cc3)CCN2CCO)c1 10.1016/j.bmcl.2006.08.012
44295282 101174 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(02)00206-8
CHEMBL299170 101174 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccc([N+](=O)[O-])cc1 10.1016/s0960-894x(02)00206-8
44295591 187624 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 11 3 4 4.9 CCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL49921 187624 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 465 11 3 4 4.9 CCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
44593555 188188 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 642 10 4 6 4.9 CSc1ccc(C(=O)NC2CC(NC(=O)OCc3ccccc3)CCC2NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)cc1 10.1016/j.bmcl.2008.12.062
CHEMBL505722 188188 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibition of CCR3 at 10 uMInhibition of CCR3 at 10 uM
ChEMBL 642 10 4 6 4.9 CSc1ccc(C(=O)NC2CC(NC(=O)OCc3ccccc3)CCC2NC(=O)CNC(=O)c2cccc(C(F)(F)F)c2)cc1 10.1016/j.bmcl.2008.12.062
10874762 16610 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL124628 16610 1 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 500 7 2 5 5.6 COC(=O)c1cccc(NC(=O)Nc2cccc(C#N)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44290020 178438 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 435 8 2 4 4.5 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-n2ccnc2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL47122 178438 0 None - 0 Human 8.2 pIC50 = 8.2 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 435 8 2 4 4.5 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-n2ccnc2)c1 10.1016/j.bmcl.2004.01.059
68826395 103018 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL3085118 103018 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 5.0 CC(=O)c1cccc(NC(=O)NCCCN2[C@H]3CC[C@@H]2C[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
44445850 93635 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL249056 93635 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 473 7 3 6 3.5 CC(=O)c1sc(NC(=O)N[C@@H]2CNC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390898 64219 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.2 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181528 64219 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 479 9 2 6 4.2 CCc1cc(NC(=O)N[C@@H]2CCCN(CCCCc3ccc(F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44290029 178558 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 436 8 2 4 4.9 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2cnco2)c1 10.1016/j.bmcl.2004.01.059
CHEMBL47211 178558 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 436 8 2 4 4.9 O=C(NCCCN1CCC[C@@H](Cc2ccc(F)cc2)C1)Nc1cccc(-c2cnco2)c1 10.1016/j.bmcl.2004.01.059
22393474 96089 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(02)00206-8
CHEMBL262918 96089 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 437 7 2 2 5.3 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc(C(F)(F)F)c1 10.1016/s0960-894x(02)00206-8
44295288 188749 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL51259 188749 0 None - 0 Human 7.2 pIC50 = 7.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 447 8 2 4 3.7 CS(=O)(=O)c1ccc(NC(=O)NCCCN2CCC(Cc3ccc(F)cc3)CC2)cc1 10.1016/s0960-894x(02)00206-8
44295510 101363 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 401 5 2 4 3.3 N#Cc1cccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
CHEMBL300472 101363 0 None - 0 Human 6.2 pIC50 = 6.2 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 401 5 2 4 3.3 N#Cc1cccc(NC(=O)NCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
10591473 64541 10 None - 2 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 279 5 0 1 4.2 c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL18222 64541 10 None - 2 Human 5.2 pIC50 = 5.2 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 279 5 0 1 4.2 c1ccc(CCN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
11812728 16557 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 4.8 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
CHEMBL124336 16557 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 471 7 2 5 4.8 O=C(NCc1ccc2c(c1)OCO2)Nc1ccccc1CN1CCC(C(=O)c2ccccc2)CC1 10.1021/jm0201767
10000888 75609 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 397 6 1 5 4.2 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccccc2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL20539 75609 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 397 6 1 5 4.2 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccccc2)CC1 10.1016/s0960-894x(01)00176-7
10142792 93295 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 521 9 5 5 2.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
CHEMBL247245 93295 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cellsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells
ChEMBL 521 9 5 5 2.8 Cc1ccc(CNC[C@H](NC(=O)CNC(=O)c2cc(C(F)(F)F)ccc2N)C(=O)NC(C)(C)C)c(C)c1 10.1016/j.bmcl.2007.07.028
11069916 16366 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL123791 16366 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 424 6 2 3 5.7 N#Cc1cccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
10993686 116424 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1ccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL338543 116424 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 429 7 2 3 5.8 COc1ccc(NC(=O)Nc2ccccc2CN2CCC(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
57394442 67512 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 407 8 2 3 4.2 O=C(NCCCCN1CCC(Oc2ccc(F)cc2)C1)Nc1ccc(F)c(F)c1 10.1016/j.bmcl.2011.09.013
CHEMBL1910165 67512 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 407 8 2 3 4.2 O=C(NCCCCN1CCC(Oc2ccc(F)cc2)C1)Nc1ccc(F)c(F)c1 10.1016/j.bmcl.2011.09.013
11072063 16413 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 597 11 3 4 7.2 COc1ccc(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)cc1 10.1021/jm0201767
CHEMBL124084 16413 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 597 11 3 4 7.2 COc1ccc(NC(=O)NCC(CCCN2CCC(O)(c3ccc(Cl)cc3)CC2)(c2ccccc2)c2ccccc2)cc1 10.1021/jm0201767
11026461 16744 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 434 8 2 3 4.7 O=C(NCCN1CCCCC1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125325 16744 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 434 8 2 3 4.7 O=C(NCCN1CCCCC1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
11005432 167784 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 487 8 2 5 5.6 COC(=O)c1ccc(CN2CCC(Cc3ccccc3)CC2)c(NC(=O)Nc2cccc(OC)c2)c1 10.1021/jm0201767
CHEMBL434437 167784 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 487 8 2 5 5.6 COC(=O)c1ccc(CN2CCC(Cc3ccccc3)CC2)c(NC(=O)Nc2cccc(OC)c2)c1 10.1021/jm0201767
11385474 78112 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
CHEMBL2112050 78112 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 453 7 2 3 5.5 COc1cccc(NC(=O)NC2CCCC(CN3CCC(Cc4ccc(F)cc4)CC3)C2)c1 10.1021/jm049530m
44346023 14911 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 406 7 1 2 5.7 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(C)c(C)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL120957 14911 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 406 7 1 2 5.7 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc(C)c(C)c3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
10873705 98864 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)cc2)CC1 10.1016/s0960-894x(01)00176-7
CHEMBL282285 98864 7 None - 0 Human 7.1 pIC50 = 7.1 Binding
Concentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cellsConcentration required for 50% inhibition of [125I]eotaxin binding to human CCR3 receptor expressed in CHO cells
ChEMBL 431 6 1 5 4.8 O=C(CSc1nc2ccccc2s1)NC1CCN(Cc2ccc(Cl)cc2)CC1 10.1016/s0960-894x(01)00176-7
44440421 93084 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 593 8 1 6 5.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N)cc2)n1C 10.1016/j.bmcl.2007.05.035
CHEMBL246339 93084 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]eotaxin from CCR3 receptor in human eosinophilsDisplacement of [125I]eotaxin from CCR3 receptor in human eosinophils
ChEMBL 593 8 1 6 5.3 Cc1c(CN(CCc2ccc(Cl)cc2)C2CCN(C(=O)c3c(F)cccc3F)CC2)c(=O)n(-c2ccc(N)cc2)n1C 10.1016/j.bmcl.2007.05.035
3492 684 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9868459 684 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
CHEMBL50593 684 0 None - 1 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 10.1016/s0960-894x(02)00206-8
9800669 108998 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 392 7 1 5 3.7 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL32210 108998 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 392 7 1 5 3.7 CCOC(=O)[C@H](Cc1ccc([N+](=O)[O-])cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
11070954 16585 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL124473 16585 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 485 7 3 4 4.9 N#Cc1cccc(NC(=O)Nc2ccc(C(N)=O)cc2CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
10962347 18296 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
CHEMBL127281 18296 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 516 8 3 4 5.5 CNC(=O)c1ccc(NC(=O)Nc2cccc(C(C)=O)c2)c(CN2CCC(Cc3ccc(F)cc3)CC2)c1 10.1021/jm0201767
11763035 168741 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL441656 168741 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 517 8 2 5 5.9 COC(=O)c1cccc(NC(=O)Nc2cccc(C(C)=O)c2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
11753159 542 3 None 1 2 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at CCR3 assessed as inhibition of eotaxin bindingAntagonist activity at CCR3 assessed as inhibition of eotaxin binding
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
7679 542 3 None 1 2 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at CCR3 assessed as inhibition of eotaxin bindingAntagonist activity at CCR3 assessed as inhibition of eotaxin binding
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
CHEMBL2158814 542 3 None 1 2 Human 8.1 pIC50 = 8.1 Binding
Antagonist activity at CCR3 assessed as inhibition of eotaxin bindingAntagonist activity at CCR3 assessed as inhibition of eotaxin binding
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1021/jm300682j
44346210 167381 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
CHEMBL431670 167381 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 531 10 3 6 4.7 COc1cc(NC(=O)N[C@@H](CN2C3CCC2CC(Cc2ccc(Cl)cc2)C3)[C@H](C)O)cc(OC)c1OC 10.1016/s0960-894x(03)00748-0
44295536 187841 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50233 187841 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 479 12 3 4 5.3 CCCC[C@H](O)[C@H]1C[C@@H](Cc2ccccc2)CCN1CCCNC(=O)Nc1cccc(C(C)=O)c1 10.1016/s0960-894x(02)00206-8
9885355 99927 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 6 2 4 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
CHEMBL290119 99927 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 363 6 2 4 3.5 CCOC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cccc2ccccc12 10.1016/s0960-894x(01)00248-7
44295353 188090 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 350 8 1 2 4.2 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(02)00206-8
CHEMBL50401 188090 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 350 8 1 2 4.2 O=C(NCCCCN1CCC(Cc2ccccc2)CC1)c1ccccc1 10.1016/s0960-894x(02)00206-8
71454583 79270 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
CHEMBL2115412 79270 0 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.Inhibitory concentration against C-C chemokine receptor type 3 using human [125I]eotaxin.
ChEMBL 437 8 2 3 4.9 CC(=O)c1cccc(NC(=O)NCCCN2CC3CCC2[C@H](Cc2ccc(F)cc2)C3)c1 10.1016/j.bmcl.2004.01.059
11015975 16304 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
CHEMBL123585 16304 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 459 8 3 4 5.3 COc1cccc(NC(=O)Nc2ccccc2C(O)CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm0201767
44295118 188446 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1cccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
CHEMBL50937 188446 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 405 7 1 4 3.4 COc1cccc(C(=O)NCCCCN2CC[C@@H]3[C@H](C2)c2cccc4c2N3CC4)c1 10.1016/s0960-894x(02)00206-8
57398008 67511 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 393 9 2 3 4.5 COc1ccc(Cl)cc1NC(=O)NCCCCN(C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.09.013
CHEMBL1910164 67511 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assayDisplacement of [125I]-eotaxin from CCR3 expressed in RBL-2H3 cells by scintillation proximity assay
ChEMBL 393 9 2 3 4.5 COc1ccc(Cl)cc1NC(=O)NCCCCN(C)Cc1ccc(F)cc1 10.1016/j.bmcl.2011.09.013
44390893 64028 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C(F)(F)F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL181302 64028 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 515 8 2 6 4.5 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C(F)(F)F)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
132072454 179134 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
CHEMBL4744046 179134 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Antagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assayAntagonist activity at human CCR3 expressed in CHO-K1 cells by PathHunter beta-arrestin assay
ChEMBL 558 6 2 8 4.7 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN(C#N)[C@H](c3[nH]c4ccccc4c3CCn3cc(-c4cccc(Cl)c4)nn3)C[C@@H]21 10.1016/j.bmc.2020.115546
44295558 101480 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 365 4 1 3 2.8 O=C(NCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
CHEMBL301332 101480 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 365 4 1 3 2.8 O=C(NCCN1CC[C@@H]2[C@H](C1)c1cccc3c1N2CC3)c1ccc(F)cc1 10.1016/s0960-894x(02)00206-8
10934382 16582 26 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 265 4 0 1 4.1 c1ccc(CC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL124457 16582 26 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 265 4 0 1 4.1 c1ccc(CC2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
11828013 17210 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 581 11 3 3 6.9 O=C(NCc1ccccc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL125753 17210 1 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 581 11 3 3 6.9 O=C(NCc1ccccc1)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11049424 116591 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 9 3 3 5.3 CNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL339349 116591 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 505 9 3 3 5.3 CNC(=O)NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
9972570 69473 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 308 7 0 2 3.8 c1ccc(CCCCN2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
CHEMBL19375 69473 0 None - 1 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 308 7 0 2 3.8 c1ccc(CCCCN2CCN(Cc3ccccc3)CC2)cc1 10.1021/jm0201767
10458117 16394 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 486 6 2 5 5.5 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
CHEMBL123961 16394 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 486 6 2 5 5.5 N#Cc1cccc(NC(=O)Nc2cc3c(cc2CN2CCC(Cc4ccc(F)cc4)CC2)OCO3)c1 10.1021/jm0201767
44346178 113744 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 423 8 1 4 5.0 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
CHEMBL333040 113744 0 None - 0 Human 5.1 pIC50 = 5.1 Binding
Binding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligandBinding affinity was determined towards C-C chemokine receptor type 3 using [125I]-labeled eotaxin as radioligand
ChEMBL 423 8 1 4 5.0 Cc1ccc(C(=O)NC(CC2CCN(Cc3ccc([N+](=O)[O-])cc3)CC2)C(C)C)cc1 10.1016/s0960-894x(03)00748-0
44447377 94377 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
CHEMBL253666 94377 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 499 11 4 8 2.2 CCN(C[C@H](O)[C@@H](C)NC(=O)Nc1cccc(-c2nnnn2C)c1)[C@@H](C)[C@H](O)Cc1ccc(F)cc1 10.1016/j.bmcl.2007.11.087
44295327 187789 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1[N+](=O)[O-] 10.1016/s0960-894x(02)00206-8
CHEMBL50158 187789 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1ccccc1[N+](=O)[O-] 10.1016/s0960-894x(02)00206-8
44447150 94491 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 3.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
CHEMBL254471 94491 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Displacement of [125I] eotaxin from human CCR3 receptor in CHO cellsDisplacement of [125I] eotaxin from human CCR3 receptor in CHO cells
ChEMBL 551 12 3 7 3.9 CCc1cc(NC(=O)N[C@H](C)[C@@H](O)CN(CCCc2ccc(F)cc2)CC(F)(F)F)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2007.11.087
44295326 168499 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(02)00206-8
CHEMBL439744 168499 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 414 8 2 4 4.2 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)Nc1cccc([N+](=O)[O-])c1 10.1016/s0960-894x(02)00206-8
44387850 60175 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 3 5.2 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
CHEMBL175679 60175 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 430 6 2 3 5.2 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC(Cc3ccccc3)CC2)c1 10.1021/jm049530m
11236236 77591 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096696 77591 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
11224689 77602 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
CHEMBL2096764 77602 0 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cellsInhibition of [125I]eotaxin binding to human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 448 6 2 3 5.3 N#Cc1cccc(NC(=O)N[C@@H]2CCCC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)c1 10.1021/jm049530m
10939698 161109 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 475 7 2 4 5.7 COC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
CHEMBL413113 161109 1 None - 0 Human 8.1 pIC50 = 8.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 475 7 2 4 5.7 COC(=O)c1cccc(NC(=O)Nc2ccccc2)c1CN1CCC(Cc2ccc(F)cc2)CC1 10.1021/jm0201767
44570582 177832 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 477 10 2 6 3.9 CCCN(CCCc1ccc(F)cc1)C[C@@H]1OC(=O)N(C)C[C@H]1NC(=O)Nc1nc(C)cs1 10.1016/j.bmcl.2008.11.002
CHEMBL465943 177832 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Binding affinity to CCR3 receptorBinding affinity to CCR3 receptor
ChEMBL 477 10 2 6 3.9 CCCN(CCCc1ccc(F)cc1)C[C@@H]1OC(=O)N(C)C[C@H]1NC(=O)Nc1nc(C)cs1 10.1016/j.bmcl.2008.11.002
44445846 93974 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
CHEMBL251078 93974 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Displacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 minsDisplacement of [125I]eotaxin from human CCR3 expressed in CHO cells after 30 mins
ChEMBL 587 7 2 7 5.5 CC(=O)c1sc(NC(=O)N[C@@H]2CN(C(=O)OC(C)(C)C)CC[C@H]2CN2CCC[C@@H](Cc3ccc(F)cc3)C2)nc1C 10.1016/j.bmcl.2007.03.065
44390882 122273 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 461 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
CHEMBL360529 122273 0 None - 0 Human 8.0 pIC50 = 8.0 Binding
Evaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cellsEvaluated for inhibition of human C-C chemokine receptor type 3 expressed in CHO cells
ChEMBL 461 8 2 6 3.8 CCc1cc(NC(=O)NC[C@@H]2CCCN(CCc3ccc(C)cc3)C2)cc(-c2nnnn2C)c1 10.1016/j.bmcl.2004.11.006
44295543 101503 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 427 7 2 2 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
CHEMBL301503 101503 0 None - 0 Human 7.1 pIC50 = 7.1 Binding
In vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxinIn vitro inhibition if C-C chemokine receptor type 3 (CCR3) using 150p M [125I]-labeled human eotaxin
ChEMBL 427 7 2 2 4.7 O=C(NCCCN1CCC(Cc2ccc(F)cc2)CC1)NC12CC3CC(CC(C3)C1)C2 10.1016/s0960-894x(02)00206-8
11811443 16424 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 399 6 2 2 5.8 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL124134 16424 3 None - 0 Human 6.1 pIC50 = 6.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 399 6 2 2 5.8 O=C(Nc1ccccc1)Nc1ccccc1CN1CCC(Cc2ccccc2)CC1 10.1021/jm0201767
6995527 111394 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 221 4 1 3 1.4 CCOC(=O)[C@H](C)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
CHEMBL32878 111394 6 None - 0 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligandInhibitory activity against human eosinophil C-C chemokine receptor type 3 using [125I]- human eotaxin as the radioligand
ChEMBL 221 4 1 3 1.4 CCOC(=O)[C@H](C)NC(=O)c1ccccc1 10.1016/s0960-894x(01)00248-7
9889700 118070 13 None - 1 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 444 7 1 3 5.9 N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
CHEMBL34166 118070 13 None - 1 Human 5.1 pIC50 = 5.1 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 444 7 1 3 5.9 N#CC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1 10.1021/jm0201767
11762084 16720 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 446 8 2 3 4.5 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
CHEMBL125220 16720 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 446 8 2 3 4.5 O=C(NCCc1ccc(F)cc1)Nc1ccccc1CN1CCN(Cc2ccccc2)CC1 10.1021/jm0201767
11060814 16976 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 567 10 3 3 7.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccccc1 10.1021/jm0201767
CHEMBL125618 16976 0 None - 0 Human 5.0 pIC50 = 5.0 Binding
Inhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cellsInhibitory activity against recombinant human Chemokine receptor type 3 (CCR3) expressed in chinese hamster ovary cells
ChEMBL 567 10 3 3 7.2 O=C(NCC(CCCN1CCC(O)(c2ccc(Cl)cc2)CC1)(c1ccccc1)c1ccccc1)Nc1ccccc1 10.1021/jm0201767
66615627 80852 0 None 158 2 Human 9.7 pKi = 9.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 8 1 4 6.1 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158790 80852 0 None 158 2 Human 9.7 pKi = 9.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 8 1 4 6.1 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
59296081 83655 0 None 7 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 9 3 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)N3CCC3)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207654 83655 0 None 7 2 Human 9.5 pKi = 9.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 9 3 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)N3CCC3)ccc12 10.1016/j.bmcl.2012.09.112
66615619 80845 0 None 79 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(Cl)ccc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158783 80845 0 None 79 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(Cl)ccc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.103
12001832 80846 0 None 63 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158784 80846 0 None 63 2 Human 9.3 pKi = 9.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.7 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
16040671 80853 0 None 56 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158791 80853 0 None 56 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963201 81840 0 None 31 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 1 5 5.0 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(C)c4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171047 81840 0 None 31 2 Human 9.2 pKi = 9.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 1 5 5.0 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(C)c4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
66615702 80849 0 None 100 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.8 C[C@](Cc1ccc(F)cc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158787 80849 0 None 100 2 Human 9.1 pKi = 9.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 522 8 1 4 5.8 C[C@](Cc1ccc(F)cc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
59296033 83590 0 None 15 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 596 9 3 7 2.7 CN(C)S(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207286 83590 0 None 15 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 596 9 3 7 2.7 CN(C)S(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
59295968 83658 0 None 3 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3c(F)cccc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207657 83658 0 None 3 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3c(F)cccc23)CC1 10.1016/j.bmcl.2012.09.112
59296099 83662 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 494 7 3 5 3.7 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]nc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207660 83662 0 None 50 2 Human 9.1 pKi = 9.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 494 7 3 5 3.7 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]nc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
46931923 128739 0 None - 1 Human 9.1 pKi = 9.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 6 1 5 4.2 Cc1cc(C(=O)N2CCCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670798 128739 0 None - 1 Human 9.1 pKi = 9.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 6 1 5 4.2 Cc1cc(C(=O)N2CCCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
59295928 83587 0 None 63 2 Human 9.0 pKi = 9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccc(S(C)(=O)=O)cc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207283 83587 0 None 63 2 Human 9.0 pKi = 9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccc(S(C)(=O)=O)cc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
66615606 80847 0 None 398 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 513 8 1 5 4.9 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(C#N)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158785 80847 0 None 398 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 513 8 1 5 4.9 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc(C#N)c1Cl 10.1016/j.bmcl.2012.08.103
71462100 80854 0 None 39 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158792 80854 0 None 39 2 Human 8.9 pKi = 8.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 502 8 1 4 5.4 Cc1cc(OC2CCN(CC3CCN([C@@](C)(Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
59295938 83666 0 None 7 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 3 5 3.6 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)cc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207664 83666 0 None 7 2 Human 8.9 pKi = 8.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 3 5 3.6 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)cc3C(F)(F)F)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
66615691 80851 0 None 125 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 518 8 1 4 5.9 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158789 80851 0 None 125 2 Human 8.8 pKi = 8.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 518 8 1 4 5.9 Cc1c(OC2CCN(CC3CCN([C@@](C)(Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
9870185 83668 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2207666 83668 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
59295931 83783 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 462 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208429 83783 0 None 5 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 462 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
59296010 83785 0 None 3 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 490 7 3 6 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208431 83785 0 None 3 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 490 7 3 6 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1n[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
71459762 83663 0 None 7 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 452 8 3 5 3.2 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C1CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207661 83663 0 None 7 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 452 8 3 5 3.2 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C1CC1 10.1016/j.bmcl.2012.09.112
9870185 83668 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207666 83668 0 None 2 2 Human 8.8 pKi = 8.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.112
56967066 128764 0 None - 1 Human 8.8 pKi = 8.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 4.0 CCN(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670824 128764 0 None - 1 Human 8.8 pKi = 8.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 4.0 CCN(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
66615617 80850 0 None 31 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158788 80850 0 None 31 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1c(OC2CCN(CC3CCN([C@@H](Cc4ccccc4)C(=O)O)CC3)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.08.103
71456722 80855 0 None 39 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 486 8 1 4 4.9 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158793 80855 0 None 39 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 486 8 1 4 4.9 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@](C)(Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
69262172 80867 1 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158822 80867 1 None 3 2 Human 8.7 pKi = 8.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
59295935 83582 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(F)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207278 83582 0 None 3 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(F)ccc12 10.1016/j.bmcl.2012.09.112
59295978 83657 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2c(F)cccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207656 83657 0 None 1 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2c(F)cccc12 10.1016/j.bmcl.2012.09.112
59296066 83665 0 None 5 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207663 83665 0 None 5 2 Human 8.7 pKi = 8.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
69347575 80866 0 None 10 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158821 80866 0 None 10 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072040 80881 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158835 80881 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072044 80883 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccccc1Cl)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158837 80883 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccccc1Cl)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072050 80885 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccccc1F)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158839 80885 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccccc1F)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072118 80887 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158841 80887 0 None 5 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
22397445 81813 0 None 2 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 499 4 1 4 5.0 O=C(c1c[nH]c(=O)c2ccccc12)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171020 81813 0 None 2 2 Human 8.0 pKi = 8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 499 4 1 4 5.0 O=C(c1c[nH]c(=O)c2ccccc12)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
57718837 115499 0 None -1 3 Mouse 8.0 pKi = 8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355932 115499 0 None -1 3 Mouse 8.0 pKi = 8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
59295946 83585 0 None 5 2 Human 8.0 pKi = 8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 612 11 5 8 1.7 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NCCO)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207281 83585 0 None 5 2 Human 8.0 pKi = 8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 612 11 5 8 1.7 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NCCO)ccc12 10.1016/j.bmcl.2012.09.112
56965995 128737 0 None - 1 Human 8.0 pKi = 8.0 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 2 5 3.3 CNC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670796 128737 0 None - 1 Human 8.0 pKi = 8.0 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 2 5 3.3 CNC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
69260946 80868 1 None -19 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158823 80868 1 None -19 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71462103 80876 1 None -2 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158830 80876 1 None -2 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
17963227 81805 0 None -39 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 0 5 5.1 Cc1ccc(S(=O)(=O)N(C)C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171013 81805 0 None -39 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 539 5 0 5 5.1 Cc1ccc(S(=O)(=O)N(C)C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
9910169 81810 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 422 7 1 4 4.3 COc1cccc(C(=O)NCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171018 81810 0 None - 1 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 422 7 1 4 4.3 COc1cccc(C(=O)NCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.08.124
17963336 81837 0 None -5 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 5 1 6 4.3 N#Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171044 81837 0 None -5 2 Human 7.0 pKi = 7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 536 5 1 6 4.3 N#Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
118721192 115508 0 None 4 2 Rat 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355941 115508 0 None 4 2 Rat 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
10300214 83770 0 None -6 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 492 9 2 5 5.0 O=C(Nc1ccccc1OCC(O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C1CCC1 10.1016/j.bmcl.2012.09.113
CHEMBL2208416 83770 0 None -6 2 Human 7.0 pKi = 7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 492 9 2 5 5.0 O=C(Nc1ccccc1OCC(O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C1CCC1 10.1016/j.bmcl.2012.09.113
44389685 64387 0 None - 1 Human 7.0 pKi = 7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 459 4 1 2 6.3 Cc1ccccc1NC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181894 64387 0 None - 1 Human 7.0 pKi = 7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 459 4 1 2 6.3 Cc1ccccc1NC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
17989653 81036 0 None - 1 Human 7.0 pKi = 7 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 301 2 1 3 3.2 Fc1ccc2c(c1)nc(CC(F)(F)F)n2C1CCNCC1 10.1016/j.bmc.2012.09.013
CHEMBL2159765 81036 0 None - 1 Human 7.0 pKi = 7 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 301 2 1 3 3.2 Fc1ccc2c(c1)nc(CC(F)(F)F)n2C1CCNCC1 10.1016/j.bmc.2012.09.013
44389678 122795 0 None - 1 Human 6.0 pKi = 6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 574 6 1 5 4.6 CS(=O)(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL361620 122795 0 None - 1 Human 6.0 pKi = 6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 574 6 1 5 4.6 CS(=O)(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44389669 62253 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178286 62253 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401055 68325 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL192162 68325 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401192 70226 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 529 7 1 3 6.4 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194943 70226 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 529 7 1 3 6.4 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401227 134705 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 421 9 1 4 4.5 COc1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL372496 134705 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 421 9 1 4 4.5 COc1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401173 69503 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 466 8 2 5 4.5 COc1ccc(NC(=O)NCC(c2ccccc2OC)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193871 69503 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 466 8 2 5 4.5 COc1ccc(NC(=O)NCC(c2ccccc2OC)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400953 68924 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 488 6 2 3 5.8 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL192751 68924 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 488 6 2 3 5.8 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401108 69468 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 5 2 3 4.1 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
CHEMBL193732 69468 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 5 2 3 4.1 Cc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
44401062 69692 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 502 9 1 4 5.6 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193975 69692 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 502 9 1 4 5.6 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721204 115531 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355964 115531 0 None 5 3 Human 8.0 pKi = 8.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
11477767 62683 0 None - 1 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178818 62683 0 None - 1 Human 8.0 pKi = 8.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391171 131261 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 294 1 0 2 4.7 Clc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL369351 131261 0 None - 1 Human 7.0 pKi = 7.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 294 1 0 2 4.7 Clc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
25024650 115527 0 None -21 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355960 115527 0 None -21 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
118721203 115530 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355963 115530 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
118721194 115511 0 None -229 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355944 115511 0 None -229 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
25024651 115523 0 None -69 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115523 0 None -69 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
44389719 62676 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 408 5 0 2 4.6 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178771 62676 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 408 5 0 2 4.6 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(F)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44389750 165525 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1cccc2[nH]ccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL425875 165525 0 None - 1 Human 7.0 pKi = 7.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1cccc2[nH]ccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401247 69067 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 6 2 3 5.7 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
CHEMBL193332 69067 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 6 2 3 5.7 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
44401111 68050 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 480 6 2 3 5.9 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191719 68050 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 480 6 2 3 5.9 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400945 70764 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 455 7 1 3 5.2 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL195473 70764 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 455 7 1 3 5.2 CC(C)(C)c1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44401128 70755 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 6 2 3 5.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195427 70755 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 6 2 3 5.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400972 165429 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 337 7 1 3 3.1 Cc1ccc(CCNCC(c2ccccc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
CHEMBL425377 165429 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 337 7 1 3 3.1 Cc1ccc(CCNCC(c2ccccc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
44401053 70708 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 371 8 1 4 3.0 COc1ccc(C(CNCCc2ccc(F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
CHEMBL195197 70708 0 None - 1 Human 4.9 pKi = 4.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 371 8 1 4 3.0 COc1ccc(C(CNCCc2ccc(F)cc2)N2CCN(C)CC2)cc1 10.1021/jm040827u
44401255 69499 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccccc1CCNCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL193850 69499 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccccc1CCNCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44389674 62289 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1ccc2[nH]ccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178367 62289 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 469 4 1 2 6.0 O=C(c1ccc2[nH]ccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
71451391 80843 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 472 8 1 4 4.5 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158781 80843 0 None 12 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 472 8 1 4 4.5 Cc1cc(F)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
10005242 80864 0 None 3 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158819 80864 0 None 3 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
23102749 81808 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.3 Cc1c(Cl)ccc(OC2CCN(C3CCN(S(=O)(=O)NC(=O)c4ccccc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171016 81808 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.3 Cc1c(Cl)ccc(OC2CCN(C3CCN(S(=O)(=O)NC(=O)c4ccccc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
59295926 83789 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 474 7 2 6 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cnnc2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208435 83789 0 None -1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 474 7 2 6 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cnnc2ccccc12 10.1016/j.bmcl.2012.09.113
59295914 83656 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 638 9 4 8 2.2 CC1(O)CN(S(=O)(=O)c2ccc3c(C(=O)NC[C@@H](O)CN4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)c[nH]c(=O)c3c2)C1 10.1016/j.bmcl.2012.09.112
CHEMBL2207655 83656 0 None 1 2 Human 7.9 pKi = 7.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 638 9 4 8 2.2 CC1(O)CN(S(=O)(=O)c2ccc3c(C(=O)NC[C@@H](O)CN4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)c[nH]c(=O)c3c2)C1 10.1016/j.bmcl.2012.09.112
11952525 115525 0 None 21 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355958 115525 0 None 21 3 Human 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
11952526 115520 0 None -24 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355953 115520 0 None -24 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44391160 122759 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 413 1 1 4 5.6 CC(C)(C)c1csc2nc3n(c(=N)c12)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL361430 122759 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 413 1 1 4 5.6 CC(C)(C)c1csc2nc3n(c(=N)c12)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44401004 70211 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 8 1 3 5.5 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL194885 70211 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 8 1 3 5.5 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44389699 63572 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1cccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2005.01.016
CHEMBL180599 63572 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1cccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2005.01.016
71462102 80862 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
CHEMBL2158817 80862 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
71455217 81835 0 None -3 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171042 81835 0 None -3 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1cccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
17963141 81842 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 491 5 1 5 4.1 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171049 81842 0 None -1 2 Human 6.9 pKi = 6.9 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 491 5 1 5 4.1 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
71459825 83771 0 None 3 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1ccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1 10.1016/j.bmcl.2012.09.113
CHEMBL2208417 83771 0 None 3 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1ccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1 10.1016/j.bmcl.2012.09.113
71463288 83775 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 441 8 1 5 5.0 COc1cccc(SC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208421 83775 0 None -6 2 Human 6.9 pKi = 6.9 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 441 8 1 5 5.0 COc1cccc(SC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
44400992 69599 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.8 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
CHEMBL193931 69599 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.8 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
44389747 168626 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL440750 168626 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cccc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401135 69295 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.8 FC(F)(F)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193507 69295 0 None - 1 Human 6.9 pKi = 6.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.8 FC(F)(F)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721187 115503 0 None -1 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355936 115503 0 None -1 3 Mouse 6.9 pKi = 6.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721188 115504 0 None -2 3 Mouse 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355937 115504 0 None -2 3 Mouse 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721200 115521 0 None -275 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355954 115521 0 None -275 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
44401202 69771 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
CHEMBL194025 69771 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
44401183 69795 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194040 69795 0 None - 1 Human 5.9 pKi = 5.9 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44389709 63359 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1ccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
CHEMBL180122 63359 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 445 4 1 3 5.1 Nc1ccc(C(=O)N2CCC(N3CCC(Cc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
44389688 64199 0 None - 1 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181460 64199 0 None - 1 Human 7.9 pKi = 7.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391330 63675 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 322 2 0 2 5.5 CCC1C/C(=C\c2ccccc2Cl)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
CHEMBL180721 63675 0 None - 1 Human 6.9 pKi = 6.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 322 2 0 2 5.5 CCC1C/C(=C\c2ccccc2Cl)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
44389721 63937 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1nccc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180988 63937 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1nccc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44391276 122425 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 278 1 0 2 4.2 Fc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL360738 122425 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 278 1 0 2 4.2 Fc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44391297 131954 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 288 2 0 2 4.6 CCc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL369778 131954 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 288 2 0 2 4.6 CCc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44391307 167738 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 337 2 0 3 4.7 CN(C)c1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
CHEMBL434151 167738 0 None - 1 Human 5.9 pKi = 5.9 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 337 2 0 3 4.7 CN(C)c1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
118721191 115507 0 None -331 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355940 115507 0 None -331 3 Rat 5.9 pKi = 5.9 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
70790201 128743 0 None - 1 Human 5.9 pKi = 5.9 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 0 4 3.7 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)N(C)c3ccccn3)CC2)ccc1Cl nan
CHEMBL3670803 128743 0 None - 1 Human 5.9 pKi = 5.9 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 0 4 3.7 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)N(C)c3ccccn3)CC2)ccc1Cl nan
44389695 63584 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180651 63584 0 None - 1 Human 6.9 pKi = 6.9 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 424 5 0 2 5.1 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44389712 62751 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178916 62751 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3F)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401086 70172 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
CHEMBL194715 70172 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(C(F)(F)F)cc1 10.1021/jm040827u
44401251 69068 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 498 7 2 4 5.4 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193334 69068 0 None - 1 Human 4.8 pKi = 4.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 498 7 2 4 5.4 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
11283679 64016 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cccnc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181273 64016 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cccnc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
17963315 81826 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 5 1 5 4.4 O=C(NS(=O)(=O)c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171033 81826 0 None 1 2 Human 7.8 pKi = 7.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 5 1 5 4.4 O=C(NS(=O)(=O)c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296109 83782 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 500 8 2 6 3.0 CS(=O)(=O)c1ccccc1C(=O)NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
CHEMBL2208428 83782 0 None 12 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 500 8 2 6 3.0 CS(=O)(=O)c1ccccc1C(=O)NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
59296077 83580 0 None 5 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(S(C)(=O)=O)ccc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207276 83580 0 None 5 2 Human 7.8 pKi = 7.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(S(C)(=O)=O)ccc23)CC1 10.1016/j.bmcl.2012.09.112
44400973 126988 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL366231 126988 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
69260851 80869 1 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158824 80869 1 None -2 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.5 O=C(O)c1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
10143016 81847 0 None -3 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.5 O=C(NS(=O)(=O)Cc1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171215 81847 0 None -3 2 Human 6.8 pKi = 6.8 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 6 1 5 4.5 O=C(NS(=O)(=O)Cc1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71454365 83772 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 465 8 2 6 4.6 O[C@@H](CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1)COc1ccc2ncsc2c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208418 83772 0 None 1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 465 8 2 6 4.6 O[C@@H](CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1)COc1ccc2ncsc2c1 10.1016/j.bmcl.2012.09.113
59296073 83776 0 None -1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 483 8 2 6 3.0 N#Cc1cccc(S(=O)(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208422 83776 0 None -1 2 Human 6.8 pKi = 6.8 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 483 8 2 6 3.0 N#Cc1cccc(S(=O)(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
44401172 123659 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 445 10 1 5 4.4 COc1ccccc1CCNCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL363409 123659 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 445 10 1 5 4.4 COc1ccccc1CCNCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
25024651 115523 0 None 39 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115523 0 None 39 3 Human 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
44391296 64957 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.0 FC(F)(F)c1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL182889 64957 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.0 FC(F)(F)c1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44389722 63938 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 538 5 1 4 5.2 CC(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL180989 63938 0 None - 1 Human 6.8 pKi = 6.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 538 5 1 4 5.2 CC(=O)N[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401052 69721 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193991 69721 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
56967062 128756 0 None - 1 Human 7.8 pKi = 7.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 531 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)n1 nan
CHEMBL3670816 128756 0 None - 1 Human 7.8 pKi = 7.8 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 531 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)n1 nan
44391318 65356 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
CHEMBL183441 65356 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
118721199 115516 0 None 2 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355949 115516 0 None 2 2 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
25024650 115527 0 None -338 3 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355960 115527 0 None -338 3 Rat 5.8 pKi = 5.8 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
44401235 69484 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193810 69484 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccc(NC(=O)NCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44400995 70740 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 505 7 2 4 5.9 CN(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195353 70740 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 505 7 2 4 5.9 CN(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401188 69459 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 428 9 1 4 4.4 CN(C)c1ccc(CCNCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193656 69459 0 None - 1 Human 5.8 pKi = 5.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 428 9 1 4 4.4 CN(C)c1ccc(CCNCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44401047 70771 0 None - 1 Human 6.8 pKi = 6.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 7 2 3 5.7 Cc1ccc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm040827u
CHEMBL195495 70771 0 None - 1 Human 6.8 pKi = 6.8 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 462 7 2 3 5.7 Cc1ccc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)cc1 10.1021/jm040827u
118721190 115506 0 None 5 3 Mouse 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355939 115506 0 None 5 3 Mouse 7.8 pKi = 7.8 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11214422 123131 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3cccc4cccnc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL362040 123131 0 None - 1 Human 7.8 pKi = 7.8 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3cccc4cccnc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391258 121866 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1cccc(Cl)c1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL360075 121866 0 None - 1 Human 5.8 pKi = 5.8 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1cccc(Cl)c1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
67114884 128742 0 None - 1 Human 7.7 pKi = 7.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 6 1 6 3.1 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCOCC4)ccn3)CC2)ccc1Cl nan
CHEMBL3670802 128742 0 None - 1 Human 7.7 pKi = 7.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 6 1 6 3.1 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCOCC4)ccn3)CC2)ccc1Cl nan
71072115 80832 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158770 80832 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71072081 80835 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158773 80835 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1cccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71072113 80836 0 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158774 80836 0 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
11444350 80839 0 None 7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 558 8 1 4 6.3 O=C(O)[C@H](Cc1cccc(C(F)(F)F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158777 80839 0 None 7 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 558 8 1 4 6.3 O=C(O)[C@H](Cc1cccc(C(F)(F)F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71449584 80870 1 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158825 80870 1 None -1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
69347719 80877 1 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccccc1CN1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158831 80877 1 None 3 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccccc1CN1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71460419 80884 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccc(Cl)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158838 80884 0 None 1 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 8 1 4 5.9 O=C(O)[C@H](Cc1ccc(Cl)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963334 81831 0 None 2 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171038 81831 0 None 2 2 Human 7.7 pKi = 7.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296064 83777 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 447 7 2 5 3.5 N#Cc1cccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208423 83777 0 None -1 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 447 7 2 5 3.5 N#Cc1cccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
59295960 83669 0 None 12 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 532 8 4 6 2.6 NC(=O)c1c(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207667 83669 0 None 12 2 Human 7.7 pKi = 7.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 532 8 4 6 2.6 NC(=O)c1c(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)ccc(Cl)c1Cl 10.1016/j.bmcl.2012.09.112
118721197 115514 0 None 19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355947 115514 0 None 19 2 Human 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389730 64252 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181678 64252 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
70790198 128736 0 None - 1 Human 6.7 pKi = 6.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 454 6 1 4 4.2 CCc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670795 128736 0 None - 1 Human 6.7 pKi = 6.7 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 454 6 1 4 4.2 CCc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
44401056 69490 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193827 69490 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
71462389 81817 0 None -1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171024 81817 0 None -1 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
71462390 81819 0 None -6 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 500 5 1 6 4.3 O=C(c1ccc(-c2nn[nH]n2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171026 81819 0 None -6 2 Human 6.7 pKi = 6.7 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 500 5 1 6 4.3 O=C(c1ccc(-c2nn[nH]n2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296114 83779 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 480 7 2 6 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cn2cc(F)ccc2n1 10.1016/j.bmcl.2012.09.113
CHEMBL2208425 83779 0 None -12 2 Human 6.7 pKi = 6.7 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 480 7 2 6 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cn2cc(F)ccc2n1 10.1016/j.bmcl.2012.09.113
67114949 128750 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.4 Cc1cc(C(=O)N(C)C(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670810 128750 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.4 Cc1cc(C(=O)N(C)C(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
56967064 128760 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 1 5 4.2 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C4CC4)n3)CC2)ccc1Cl nan
CHEMBL3670820 128760 0 None - 1 Human 8.6 pKi = 8.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 1 5 4.2 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C4CC4)n3)CC2)ccc1Cl nan
59295939 83784 0 None 12 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 461 7 3 4 4.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208430 83784 0 None 12 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 461 7 3 4 4.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
59296000 83786 0 None 7 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 478 6 3 6 3.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)n1c(=O)[nH]c2ccccc21 10.1016/j.bmcl.2012.09.113
CHEMBL2208432 83786 0 None 7 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 478 6 3 6 3.1 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)n1c(=O)[nH]c2ccccc21 10.1016/j.bmcl.2012.09.113
59296104 83787 0 None 1 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 503 7 2 5 3.8 CN(C[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C(=O)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208433 83787 0 None 1 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 503 7 2 5 3.8 CN(C[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)C(=O)c1c[nH]c(=O)c2ccccc12 10.1016/j.bmcl.2012.09.113
59295974 83674 0 None 19 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4cc(S(C)(=O)=O)ccc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207672 83674 0 None 19 2 Human 8.6 pKi = 8.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 581 8 3 7 3.2 Cc1c(Cl)ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4cc(S(C)(=O)=O)ccc34)CC2)c1Cl 10.1016/j.bmcl.2012.09.112
11179794 63947 0 None - 1 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3nccc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181034 63947 0 None - 1 Human 7.7 pKi = 7.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3nccc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44389770 123290 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 552 6 1 4 5.5 CC(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL362401 123290 0 None - 1 Human 6.7 pKi = 6.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 552 6 1 4 5.5 CC(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44400954 126521 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 518 6 2 3 7.1 CC(C)(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL365584 126521 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 518 6 2 3 7.1 CC(C)(C)c1ccc(NC(=O)NCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721186 115502 0 None -2 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355935 115502 0 None -2 3 Mouse 6.7 pKi = 6.7 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400982 70766 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL195480 70766 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401252 70457 0 None - 1 Human 4.7 pKi = 4.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 323 7 1 3 2.8 CN1CCN(C(CNCCc2ccccc2)c2ccccc2)CC1 10.1021/jm040827u
CHEMBL195093 70457 0 None - 1 Human 4.7 pKi = 4.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 323 7 1 3 2.8 CN1CCN(C(CNCCc2ccccc2)c2ccccc2)CC1 10.1021/jm040827u
44401225 69602 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 7.1 CC(C)(C)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193938 69602 0 None - 1 Human 6.7 pKi = 6.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 7.1 CC(C)(C)c1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401067 167850 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 450 7 2 4 4.8 COc1ccc(C(CNC(=O)Nc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL434918 167850 0 None - 1 Human 5.7 pKi = 5.7 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 450 7 2 4 4.8 COc1ccc(C(CNC(=O)Nc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44389690 64321 0 None - 1 Human 5.7 pKi = 5.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 426 5 0 2 4.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181827 64321 0 None - 1 Human 5.7 pKi = 5.7 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 426 5 0 2 4.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(F)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
11386642 62745 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 507 5 0 3 6.5 C=C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178887 62745 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 507 5 0 3 6.5 C=C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
56966925 128732 0 None - 1 Human 7.6 pKi = 7.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670791 128732 0 None - 1 Human 7.6 pKi = 7.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
24937092 115524 0 None -2 2 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
CHEMBL3355957 115524 0 None -2 2 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
118721186 115502 0 None -29 3 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355935 115502 0 None -29 3 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401109 70722 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195293 70722 0 None - 1 Human 6.6 pKi = 6.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
56966998 128754 0 None - 1 Human 6.6 pKi = 6.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 527 7 1 6 3.3 COc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670814 128754 0 None - 1 Human 6.6 pKi = 6.6 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 527 7 1 6 3.3 COc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721194 115511 0 None -5 3 Mouse 7.6 pKi = 7.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355944 115511 0 None -5 3 Mouse 7.6 pKi = 7.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
71460416 80838 0 None 2 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158776 80838 0 None 2 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
71456725 80872 1 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158827 80872 1 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1ccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
71072057 80886 0 None 5 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1cccc(F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158840 80886 0 None 5 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1cccc(F)c1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963332 81833 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171040 81833 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
17963153 81839 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171046 81839 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4Cl)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
59295982 83586 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 568 8 4 7 2.1 NS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207282 83586 0 None -1 2 Human 7.6 pKi = 7.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 568 8 4 7 2.1 NS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
44391331 64488 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 394 4 0 2 6.3 CCCCC1C/C(=C\c2ccccc2Br)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
CHEMBL181984 64488 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 394 4 0 2 6.3 CCCCC1C/C(=C\c2ccccc2Br)C2=Nc3ccccc3CN21 10.1016/j.bmcl.2004.11.039
44389698 64024 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)ccc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181290 64024 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)ccc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
69347980 80878 1 None -5 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1cccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158832 80878 1 None -5 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1cccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71458869 81815 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 506 7 1 5 4.6 O=C(O)COc1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171022 81815 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 506 7 1 5 4.6 O=C(O)COc1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
71449857 81816 0 None -10 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171023 81816 0 None -10 2 Human 6.6 pKi = 6.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 5 1 4 4.8 O=C(O)c1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71463287 83773 0 None -79 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 420 7 1 5 4.1 N#Cc1cccc(OC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208419 83773 0 None -79 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 420 7 1 5 4.1 N#Cc1cccc(OC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
59296085 83780 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 506 8 2 7 3.1 CS(=O)(=O)c1ccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)s1 10.1016/j.bmcl.2012.09.113
CHEMBL2208426 83780 0 None -2 2 Human 6.6 pKi = 6.6 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 506 8 2 7 3.1 CS(=O)(=O)c1ccc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)s1 10.1016/j.bmcl.2012.09.113
71458870 81824 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@@H](Oc4ccc(Cl)c(C)c4Cl)C[C@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171031 81824 0 None - 1 Human 5.6 pKi = 5.6 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@@H](Oc4ccc(Cl)c(C)c4Cl)C[C@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
44389832 63578 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL180621 63578 0 None - 1 Human 7.6 pKi = 7.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391176 122083 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 385 1 1 4 4.9 Cc1sc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL360268 122083 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 385 1 1 4 4.9 Cc1sc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
57718837 115499 0 None -45 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355932 115499 0 None -45 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721189 115505 0 None -7 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355938 115505 0 None -7 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11952524 115518 0 None -3 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355951 115518 0 None -3 3 Rat 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
11952525 115525 0 None -21 3 Mouse 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355958 115525 0 None -21 3 Mouse 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
118721201 115522 0 None 2 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355955 115522 0 None 2 2 Rat 5.6 pKi = 5.6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44389688 64199 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181460 64199 0 None - 1 Human 6.6 pKi = 6.6 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 495 4 0 3 6.3 C[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401117 69847 0 None - 1 Human 4.6 pKi = 4.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 413 7 1 3 4.2 Cc1ccc(CC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL194070 69847 0 None - 1 Human 4.6 pKi = 4.6 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 413 7 1 3 4.2 Cc1ccc(CC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44391277 65440 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 369 1 1 4 4.4 Cc1oc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL183478 65440 0 None - 1 Human 6.6 pKi = 6.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 369 1 1 4 4.4 Cc1oc2nc3n(c(=N)c2c1C)CC/C3=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
118721205 115532 0 None -67 3 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355965 115532 0 None -67 3 Mouse 6.6 pKi = 6.6 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44391236 122594 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 357 1 1 4 4.3 N=c1c2ccsc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL361149 122594 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 357 1 1 4 4.3 N=c1c2ccsc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
11360133 122791 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 351 1 1 3 4.2 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL361606 122791 0 None - 1 Human 7.6 pKi = 7.6 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 351 1 1 3 4.2 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44389704 62159 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 509 5 0 3 6.7 CC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178136 62159 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 509 5 0 3 6.7 CC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391252 65498 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 397 2 1 4 5.2 N=c1c2c(C3CC3)csc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL183520 65498 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 397 2 1 4 5.2 N=c1c2c(C3CC3)csc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44391317 65156 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 336 2 0 2 5.7 C(=C1\CCN2Cc3ccccc3N=C12)\c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.11.039
CHEMBL183052 65156 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 336 2 0 2 5.7 C(=C1\CCN2Cc3ccccc3N=C12)\c1ccccc1-c1ccccc1 10.1016/j.bmcl.2004.11.039
44400990 165687 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 3 5.5 CC(C)CC(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL426822 165687 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 3 5.5 CC(C)CC(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
11466397 62535 0 None -407 4 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity against rat CC chemokine receptor 3In vitro binding affinity against rat CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62535 0 None -407 4 Rat 5.5 pKi = 5.5 Binding
In vitro binding affinity against rat CC chemokine receptor 3In vitro binding affinity against rat CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
71451392 80848 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 C[C@](Cc1ccccc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158786 80848 0 None 31 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 C[C@](Cc1ccccc1)(C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71458868 81806 0 None 6 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 568 6 1 6 4.8 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)NS(=O)(=O)c4ccc(N(C)C)cc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171014 81806 0 None 6 2 Human 8.5 pKi = 8.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 568 6 1 6 4.8 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)NS(=O)(=O)c4ccc(N(C)C)cc4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
59295958 83584 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccc(F)cc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207280 83584 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.6 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2ccc(F)cc12 10.1016/j.bmcl.2012.09.112
59296100 83660 0 None 7 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 460 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]nc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207659 83660 0 None 7 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 460 7 3 5 3.0 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]nc2C(F)(F)F)CC1 10.1016/j.bmcl.2012.09.112
59296090 83664 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.3 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)cc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
CHEMBL2207662 83664 0 None 1 2 Human 8.5 pKi = 8.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 507 7 3 5 3.3 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)cc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
10653 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
59534386 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
CHEMBL3670800 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
DB15269 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C nan
11466397 62535 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62535 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
11466397 62535 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62535 0 None -1 4 Human 8.5 pKi = 8.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
56966926 128744 0 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 8 2 5 4.1 Cc1cc(C(=O)NCC2CC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670804 128744 0 None - 1 Human 8.5 pKi = 8.5 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 8 2 5 4.1 Cc1cc(C(=O)NCC2CC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
71072104 80837 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158775 80837 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 520 9 1 5 5.3 COc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
66615678 80842 0 None 19 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158780 80842 0 None 19 2 Human 8.4 pKi = 8.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(Cl)ccc1OC1CCN(CC2CCN([C@@H](Cc3ccc(F)cc3)C(=O)O)CC2)CC1 10.1016/j.bmcl.2012.08.103
59296039 83781 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 467 8 3 6 3.2 COc1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)ccc1N 10.1016/j.bmcl.2012.09.113
CHEMBL2208427 83781 0 None 15 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 467 8 3 6 3.2 COc1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)ccc1N 10.1016/j.bmcl.2012.09.113
59295984 83583 0 None 3 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(F)ccc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207279 83583 0 None 3 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 487 7 3 5 3.3 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3cc(F)ccc23)CC1 10.1016/j.bmcl.2012.09.112
59296048 83588 0 None 6 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 582 9 4 7 2.4 CNS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207284 83588 0 None 6 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 582 9 4 7 2.4 CNS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
59295969 83589 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 10 4 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NC3CC3)ccc12 10.1016/j.bmcl.2012.09.112
CHEMBL2207285 83589 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 608 10 4 7 2.9 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]c(=O)c2cc(S(=O)(=O)NC3CC3)ccc12 10.1016/j.bmcl.2012.09.112
71454296 83667 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 2 6 3.3 Cn1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c(C(F)(F)F)cc1=O 10.1016/j.bmcl.2012.09.112
CHEMBL2207665 83667 0 None 1 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 521 7 2 6 3.3 Cn1cc(C(=O)NC[C@@H](O)CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c(C(F)(F)F)cc1=O 10.1016/j.bmcl.2012.09.112
59296094 83671 0 None 31 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 6 2.7 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1Cl 10.1016/j.bmcl.2012.09.112
CHEMBL2207669 83671 0 None 31 2 Human 8.4 pKi = 8.4 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 6 2.7 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1Cl 10.1016/j.bmcl.2012.09.112
44389737 123331 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccc2ncccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL362649 123331 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccc2ncccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
66906657 115509 0 None 12 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355942 115509 0 None 12 2 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
68849581 80863 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
CHEMBL2158818 80863 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 478 7 1 5 4.4 O=C(O)C(c1ccccc1)N1CCO[C@H](CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
69348078 80865 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158820 80865 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)[C@H](c1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
69272932 80873 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158828 80873 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1ccccc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71072034 80882 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158836 80882 0 None 3 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 490 8 1 4 5.2 O=C(O)[C@@H](Cc1ccccc1)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
17963208 81827 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 529 5 1 5 4.5 O=C(NS(=O)(=O)c1ccc(F)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171034 81827 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 529 5 1 5 4.5 O=C(NS(=O)(=O)c1ccc(F)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71453505 81834 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171041 81834 0 None -1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccccc1S(=O)(=O)NC(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
17963347 81838 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 579 5 1 5 5.4 O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171045 81838 0 None 1 2 Human 7.5 pKi = 7.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 579 5 1 5 5.4 O=C(NS(=O)(=O)c1cccc(C(F)(F)F)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71452601 83778 0 None -100 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 434 8 1 5 4.5 N#Cc1cccc(OC[C@@H](O)CCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208424 83778 0 None -100 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 434 8 1 5 4.5 N#Cc1cccc(OC[C@@H](O)CCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
59296098 83670 0 None 15 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 446 7 3 6 2.0 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1 10.1016/j.bmcl.2012.09.112
CHEMBL2207668 83670 0 None 15 2 Human 7.5 pKi = 7.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 446 7 3 6 2.0 N#Cc1ccc(OC2CCN(C[C@H](O)CNC(=O)c3c[nH]c(=O)c4ccccc34)CC2)cc1 10.1016/j.bmcl.2012.09.112
44391213 122336 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 365 1 0 3 4.3 C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL360560 122336 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 365 1 0 3 4.3 C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
118721198 115515 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355948 115515 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401177 68043 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 490 9 1 4 5.9 CN(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191693 68043 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 490 9 1 4 5.9 CN(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401182 70710 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 476 7 2 3 6.0 Cc1cc(C)cc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)c1 10.1021/jm040827u
CHEMBL195202 70710 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 476 7 2 3 6.0 Cc1cc(C)cc(NC(=O)NCC(CC(C)C)N2CCN(c3ccc(Cl)c(Cl)c3)CC2)c1 10.1021/jm040827u
25056325 70818 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 7 2 3 6.5 Cc1ccc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195610 70818 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 7 2 3 6.5 Cc1ccc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
136229178 81818 0 None -19 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 516 5 1 6 4.5 O=C(c1ccc(-c2noc(=O)[nH]2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171025 81818 0 None -19 2 Human 6.5 pKi = 6.5 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 516 5 1 6 4.5 O=C(c1ccc(-c2noc(=O)[nH]2)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71452602 83790 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1cccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208436 83790 0 None 1 2 Human 6.5 pKi = 6.5 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 433 8 2 5 3.9 N#Cc1cccc(OC[C@@H](O)CNC2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
118721185 115501 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355934 115501 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721204 115531 0 None -28 3 Rat 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355964 115531 0 None -28 3 Rat 6.5 pKi = 6.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44391329 121813 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 344 2 0 3 4.9 FC(F)(F)Oc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL359918 121813 0 None - 1 Human 5.5 pKi = 5.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 344 2 0 3 4.9 FC(F)(F)Oc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
11477767 62683 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178818 62683 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44400948 70712 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 7 2 3 6.8 Cc1cc(C)cc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
CHEMBL195214 70712 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 7 2 3 6.8 Cc1cc(C)cc(NC(=O)NCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
118721189 115505 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355938 115505 0 None 1 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389738 64125 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.1 CCO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181379 64125 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.1 CCO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
118721206 115533 0 None -97 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355966 115533 0 None -97 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44389868 64293 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 588 7 1 5 4.9 CS(=O)(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181789 64293 0 None - 1 Human 6.5 pKi = 6.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 588 7 1 5 4.9 CS(=O)(=O)NC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401160 69107 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 6 2 4 3.8 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C)CC1 10.1021/jm040827u
CHEMBL193369 69107 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 6 2 4 3.8 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C)CC1 10.1021/jm040827u
118721206 115533 0 None 19 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355966 115533 0 None 19 3 Human 7.5 pKi = 7.5 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44389784 63979 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnc4ccccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181137 63979 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnc4ccccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44401083 124006 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccccc1C(CNCCc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL364047 124006 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccccc1C(CNCCc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401154 69906 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194161 69906 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401031 69677 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 503 8 1 3 7.1 CC(C)(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193973 69677 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 503 8 1 3 7.1 CC(C)(C)c1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401011 134704 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 8 1 4 5.0 CN(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL372493 134704 0 None - 1 Human 4.5 pKi = 4.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 510 8 1 4 5.0 CN(C)c1ccc(C(CNC(=O)Cc2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44391247 122968 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 307 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Cl 10.1016/j.bmcl.2004.11.039
CHEMBL361761 122968 0 None - 1 Human 7.5 pKi = 7.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 307 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1Cl 10.1016/j.bmcl.2004.11.039
44389910 63011 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cnccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL179490 63011 0 None - 1 Human 7.5 pKi = 7.5 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4cnccc4n3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
44391177 64123 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 411 1 1 4 5.2 N=c1c2c3c(sc2nc2n1CC/C2=C\c1ccccc1Br)CCCC3 10.1016/j.bmcl.2004.11.039
CHEMBL181367 64123 0 None - 1 Human 6.5 pKi = 6.5 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 411 1 1 4 5.2 N=c1c2c3c(sc2nc2n1CC/C2=C\c1ccccc1Br)CCCC3 10.1016/j.bmcl.2004.11.039
44401206 126522 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 447 8 1 3 5.8 CC(C)(C)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL365596 126522 0 None - 1 Human 6.5 pKi = 6.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 447 8 1 3 5.8 CC(C)(C)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721205 115532 0 None -870 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355965 115532 0 None -870 3 Rat 5.5 pKi = 5.5 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
44401063 132565 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 444 7 2 4 4.7 COc1ccccc1C(CNC(=O)Nc1ccc(C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL370244 132565 0 None - 1 Human 5.5 pKi = 5.5 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 444 7 2 4 4.7 COc1ccccc1C(CNC(=O)Nc1ccc(C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
44391192 63541 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 301 2 1 3 4.0 CCc1ccccc1/C=C1\CCn2c1nc1ccccc1c2=N 10.1016/j.bmcl.2004.11.039
CHEMBL180446 63541 0 None - 1 Human 6.4 pKi = 6.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 301 2 1 3 4.0 CCc1ccccc1/C=C1\CCn2c1nc1ccccc1c2=N 10.1016/j.bmcl.2004.11.039
44401248 135451 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL373158 135451 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.5 COc1ccccc1NC(=O)NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
118721189 115505 0 None -1 3 Mouse 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355938 115505 0 None -1 3 Mouse 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 400 6 1 2 6.1 Cc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721196 115513 0 None -4 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355946 115513 0 None -4 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721197 115514 0 None -19 2 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355947 115514 0 None -19 2 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(OC)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
57718829 115517 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
CHEMBL3355950 115517 0 None 2 2 Human 7.4 pKi = 7.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
44389752 63762 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180813 63762 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1ccnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721198 115515 0 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355948 115515 0 None -1 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(C(N)=O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400950 68310 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 6 2 4 4.2 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
CHEMBL192045 68310 0 None - 1 Human 5.4 pKi = 5.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 6 2 4 4.2 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
10151756 80860 0 None 1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.1 O=C(O)C(c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158815 80860 0 None 1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 462 6 1 4 5.1 O=C(O)C(c1ccccc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
69274365 80871 1 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158826 80871 1 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)Cc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
71449585 80874 0 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
CHEMBL2158829 80874 0 None -7 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 492 8 1 5 5.2 O=C(O)COc1cccc(N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.103
17963196 81829 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171036 81829 0 None -1 2 Human 7.4 pKi = 7.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 541 6 1 6 4.4 COc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
118721202 115529 0 None -77 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355962 115529 0 None -77 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
44391212 65497 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 303 2 1 4 3.5 COc1ccc(/C=C2\CCn3c2nc2ccccc2c3=N)cc1 10.1016/j.bmcl.2004.11.039
CHEMBL183519 65497 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 303 2 1 4 3.5 COc1ccc(/C=C2\CCn3c2nc2ccccc2c3=N)cc1 10.1016/j.bmcl.2004.11.039
44401088 165786 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 483 9 1 4 5.4 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL427357 165786 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 483 9 1 4 5.4 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44389675 62517 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178438 62517 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
71449859 81822 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 600 10 1 8 5.1 O=C(O)CCCCn1nnc(-c2ccc(C(=O)N3CCC(N4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)CC3)cc2)n1 10.1016/j.bmcl.2012.08.124
CHEMBL2171029 81822 0 None -10 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 600 10 1 8 5.1 O=C(O)CCCCn1nnc(-c2ccc(C(=O)N3CCC(N4CCC(Oc5ccc(Cl)c(Cl)c5)CC4)CC3)cc2)n1 10.1016/j.bmcl.2012.08.124
71462391 81825 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 3.9 CS(=O)(=O)c1cccc(C(=O)N2CC[C@@H](N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)[C@H](C(=O)O)C2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171032 81825 0 None -1 2 Human 6.4 pKi = 6.4 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 3.9 CS(=O)(=O)c1cccc(C(=O)N2CC[C@@H](N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)[C@H](C(=O)O)C2)c1 10.1016/j.bmcl.2012.08.124
118721205 115532 0 None 67 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355965 115532 0 None 67 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 653 11 3 5 7.2 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)O)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
67115149 128748 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.5 CCC(C)NC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670808 128748 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.5 CCC(C)NC(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
68028908 128757 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.5 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C(C)C)n3)CC2)ccc1Cl nan
CHEMBL3670817 128757 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 7 1 5 4.5 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C(C)C)n3)CC2)ccc1Cl nan
68029259 128751 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 2 5 4.2 Cc1cc(C(=O)NC2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670811 128751 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 537 7 2 5 4.2 Cc1cc(C(=O)NC2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721191 115507 0 None 12 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355940 115507 0 None 12 3 Human 8.4 pKi = 8.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
67115103 128746 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.3 Cc1cc(C(=O)NCC(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670806 128746 0 None - 1 Human 8.4 pKi = 8.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 539 8 2 5 4.3 Cc1cc(C(=O)NCC(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
56966996 128747 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 547 8 2 5 3.9 Cc1cc(C(=O)NCC(F)F)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670807 128747 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 547 8 2 5 3.9 Cc1cc(C(=O)NCC(F)F)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721200 115521 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355954 115521 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
67115023 128741 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.9 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCCC4)ccn3)CC2)ccc1Cl nan
CHEMBL3670801 128741 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.9 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N4CCCC4)ccn3)CC2)ccc1Cl nan
118721194 115511 0 None 5 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355944 115511 0 None 5 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.4 COC(C)c1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11952526 115520 0 None 24 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355953 115520 0 None 24 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44389744 123342 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL362700 123342 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
66906657 115509 0 None -12 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355942 115509 0 None -12 2 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721199 115516 0 None -2 2 Human 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355949 115516 0 None -2 2 Human 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 440 8 2 3 5.9 CCc1[nH]c2cc(C(=O)O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721188 115504 0 None -8 3 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355937 115504 0 None -8 3 Rat 5.4 pKi = 5.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401189 69485 0 None - 1 Human 4.4 pKi = 4.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 8 1 4 3.9 COc1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193818 69485 0 None - 1 Human 4.4 pKi = 4.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 8 1 4 3.9 COc1ccc(C(CNC(=O)Cc2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
44391800 63927 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 484 6 0 3 4.9 COc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL180939 63927 0 None - 1 Human 6.4 pKi = 6.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 484 6 0 3 4.9 COc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44389675 62517 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178438 62517 0 None - 1 Human 7.4 pKi = 7.4 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 525 6 0 4 6.0 COC[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
25024850 115528 0 None -6 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355961 115528 0 None -6 3 Mouse 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
68028909 128755 0 None - 1 Human 6.4 pKi = 6.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 9 1 5 4.7 CCCCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670815 128755 0 None - 1 Human 6.4 pKi = 6.4 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 9 1 5 4.7 CCCCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721195 115512 0 None -9 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355945 115512 0 None -9 3 Rat 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400977 69598 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 7 2 3 4.8 CC(C)CC(CNC(=O)Nc1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL193916 69598 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 7 2 3 4.8 CC(C)CC(CNC(=O)Nc1ccc(Cl)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44400944 69958 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 442 9 1 4 4.8 Cc1ccc(CCNCC(c2ccc(N(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL194435 69958 0 None - 1 Human 6.4 pKi = 6.4 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 442 9 1 4 4.8 Cc1ccc(CCNCC(c2ccc(N(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
118721188 115504 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355937 115504 0 None 2 3 Human 6.4 pKi = 6.4 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 439 8 2 3 5.3 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C(N)=O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44391312 65241 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 304 3 0 3 4.4 CCOc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL183229 65241 0 None - 1 Human 5.4 pKi = 5.4 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 304 3 0 3 4.4 CCOc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44389735 121797 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cnc2ccccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL359850 121797 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cnc2ccccc2c1)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721195 115512 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355945 115512 0 None 1 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389736 62492 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 513 5 0 3 6.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CF)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178422 62492 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 513 5 0 3 6.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CF)C2)CC1 10.1016/j.bmcl.2005.01.016
44389725 123125 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 482 4 0 4 5.5 O=C(c1cnnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL362017 123125 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 482 4 0 4 5.5 O=C(c1cnnc2ccccc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
56966927 128734 0 None - 1 Human 7.3 pKi = 7.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 456 6 1 5 3.6 COc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670793 128734 0 None - 1 Human 7.3 pKi = 7.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 456 6 1 5 3.6 COc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
118721193 115510 0 None -69 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355943 115510 0 None -69 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
11952525 115525 0 None -38 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355958 115525 0 None -38 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 562 10 0 5 8.0 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)cc1 10.1016/j.bmcl.2014.11.063
44401129 126243 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
CHEMBL365369 126243 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccccc2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
44401175 126696 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL365806 126696 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401037 70721 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccccc1 10.1021/jm040827u
CHEMBL195291 70721 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 6 2 3 5.5 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1ccccc1 10.1021/jm040827u
118721195 115512 0 None -1 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355945 115512 0 None -1 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(C)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389765 168759 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4nccnc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL441848 168759 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4nccnc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
118721192 115508 0 None -4 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355941 115508 0 None -4 2 Human 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 458 8 1 4 6.0 CCOC(=O)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401146 69903 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194135 69903 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.5 FC(F)(F)c1ccc(C(CNCCc2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401256 70875 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL195657 70875 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccccc1CCNCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
25024650 115527 0 None 21 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355960 115527 0 None 21 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cccc(C(=O)O)n1 10.1016/j.bmcl.2014.11.063
118721202 115529 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355962 115529 0 None 15 3 Human 8.3 pKi = 8.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
9914506 80831 0 None 3 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158769 80831 0 None 3 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
68938028 80834 0 None 6 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158772 80834 0 None 6 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 8 1 4 5.6 Cc1ccccc1C[C@@H](C(=O)O)N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
66615705 80841 0 None 19 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158779 80841 0 None 19 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 508 8 1 4 5.4 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2012.08.103
69826668 81814 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 5 0 5 4.9 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)c4cccc(S(C)(=O)=O)c4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171021 81814 0 None 5 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 524 5 0 5 4.9 Cc1c(Cl)ccc(OC2CCN(C3CCN(C(=O)c4cccc(S(C)(=O)=O)c4)CC3)CC2)c1Cl 10.1016/j.bmcl.2012.08.124
71457010 81832 0 None 10 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccccc1Cl)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171039 81832 0 None 10 2 Human 8.3 pKi = 8.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccccc1Cl)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
70790202 128749 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 8 1 5 4.8 CCC(C)N(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670809 128749 0 None - 1 Human 8.3 pKi = 8.3 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 8 1 5 4.8 CCC(C)N(C)C(=O)c1cc(C)nc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
57718837 115499 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355932 115499 0 None 1 3 Human 8.2 pKi = 8.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 414 7 1 2 6.4 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
56966997 128752 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 555 6 1 5 3.8 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Br)c(C)c3)CC2)n1 nan
CHEMBL3670812 128752 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 555 6 1 5 3.8 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Br)c(C)c3)CC2)n1 nan
11466397 62535 0 None -1 4 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62535 0 None -1 4 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
10003872 69924 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 9 1 4 5.1 COc1ccc(C(CNCCc2cc(C)cc(C)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194283 69924 0 None - 1 Human 7.3 pKi = 7.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 449 9 1 4 5.1 COc1ccc(C(CNCCc2cc(C)cc(C)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
71451390 80840 0 None 7 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 474 8 1 4 4.7 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158778 80840 0 None 7 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 474 8 1 4 4.7 O=C(O)[C@H](Cc1ccc(F)cc1)N1CCC(CN2CCC(Oc3ccc(Cl)cc3)CC2)CC1 10.1016/j.bmcl.2012.08.103
22397436 81811 0 None -6 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 510 5 0 5 4.5 CS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171019 81811 0 None -6 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 510 5 0 5 4.5 CS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
17963258 81830 0 None -2 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171037 81830 0 None -2 2 Human 7.3 pKi = 7.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 554 6 1 6 4.5 CN(C)c1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
71451671 81821 0 None -31 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 519 8 2 5 5.0 O=C(O)CCNc1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171028 81821 0 None -31 2 Human 6.3 pKi = 6.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 519 8 2 5 5.0 O=C(O)CCNc1ccccc1C(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
71451670 81809 0 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 455 7 1 4 4.2 COc1ccc(C(=O)NCCN2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2171017 81809 0 None - 1 Human 5.3 pKi = 5.3 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 455 7 1 4 4.2 COc1ccc(C(=O)NCCN2CCN(Cc3ccc(Cl)c(Cl)c3)CC2)cc1Cl 10.1016/j.bmcl.2012.08.124
44389751 64298 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181794 64298 0 None - 1 Human 6.3 pKi = 6.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 442 5 0 2 5.3 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(F)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
44401136 70417 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 495 9 1 3 6.8 Cc1cc(C)cc(CCNCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
CHEMBL195081 70417 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 495 9 1 3 6.8 Cc1cc(C)cc(CCNCC(c2ccc(-c3ccccc3)cc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
44401132 68279 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 5 2 3 5.1 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
CHEMBL191824 68279 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 474 5 2 3 5.1 CN1CCN(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)c2ccc(C(F)(F)F)cc2)CC1 10.1021/jm040827u
118721191 115507 0 None -12 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355940 115507 0 None -12 3 Mouse 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 444 8 1 3 6.5 COC(C)c1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
25024849 115526 0 None -97 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355959 115526 0 None -97 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
44401012 68313 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccccc1C(CNC(=O)Nc1ccc(F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL192066 68313 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 454 7 2 4 4.6 COc1ccccc1C(CNC(=O)Nc1ccc(F)cc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401145 69879 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 6 2 3 4.8 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194086 69879 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 420 6 2 3 4.8 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
25024849 115526 0 None 13 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355959 115526 0 None 13 3 Human 7.3 pKi = 7.3 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
44401048 69491 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 8 1 3 5.8 Cc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193828 69491 0 None - 1 Human 6.3 pKi = 6.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 8 1 3 5.8 Cc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
11952526 115520 0 None -1122 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355953 115520 0 None -1122 3 Rat 5.3 pKi = 5.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 534 9 1 4 7.5 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
44401209 69446 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 418 6 2 3 4.5 O=C(NCC(c1ccccc1)N1CCN(c2ccccc2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
CHEMBL193592 69446 0 None - 1 Human 5.3 pKi = 5.3 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 418 6 2 3 4.5 O=C(NCC(c1ccccc1)N1CCN(c2ccccc2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
44389683 131115 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL369287 131115 0 None - 1 Human 7.3 pKi = 7.3 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Cl)cc3Cl)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721196 115513 0 None -6 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355946 115513 0 None -6 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
24937215 115519 0 None -9 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
CHEMBL3355952 115519 0 None -9 3 Rat 6.3 pKi = 6.3 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
44401226 70748 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 9 1 4 4.7 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL195406 70748 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 429 9 1 4 4.7 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
56966929 128740 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 6 1 6 3.4 Cc1cc(C(=O)N2CCOCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670799 128740 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 553 6 1 6 3.4 Cc1cc(C(=O)N2CCOCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
11753159 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.103
7679 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158814 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.103
11753159 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
7679 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
CHEMBL2158814 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 10.1016/j.bmcl.2012.08.124
17963183 81836 0 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1cccc(Cl)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171043 81836 0 None 1 2 Human 8.2 pKi = 8.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1cccc(Cl)c1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
59296024 83581 0 None 9 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3ccc(S(C)(=O)=O)cc23)CC1 10.1016/j.bmcl.2012.09.112
CHEMBL2207277 83581 0 None 9 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 547 8 3 7 2.5 Cc1cc(Cl)ccc1OC1CCN(C[C@H](O)CNC(=O)c2c[nH]c(=O)c3ccc(S(C)(=O)=O)cc23)CC1 10.1016/j.bmcl.2012.09.112
59296111 83659 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 5 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
CHEMBL2207658 83659 0 None 2 2 Human 8.2 pKi = 8.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 480 7 3 5 3.4 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1c[nH]nc1C(F)(F)F 10.1016/j.bmcl.2012.09.112
56966995 128745 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.8 Cc1cc(C(=O)N2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670805 128745 0 None - 1 Human 8.2 pKi = 8.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 523 6 1 5 3.8 Cc1cc(C(=O)N2CCC2)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721184 115500 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355933 115500 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
25024850 115528 0 None 6 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355961 115528 0 None 6 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
44401005 70212 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 9 1 5 3.9 COc1ccccc1CC(=O)NCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL194886 70212 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 9 1 5 3.9 COc1ccccc1CC(=O)NCC(c1ccccc1OC)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
44401025 69319 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193535 69319 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 496 9 1 4 5.5 CN(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
11466397 62535 0 None -83 4 Mouse 6.2 pKi = 6.2 Binding
In vitro binding affinity against mouse CC chemokine receptor 3In vitro binding affinity against mouse CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62535 0 None -83 4 Mouse 6.2 pKi = 6.2 Binding
In vitro binding affinity against mouse CC chemokine receptor 3In vitro binding affinity against mouse CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
24937215 115519 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
CHEMBL3355952 115519 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
70790203 128763 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3cc(C)c(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670823 128763 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 6 1 5 4.0 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3cc(C)c(Cl)c(C)c3)CC2)n1 nan
44391235 64899 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 376 1 0 4 4.1 N#C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL182719 64899 0 None - 1 Human 5.2 pKi = 5.2 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 376 1 0 4 4.1 N#C/N=c1/c2ccccc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
118721185 115501 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355934 115501 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
25056323 70877 0 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195671 70877 0 None - 1 Human 7.2 pKi = 7.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.8 COc1ccc(C(CNCCc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401069 68753 0 None - 1 Human 4.2 pKi = 4.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 7 1 3 5.3 O=C(Cc1cc(Cl)cc(Cl)c1)NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL192384 68753 0 None - 1 Human 4.2 pKi = 4.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 473 7 1 3 5.3 O=C(Cc1cc(Cl)cc(Cl)c1)NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401110 68297 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(C(CNCCc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191959 68297 0 None - 1 Human 6.2 pKi = 6.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 9 1 4 5.8 COc1ccc(C(CNCCc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
59296041 83672 0 None 3 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 558 8 3 8 2.1 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(C#N)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207670 83672 0 None 3 2 Human 7.2 pKi = 7.2 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 558 8 3 8 2.1 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(C#N)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
25024651 115523 0 None -39 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355956 115523 0 None -39 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(C(=O)O)cn1 10.1016/j.bmcl.2014.11.063
118721185 115501 0 None -19 3 Rat 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355934 115501 0 None -19 3 Rat 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 410 7 1 2 6.5 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(C)cc2)CC1 10.1016/j.bmcl.2014.11.063
69347707 80879 1 None -5 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158833 80879 1 None -5 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)c1ccc(CN2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
69260079 80880 2 None -63 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 463 6 1 5 4.8 O=C(O)c1cccnc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
CHEMBL2158834 80880 2 None -63 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 463 6 1 5 4.8 O=C(O)c1cccnc1N1CCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.103
71457009 81823 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@H](Oc4ccc(Cl)c(C)c4Cl)C[C@@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171030 81823 0 None - 1 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 504 5 1 4 5.2 Cc1ccc(C(=O)N2CCC(N3CC[C@H](Oc4ccc(Cl)c(C)c4Cl)C[C@@H]3C(=O)O)CC2)cc1 10.1016/j.bmcl.2012.08.124
17963199 81844 0 None 1 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 493 5 1 5 3.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(F)c(F)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171050 81844 0 None 1 2 Human 6.2 pKi = 6.2 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 493 5 1 5 3.7 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(F)c(F)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
44401203 69772 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 424 6 2 3 4.6 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
CHEMBL194026 69772 0 None - 1 Human 5.2 pKi = 5.2 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 424 6 2 3 4.6 O=C(NCC(c1ccccc1)N1CCN(C2CCCCC2)CC1)Nc1ccc(F)cc1 10.1021/jm040827u
118721204 115531 0 None -5 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355964 115531 0 None -5 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 532 9 3 2 6.7 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)[nH]c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
25024850 115528 0 None -107 3 Rat 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
CHEMBL3355961 115528 0 None -107 3 Rat 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1cccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)n1 10.1016/j.bmcl.2014.11.063
118721184 115500 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355933 115500 0 None -1 3 Mouse 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
11952524 115518 0 None -9 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355951 115518 0 None -9 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
118721193 115510 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355943 115510 0 None 1 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389684 62638 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 468 5 0 2 5.2 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178576 62638 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 468 5 0 2 5.2 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3ccc(Br)cc3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721206 115533 0 None -19 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355966 115533 0 None -19 3 Mouse 6.2 pKi = 6.2 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 667 11 2 6 7.3 CCNC(=O)N[C@@H](CCN1CCC(c2c(CC)n(-c3ccc(C(=O)OC)cn3)c3cc(F)ccc23)CC1)Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2014.11.063
11952524 115518 0 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355951 115518 0 None 3 3 Human 7.2 pKi = 7.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 490 8 0 3 7.8 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccccc1 10.1016/j.bmcl.2014.11.063
56966928 128735 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
CHEMBL3670794 128735 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1ccnc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)c1 nan
44389677 62743 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cccc2cccnc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178875 62743 0 None - 1 Human 7.2 pKi = 7.2 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 481 4 0 3 6.1 O=C(c1cccc2cccnc12)N1CCC(N2CCC(Cc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
56965997 128733 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670792 128733 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 440 5 1 4 3.9 Cc1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
118721201 115522 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355955 115522 0 None -2 2 Human 5.2 pKi = 5.2 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 548 10 1 4 7.6 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1Cc1ccc(C(=O)O)cc1 10.1016/j.bmcl.2014.11.063
11466397 62535 0 None 1 4 Rhesus macaque 8.1 pKi = 8.1 Binding
In vitro binding affinity against monkey CC chemokine receptor 3In vitro binding affinity against monkey CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL178447 62535 0 None 1 4 Rhesus macaque 8.1 pKi = 8.1 Binding
In vitro binding affinity against monkey CC chemokine receptor 3In vitro binding affinity against monkey CC chemokine receptor 3
ChEMBL 511 5 1 4 5.3 O=C(c1ccc2ncccc2c1)N1CCC(N2CC[C@H](Cc3ccc(Cl)c(Cl)c3)[C@H](CO)C2)CC1 10.1016/j.bmcl.2005.01.016
11477767 62683 0 None - 1 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL178818 62683 0 None - 1 Human 8.1 pKi = 8.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 511 5 0 4 5.7 CO[C@@H]1CN(C2CCN(C(=O)c3ccc4ncccc4c3)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
67115945 128761 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C)n3)CC2)ccc1Cl nan
CHEMBL3670821 128761 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)cc(C)n3)CC2)ccc1Cl nan
56967065 128762 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 521 6 1 5 3.3 C#Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670822 128762 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 521 6 1 5 3.3 C#Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
71072052 80833 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
CHEMBL2158771 80833 0 None 1 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 515 8 1 5 5.1 N#Cc1ccc(C[C@@H](C(=O)O)N2CCC(CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.103
71453204 80844 0 None 12 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
CHEMBL2158782 80844 0 None 12 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 488 8 1 4 5.0 Cc1cc(OC2CCN(CC3CCN([C@@H](Cc4ccc(F)cc4)C(=O)O)CC3)CC2)ccc1Cl 10.1016/j.bmcl.2012.08.103
17963363 81828 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
CHEMBL2171035 81828 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 545 5 1 5 5.1 O=C(NS(=O)(=O)c1ccc(Cl)cc1)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1 10.1016/j.bmcl.2012.08.124
17963226 81841 0 None 3 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 505 5 1 5 4.4 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4C)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171048 81841 0 None 3 2 Human 8.1 pKi = 8.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 505 5 1 5 4.4 Cc1ccc(S(=O)(=O)NC(=O)N2CCC(N3CCC(Oc4ccc(Cl)cc4C)CC3)CC2)cc1 10.1016/j.bmcl.2012.08.124
59295994 83788 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cc(=O)[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
CHEMBL2208434 83788 0 None -1 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 489 7 3 5 3.5 O=C(NC[C@@H](O)CN1CCC(Oc2ccc(Cl)c(Cl)c2)CC1)c1cc(=O)[nH]c2ccccc12 10.1016/j.bmcl.2012.09.113
59295925 83673 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 567 8 3 7 2.9 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
CHEMBL2207671 83673 0 None 2 2 Human 8.1 pKi = 8.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation countingDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4-(methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting
ChEMBL 567 8 3 7 2.9 CS(=O)(=O)c1ccc2c(C(=O)NC[C@@H](O)CN3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)c[nH]c(=O)c2c1 10.1016/j.bmcl.2012.09.112
56966999 128758 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 495 6 1 5 3.1 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(F)c(C)c3)CC2)n1 nan
CHEMBL3670818 128758 0 None - 1 Human 7.2 pKi = 7.2 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 495 6 1 5 3.1 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(F)c(C)c3)CC2)n1 nan
118721200 115521 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355954 115521 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 558 9 1 6 7.0 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1ccc(-c2nnn[nH]2)cc1 10.1016/j.bmcl.2014.11.063
67115364 123905 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3639696 123905 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 483 6 2 5 3.0 CNC(=O)c1cccc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
44391319 63992 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)cc1Cl 10.1016/j.bmcl.2004.11.039
CHEMBL181195 63992 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 328 1 0 2 5.3 Clc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)cc1Cl 10.1016/j.bmcl.2004.11.039
118721190 115506 0 None -40 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355939 115506 0 None -40 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
24937215 115519 0 None -1 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
CHEMBL3355952 115519 0 None -1 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 472 9 1 4 5.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1CC(=O)O 10.1016/j.bmcl.2014.11.063
25024849 115526 0 None -13 3 Mouse 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
CHEMBL3355959 115526 0 None -13 3 Mouse 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)nc1 10.1016/j.bmcl.2014.11.063
44391170 65373 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 399 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1I 10.1016/j.bmcl.2004.11.039
CHEMBL183461 65373 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 399 1 1 3 4.1 N=c1c2ccccc2nc2n1CC/C2=C\c1ccccc1I 10.1016/j.bmcl.2004.11.039
44400991 69455 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL193633 69455 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 471 9 1 4 5.7 COc1ccc(CCNCC(c2ccc(C(C)(C)C)cc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
43957010 68280 7 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 399 6 2 4 3.0 CN1CCN(C(CNC(=O)Nc2ccc(F)cc2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
CHEMBL191828 68280 7 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 399 6 2 4 3.0 CN1CCN(C(CNC(=O)Nc2ccc(F)cc2)c2ccc(N(C)C)cc2)CC1 10.1021/jm040827u
118721186 115502 0 None 2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355935 115502 0 None 2 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(O)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401085 134966 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.5 FC(F)(F)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL372858 134966 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 527 8 1 3 6.5 FC(F)(F)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721202 115529 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
CHEMBL3355962 115529 0 None -15 3 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 535 9 1 5 6.9 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1-c1cc(C(=O)O)ccn1 10.1016/j.bmcl.2014.11.063
68846936 80861 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
CHEMBL2158816 80861 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 476 7 1 4 5.4 O=C(O)C(c1ccccc1)N1CCCC(CN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)C1 10.1016/j.bmcl.2012.08.103
23102733 81807 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 6 1 5 4.0 O=C(NS(=O)(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1)c1ccccc1 10.1016/j.bmcl.2012.08.124
CHEMBL2171015 81807 0 None 1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 511 6 1 5 4.0 O=C(NS(=O)(=O)N1CCC(N2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)CC1)c1ccccc1 10.1016/j.bmcl.2012.08.124
71449858 81820 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 582 9 1 6 4.8 O=C(O)CCCS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
CHEMBL2171027 81820 0 None -1 2 Human 7.1 pKi = 7.1 Binding
Binding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assayBinding affinity to human CCR3 receptor expressed in CHOK1 cells by radioligand displacement assay
ChEMBL 582 9 1 6 4.8 O=C(O)CCCS(=O)(=O)c1cccc(C(=O)N2CCC(N3CCC(Oc4ccc(Cl)c(Cl)c4)CC3)CC2)c1 10.1016/j.bmcl.2012.08.124
71461541 83791 0 None 15 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 513 9 3 6 2.7 CS(=O)(=O)c1ccccc1C(=O)NCC(O)CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
CHEMBL2208437 83791 0 None 15 2 Human 7.1 pKi = 7.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 513 9 3 6 2.7 CS(=O)(=O)c1ccccc1C(=O)NCC(O)CNC1CCN(Cc2ccc(Cl)c(Cl)c2)CC1 10.1016/j.bmcl.2012.09.113
44391240 123128 0 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 432 2 0 2 6.7 Fc1ccc(C2C/C(=C\c3ccccc3Br)C3=Nc4ccccc4CN32)cc1 10.1016/j.bmcl.2004.11.039
CHEMBL362032 123128 0 None - 1 Human 5.1 pKi = 5.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 432 2 0 2 6.7 Fc1ccc(C2C/C(=C\c3ccccc3Br)C3=Nc4ccccc4CN32)cc1 10.1016/j.bmcl.2004.11.039
44389732 64002 0 None - 1 Human 6.1 pKi = 6.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 420 6 0 3 4.5 COc1ccc(CC2CCN(C3CCN(C(=O)Cc4ccccc4C)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
CHEMBL181230 64002 0 None - 1 Human 6.1 pKi = 6.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 420 6 0 3 4.5 COc1ccc(CC2CCN(C3CCN(C(=O)Cc4ccccc4C)CC3)CC2)cc1 10.1016/j.bmcl.2005.01.016
71450777 83774 0 None -63 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 404 7 0 4 5.2 N#Cc1cccc(OCCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
CHEMBL2208420 83774 0 None -63 2 Human 6.1 pKi = 6.1 Binding
Displacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysisDisplacement of [3H]-4-(2,4-dichloro-3-methylphenoxy)-l'-[4- (methylsulfonyl)benzoyl]-l,4'-bipiperidine from human recombinant CCR3 expressed in CHOK1 cells after 2 hrs by scintillation counting analysis
ChEMBL 404 7 0 4 5.2 N#Cc1cccc(OCCCN2CCC(Oc3ccc(Cl)c(Cl)c3)CC2)c1 10.1016/j.bmcl.2012.09.113
56965994 128753 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
CHEMBL3670813 128753 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 525 7 1 5 3.9 CCc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C)c3)CC2)n1 nan
56965996 128738 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 1 5 3.3 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)ccn3)CC2)ccc1Cl nan
CHEMBL3670797 128738 0 None - 1 Human 8.1 pKi = 8.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 497 6 1 5 3.3 Cc1cc(CN2CCC(N3C(=O)CC[C@@H]3C(=O)Nc3cc(C(=O)N(C)C)ccn3)CC2)ccc1Cl nan
25056324 126411 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.8 Clc1cc(Cl)cc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
CHEMBL365551 126411 0 None - 1 Human 7.1 pKi = 7.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 459 8 1 3 5.8 Clc1cc(Cl)cc(CCNCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)c1 10.1021/jm040827u
44401070 68754 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 414 6 2 3 4.7 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
CHEMBL192385 68754 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 414 6 2 3 4.7 Cc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(c3ccccc3)CC2)cc1 10.1021/jm040827u
24937092 115524 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
CHEMBL3355957 115524 0 None 2 2 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 500 10 0 5 6.4 CCOC(=O)Cn1c(CC)c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc21 10.1016/j.bmcl.2014.11.063
44391282 122093 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 352 1 1 4 3.6 N=c1c2cccnc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL360308 122093 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 352 1 1 4 3.6 N=c1c2cccnc2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
136216709 78541 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 341 1 2 4 2.9 N=c1c2nc[nH]c2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
CHEMBL2113024 78541 0 None - 1 Human 6.1 pKi = 6.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 341 1 2 4 2.9 N=c1c2nc[nH]c2nc2n1CC/C2=C\c1ccccc1Br 10.1016/j.bmcl.2004.11.039
44387847 60157 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL175547 60157 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44387853 63100 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL179752 63100 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 515 8 1 3 6.8 CC(C)(C)c1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
57718829 115517 0 None -2 2 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
CHEMBL3355950 115517 0 None -2 2 Mouse 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 428 7 0 3 6.4 CCc1c(C2CCN(CCCSc3ccc(F)cc3)CC2)c2ccc(F)cc2n1C 10.1016/j.bmcl.2014.11.063
118721196 115513 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355946 115513 0 None 4 3 Human 7.1 pKi = 7.1 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 412 7 2 3 5.9 CCc1[nH]c2cc(O)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44389790 64426 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
CHEMBL181929 64426 0 None - 1 Human 7.1 pKi = 7.1 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 512 5 0 5 5.1 CO[C@@H]1CN(C2CCN(C(=O)c3cnnc4ccccc34)CC2)CC[C@@H]1Cc1ccc(Cl)c(Cl)c1 10.1016/j.bmcl.2005.01.016
56967063 128759 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 565 6 1 5 4.4 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C(F)(F)F)c3)CC2)n1 nan
CHEMBL3670819 128759 0 None - 1 Human 7.1 pKi = 7.1 Binding
Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.Scintillation Proximity Assay: The CCR3 receptor binding assay was performed in a Scintillation Proximity Assay (SPA) design with the radioligand recombinant human 125Iodine-eotaxin-1. Cell membranes of hCCR3 C1 cells were again homogenized by passing through a single use needle (Terumo, 23Gx1'') and diluted in SPA incubation buffer in suitable concentrations (0.5-10 ug protein/well) in 96 well microtiter plates (1450-514, Perkin Elmer). The SPA assay was set up in the SPA incubation buffer with a final volume of 200 ul and final concentration of 25 mM HEPES, 25 mM MgCl2 6H2O, 1 mM CaCl2 2H2O and 0.1% bovine serum albumin. The SPA assay mixture contained 60 ul of the membrane suspension, 80 ul of Wheat Germ Agglutinin coated PVT beads (organic scintillator, GE Healthcare, RPNQ-0001) 0.2 mg/well), 40 ul of recombinant human 125Jodine-eotaxin-1 (Biotrend), diluted in SPA buffer to a final concentration of 30.000 dpm per well.
ChEMBL 565 6 1 5 4.4 Cc1cc(C(=O)N(C)C)cc(NC(=O)[C@H]2CCC(=O)N2C2CCN(Cc3ccc(Cl)c(C(F)(F)F)c3)CC2)n1 nan
118721184 115500 0 None -14 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355933 115500 0 None -14 3 Rat 6.1 pKi = 6.1 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 396 7 1 2 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccccc2)CC1 10.1016/j.bmcl.2014.11.063
44400974 134754 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 485 8 1 4 5.2 COc1ccccc1CC(=O)NCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
CHEMBL372725 134754 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 485 8 1 4 5.2 COc1ccccc1CC(=O)NCC(c1ccc(C(C)(C)C)cc1)N1CCN(c2ccccc2)CC1 10.1021/jm040827u
44400949 68799 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 8 1 3 5.7 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL192412 68799 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 477 8 1 3 5.7 Fc1ccc(CCNCC(c2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401155 69815 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccccc1C(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
CHEMBL194044 69815 0 None - 1 Human 6.1 pKi = 6.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 504 7 2 4 5.8 COc1ccccc1C(CNC(=O)Nc1cc(Cl)cc(Cl)c1)N1CCN(C2CCCCC2)CC1 10.1021/jm040827u
44401094 70770 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccc(C(F)(F)F)cc2)c2ccccc2)CC1 10.1021/jm040827u
CHEMBL195488 70770 0 None - 1 Human 5.1 pKi = 5.1 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 391 7 1 3 3.8 CN1CCN(C(CNCCc2ccc(C(F)(F)F)cc2)c2ccccc2)CC1 10.1021/jm040827u
11397231 81037 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 469 7 0 4 6.2 Fc1ccc(SCCCN2CCC(n3c(CC(F)(F)F)nc4cc(F)ccc43)CC2)cc1 10.1016/j.bmc.2012.09.013
CHEMBL2159766 81037 0 None - 1 Human 8.1 pKi = 8.1 Binding
Inhibition of CCR3 receptorInhibition of CCR3 receptor
ChEMBL 469 7 0 4 6.2 Fc1ccc(SCCCN2CCC(n3c(CC(F)(F)F)nc4cc(F)ccc43)CC2)cc1 10.1016/j.bmc.2012.09.013
9797962 65328 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 338 1 0 2 4.8 Brc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
CHEMBL183429 65328 0 None - 1 Human 7.1 pKi = 7.1 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 338 1 0 2 4.8 Brc1ccccc1/C=C1\CCN2Cc3ccccc3N=C12 10.1016/j.bmcl.2004.11.039
44401032 69770 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL194022 69770 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 492 7 2 4 5.8 COc1ccc(C(CNC(=O)Nc2ccc(C(C)(C)C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401234 69483 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 435 9 1 4 4.8 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL193809 69483 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 435 9 1 4 4.8 COc1ccc(C(CNCCc2ccc(C)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721193 115510 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355943 115510 0 None -1 3 Mouse 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from mouse CCR3 transfected in CHO cells
ChEMBL 398 7 2 3 5.2 OCc1[nH]c2ccccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
44401089 123528 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL363181 123528 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 489 9 1 4 5.5 COc1ccc(C(CNCCc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44391268 63553 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 312 1 0 2 4.8 Fc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
CHEMBL180493 63553 0 None - 1 Human 6.0 pKi = 6.0 Binding
Binding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membraneBinding affinity measured for human C-C chemokine receptor type 3 expressed on human K562 cell membrane
ChEMBL 312 1 0 2 4.8 Fc1ccc(/C=C2\CCN3Cc4ccccc4N=C23)c(Cl)c1 10.1016/j.bmcl.2004.11.039
44387857 60694 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.8 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
CHEMBL176281 60694 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 542 6 2 3 6.8 O=C(NCC(c1ccc(C(F)(F)F)cc1)N1CCN(C2CCCCC2)CC1)Nc1cc(Cl)cc(Cl)c1 10.1021/jm040827u
44389729 64003 0 None - 1 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
CHEMBL181232 64003 0 None - 1 Human 6.0 pKi = 6.0 Binding
In vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell lineIn vitro binding affinity against C-C chemokine receptor type 3 expressing in rat Y3 cell line
ChEMBL 458 5 0 2 5.8 Cc1ccccc1CC(=O)N1CCC(N2CCC(Cc3cc(Cl)cc(Cl)c3)CC2)CC1 10.1016/j.bmcl.2005.01.016
118721187 115503 0 None -10 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355936 115503 0 None -10 3 Rat 6.0 pKi = 6.0 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721187 115503 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355936 115503 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 426 8 1 3 6.2 CCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(OC)cc2)CC1 10.1016/j.bmcl.2014.11.063
44400978 135340 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 530 6 2 3 6.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL373092 135340 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 530 6 2 3 6.8 CC(C)(C)c1ccc(C(CNC(=O)Nc2ccc(C(F)(F)F)cc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721203 115530 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355963 115530 0 None 1 3 Human 7.0 pKi = 7.0 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
44400983 70779 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 7 2 4 4.5 COc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL195533 70779 0 None - 1 Human 5.0 pKi = 5.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 436 7 2 4 4.5 COc1ccc(NC(=O)NCC(c2ccccc2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
44401176 68044 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 517 7 2 4 5.9 CN(C)c1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
CHEMBL191696 68044 0 None - 1 Human 6.0 pKi = 6.0 Binding
Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)Inhibition of [125I]eotaxin-1 binding to human chemokine receptor (hCCR3-C1)
ChEMBL 517 7 2 4 5.9 CN(C)c1ccc(C(CNC(=O)Nc2cc(Cl)cc(Cl)c2)N2CCN(C3CCCCC3)CC2)cc1 10.1021/jm040827u
118721190 115506 0 None -5 3 Human 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
CHEMBL3355939 115506 0 None -5 3 Human 7.0 pKi = 7 Binding
Displacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cellsDisplacement of [125J]-eotaxin-1 from human CCR3 transfected in human K562 cells
ChEMBL 416 7 2 3 5.3 OCc1[nH]c2cc(F)ccc2c1C1CCN(CCCSc2ccc(F)cc2)CC1 10.1016/j.bmcl.2014.11.063
118721203 115530 0 None -10 3 Rat 6.0 pKi = 6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
CHEMBL3355963 115530 0 None -10 3 Rat 6.0 pKi = 6 Binding
Displacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cellsDisplacement of [125J]-eotaxin-1 from rat CCR3 transfected in CHO cells
ChEMBL 563 10 0 6 7.4 CCOC(=O)c1ccnc(-n2c(CC)c(C3CCN(CCCSc4ccc(F)cc4)CC3)c3ccc(F)cc32)c1 10.1016/j.bmcl.2014.11.063
795 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
796 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
9913085 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
CHEMBL20921 568 3 None - 1 Human 8.3 pKd None 8.3 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
11753159 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Assay using sodium salt of the compoundAssay using sodium salt of the compound
Guide to Pharmacology 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 23031591
7679 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Assay using sodium salt of the compoundAssay using sodium salt of the compound
Guide to Pharmacology 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 23031591
CHEMBL2158814 542 3 None 1 2 Human 8.2 pKi = 8.2 Binding
Assay using sodium salt of the compoundAssay using sodium salt of the compound
Guide to Pharmacology 525 5 1 5 4.7 Cc1ccc(cc1)S(=O)(=O)NC(=O)N1CCC(CC1)N1CCC(CC1)Oc1ccc(c(c1)Cl)Cl 23031591
10653 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
59534386 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
CHEMBL3670800 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
DB15269 2247 6 None - 1 Human 8.5 pKi = 8.5 Binding
Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.Dissociation constant determined in a scintillation proximity binding assay using recombinant human [<sup>125</sup>]l-eotaxin-1 as radioligand and cell membranes prepared from K562 cells transfected with hCCR3.
Guide to Pharmacology 511 6 1 5 3.6 O=C([C@H]1CCC(=O)N1C1CCN(CC1)Cc1ccc(c(c1)C)Cl)Nc1nc(C)cc(c1)C(=O)N(C)C None
3492 684 0 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 12067561
9868459 684 0 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 12067561
CHEMBL50593 684 0 None - 1 Human 8.1 pKi = 8.1 Binding
UnclassifiedUnclassified
Guide to Pharmacology 451 10 3 4 4.5 CC[C@@H]([C@H]1C[C@H](CCN1CCCNC(=O)Nc1cccc(c1)C(=O)C)Cc1ccccc1)O 12067561
3530 3449 0 None - 1 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 378 6 1 5 3.3 COC(=O)[C@@H](NC(=O)c1ccc2c(c1)cccc2)Cc1ccc(cc1)N(=O)=O None
5311092 3449 0 None - 1 Human 8.4 pKi = 8.4 Binding
UnclassifiedUnclassified
Guide to Pharmacology 378 6 1 5 3.3 COC(=O)[C@@H](NC(=O)c1ccc2c(c1)cccc2)Cc1ccc(cc1)N(=O)=O None
795 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
796 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
9913085 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
CHEMBL20921 568 3 None - 1 Human 8.5 pKi = 8.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology 480 6 2 6 5.1 O=C(NC1CCN(CC1)Cc1ccc(c(c1)Cl)Cl)CSc1nc2c(s1)cc(cc2)N 12450563
758 850 0 None -3 4 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
759 851 0 None 6 4 Human 8.9 pKi = 8.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
787 812 0 None - 1 Human 9.8 pKi = 9.8 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
769 810 0 None 446 2 Human 9.9 pKi = 9.9 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344
771 823 0 None 1 2 Human 7.5 pKi None 7.5 Binding
UnclassifiedUnclassified
Guide to Pharmacology None None None None 8642344